Actinobacillus actinomycetemcomitans and Periodontal Disease (Laboratory and Clinical Studies) by Taher, Ibrahim Abdussalam Abeid
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
ACTINOBACILLUS ACTINOMYCETEMCOMITANS AND PERIODONTAL 
DISEASE (LABORATORY AND CLINICAL STUDIES)
IBRAHIM ABDUSSALAM ABEID TAHER 
BSc (Libya), Dip-Bact., MSc (Manchester, UK)
Thesis Submitted for the Degree of Doctor of Philosophy 
in the Faculty of Medicine,- University of Glasgow 
Department of Oral Medicine and Pathology 
Glasgow Dental Hospital and School
May, 1990 
©  I A A Taher
1
ProQuest Number: 11007346
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 11007346
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
TITLE PAGE
TABLE OF CONTENTS
1
TABLE OF CONTENTS
INDEX OF FIGURES 9
INDEX OF TABLES 11
ACKNOWLEDGEMENTS 17
DECLARATION 18
SUMMARY 19
PREFACE 23
ABBREVIATIONS 24
CHAPTER 1
LITERATURE REVIEW 25
1.1 Historical Review 25
1.2 Morphological Characteristics 2$
1.2.1 Colonial morpholoqy 26
1.2.2 Liaht microscopy 27
1.2.3 Electron microscopy 27
1.3 Biochemical Characteristics 28
1.4 Serolocrical Characteristics 30
1.5 Isolation and Selectivity 32
1. 6 Oral Ecolocrv 33
1.7 Pathogenicity of A .actinomvcetemcomitans 35
1.7.1 Leucotoxic activity of A .actinomvcetemcomitans 35
1.7.2 Chemotaxis suppression 41
1.7.3 Lymphocyte suppression 42
1.7.4 Tissue destruction by A. 
Endotoxin
,actinomycetemcomitans„ 43
43
Collagenase 45
Fibroblasts 46
Epitheliotoxin 46
1.7.5 Adherence 47
1.7.6 Hydrophobicity_______________________  4 9
2
Table of contents continued
1.8 General Infections Related to A.actinomycetem- 
comitans   51
1.9 Periodontal Infections Related to A.actinomycetem-
c omit an s   52
1.9.1 Prepubertal periodontitis_______________________ §2.
1.9.2 Juvenile periodontitis___________________  53
1.9.3 Chronic periodontitis___________________________Jjj1_
1.10 Aims of this study  ._________ 59
CHAPTER 2
THE PREVALENCE OF A . ACTINOMYCETEMCOMITANS 
IN CHRONIC PERIODONTITIS (MICROBIOLOGICAL 
AND CLINICAL STUDIES)__________________  £1
2.1 Introduction____________________________________________61
2 Comparison of selective media 61
2 .2.1 Introduction 61
2 .2.2 Material and Methods 62
2.2.3 Bacteria used to compare the selective media 62
2.2.4 Identification of A.actinomycetemcomitans
strains 62
Microscopic examination (Gram-stain) 62
CO? requirement 63
Catalase test 65
X and V requirements 65
API 20 A System 65
2.2.5 Inoculation procedure 66
2 .2.6 Colonv countina 69
2.2.7 Statistical analysis 72
2 .2.8 Results 72
Comparison of selective media 72
2.2.9 Discussion 77
2 .2.10 Isolation of A.actinomycetemcomitans from 
mixed cultures 80
2 .2.11 Results 81
2 .2.12 Discussion 83
3 Clinical Study 84
2.3.1 Introduction 84
Table of contents continued
2.3.2 Material and methods____________________________ 85
Patients and controls 85
2.3.3 Clinical Assessment 86
Chronic periodontitis patients 86
Healthy volunteers 86
2.3.4 Culture of samples 88
2.3.5 Identification of the freshly isolated 
A.actinomvcetemcomitans strains 88
Colonial morpholocrv 88
API-ZYM test 89
2.3.6 Antimicrobial sensitivity testincr 92
2.3.7 Maintenance of cultures 95
4 Results 98
2.4.1 Isolation of A.actinomycetemcomitans from 
98 patients with chronic periodontitis ._a&
2.4.2 Isolation of A.actinomycetemcomitans from 
healthv control subiects 98
2.4.3 Isolation frequency of A.actinomycetemco­
mitans from 302 sites sampled in 98 patients 99
2.4.4 Viable counts of A.actinomvcetemcomitans 100
2.4.5 Biochemical results of the freshly isolated 
strains of A.actinomvcetemcomitans 108
CM The enzymatic characterization of A.actino­
mvcetemcomitans 108
2.4.7 The prevalence of star-shaped and non-star- 
shaped colonies in primary cultures of 
A.actinomycetemcomitans isolated from 
subcrincrival placrue samples 111
2.4.8 The antimicrobial sensitivity of A.actino­
mvcetemcomitans 116
5 Discussion 118
2.5.1 The prevalence of A.actinomycetemcomitans 
in healthy subjects and chronic periodon­
titis patients 118
(I) Health 118
(II) Chronic Periodontitis 119
(III) Progressive and Non-progressive 
Chronic Periodontitis 121
Table of contents continued
2.5.2 Percentage proportion of A.actinomycetem­
comitans in total microbial counts of 
subgingival plaque in healthy subjects 
and chronic periodontitis 122
(I) Health 122
(II) Chronic Periodontitis 123
(III) Progressive and Non-progressive 
chronic periodontitis 124
2.5.3 Biochemical characteristics of A.actinomy­
cetemcomitans 126
2.5.4 Colonial morphology of A.actinomycetemcomitans 
on primary isolation 127
2.5.5 Antimicrobial susceptibility of A.actino­
mvcetemcomitans 128
2.6 Conclusions 130
CHAPTER 3
ADHERENCE OF A. ACTINOMYCETEMCOMITANS
TO BUCCAL EPITHELIAL CELLS 132
3.1 Introduction_____ '______________________________________132
3.2 Material and methods 133
3.2.1 Determination of bacterial concentration 133
3.2.2 Calculation of of the total number of
bacteria in each suspension 139
3.2.3 Donor 141
.3.2.4 Preparation and clarification of saliva 141
3.2.5 Separation of serum 141
3.2.6 Collection of buccal epithelial cells (BECs) 142
3.2.7 Enumeration of BECs 142
3.2.8 Buccal cell adherence assay 142
3.2.9 Adherence in the presence of saliva 143
3.2.10 Adherence in the presence of serum 144
3.2.11 Adherence of repeatedly subcultured strains 144
3.2.12 Staininq procedure 145
3.2.13 Enumeration of attached bacteria 145
3.2.14 Statistical analysis 146
3.3 Results 147
3.3.1 Determination of A.actinomycetemcomitans
concentration 147
5
Table of contents continued
3.3.2 Adherence of A.actinomycetemcomitans to BECs 150
3.3.3 Effect of saliva on the adherence 
of A.actinomvcetemcomitans to BECs 163
3.3.4 Effect of serum on the adherence 
of A.actinomycetemcomitans to BECs 159
3.3.5 Effect of repeated subculturing on adherence 177
3.4 Discussion 190
3.4.1 Experimental methods 180
3.4.2 Adherence of A.actinomycetemcomitans to BECs 182
3.4.3 Effect of saliva on the adherence of 
A.actinomvcetemcomitans to BECs 184
3.4.4 Effect of serum on the adherence of 
A.actinomvcetemcomitans to BECs 185
3.4.5 Effect of repeated subculturing on adherence 186
3.4.6 Adherence of fresh isolates compared to Type 
strains of A.actinomvcetemcomitans 188
3.4.7 Adherence of A.actinomycetemcomitans to 
other surfaces 189
3.5 Conclusions 190
CHAPTER 4
HYDROPHOBICITY OF A . ACTINOMYCETEMCOMITANS 192
4.1 Introduction 192
4.2 Material and Methods 193
4.2.1 Preparation of A.actinomycetemcomitans 
suspensions 193
4.2.2 Hydrophobicity assay 193
4.2.3 Hydrophobicity of A.actinomycetemcomitans 
after repeated subculturina 195
4.2.4 Effect of suspending media on hydrophobicity 195
4.2.5 Effect of growth conditions on the 
hydrophobicity of the subcultured strains 197
4.2.6 Calculation of hydrophobicity values 197
A.2.1 Statistical analysis 197
4.3 Results 198
4.3.1 Hydrophobicity of A.actinomycetemcomitans 
in SIB 198
4.3.2 Effect of repeated subculturing on 
hydrophobicity________________________  201
4.3.3 Effect of suspending medium on hydrophobicity 201
6
Table of contents continued
4.3.4 Effect of incubation time on hydrophobicity 20 6
4 Discussion
4.4.1 Experimental method 209
4.4.2 Hydrophobicity results 210
4.4.3 Effect of repeated subculturing on 
hydrophobicity 211
4.4.4 Suspendincr medium 212
4.4.5 Acre of culture 213
4.4.6 Correlation between hydrophobicity 
and adherence 214
4.5 Conclusions 218
CHAPTER 5
LEUCOTOXIC ACTIVITY OF A . ACTINOMYCETEMCOMITANS 219
5.1 Introduction 219
5.2 Material and methods 220
5.2.1 Bacterial strains 220
5.2.2 Isolation of polymorphonuclear leucocytes 
(PMNLs) 222
5.2.3 Promyelocytic Leukaemia Cell Line (HL-60) 223
5.2.4 Leucotoxic assay procedure 224
5.2.5 Measurement of cell death by the trypan blue 
exclusion method 226
5.2.6 Measurement of cell death by the Lactate 
dehydrogenase method (LDH) 226
5.2.7 Quantitation of LDH release 228
5.3 Results 231
5.3.1 Leucotoxic activity as measured by trypan 
blue exclusion of five Type strains of 
A .actinomycetemcomitans for HL-60 cells 
after 7 hours exposure 231
5.3.2 Leucotoxic activity as measured by trypan 
blue exclusion of five Type strains of 
A.actinomycetemcomitans for PMNLs after 
7 hours exposure 234
5.3.3 Leucotoxic activity as measured by trypan 
blue exclusion of 12 GDH-strains of 
A. actinomycetemcomitans against HL-60 cells,._
5.3.4 Leucotoxic activity of five strains of A.act­
inomycetemcomitans for HL-60 cells as deter­
mined by both'trypan blue and LDH release.. 241
7
Table of contents continued
5.3.5 Leucotoxic activity of five strains of 
A.actinomycetemcomitans for PMNLs as deter­
mined by both trypan blue and LDH release 244
5.4 Discussion 247
5.4.1 Experimental methods 247
5.4.2 Factors affecting the leucotoxicity of 
A.actinomycetemcomitans 248
Effect of media 249
Effect of bacteria concentration 250
Whole cells 250
Sonic extracts 253
Effect of exposure time 257
Effect of temperature 259
Type of tarcret cells 259
Criteria used to determine leucotoxicity ..261
Trypan Blue Exclusion 261
LDH release 262
5.4.3 Leucotoxic activity of fresh isolates of 
A.actinomvcetemcomitans 264
5.4.4 Leucotoxic activity of Type strains of 
A.actinomvcetemcomitans 267
5.4.5 Action of leucotoxin 269
5.5 Conclusions 270
CHAPTER 6
GENERAL DISCUSSION 272
6.1 Introduction 272
6.2 Adherence and hydrophobicity 272
6.2.1 Adherence 272
6.2.2 Hydrophobicity 275
6.3 Morphological and Biochemical characteristics
of A. actinomycetemcomitans ______________________  27 6
6.4 Detection and Distribution of A.actinomycetemcomit­
ans in healthy and chronic periodontitis patients 27 8
6.4.1 Prevalence of A. actinomycetemcomitans__________27 8
6.4.2 Leucotoxicity__________________  280
APPENDIX I Media preparation................. .........286
APPENDIX II Buffers and Stains___________ 296
BIBLIOGRAPHY 301
INDEX OF FIGURES
Figure 2.1 API 20 A strip (System) used for the bioche­
mical identification of A.actinomycetemcomitans.
The control test (E) shows no change in colour, 
while the test strips (A, B, C & D) show four 
different biochemical profiles ._______________________ 67
Figure 2.2 Strains of A.actinomycetemcomitans cultured 
in thioglycollate broth; the type strain Y4 shown
here produced uniform turbidity while the fresh
isolates GDH 87034 & GDH 1115 show marked
aggregation.___________________________________________ 68
Figure 2.3 Spiral plater model D used for inoculating
agar plates._______________________________________ 70
Figure 2.4 A manual grid used in conjunction with the 
spiral plater for counting bacterial colonies in 
different zones on agar plates._______________________7JL
Figure 2.5 Chart for the isolation and identification
of A. actinomycetemcomitans.___________________________ 87
Figure 2.6 Variations in the colonial morphology of 
A.actinomycetemcomitans strains selected for 
isolation and i d e n t i f i c a t i o n .  90
Figure 2.7 API-ZYM strip inoculated with A.actino­
mycetemcomitans (the test (A) shows change in 
colour, while the control (B) remains unchanged) . 9JL
Figure 2.8 Diagrammatic representation of an antimi­
crobial sensitivity test plate using Stoke1s 
method before incubation._____________________________ 9^.
Figure 2.9 A DST agar plate inoculated with the test 
organism.A.actinomycetemcomitans and S .aureus 
NCTC 6571 as a control, for sensitivity testing 
of amoxycillin, erythromycin, tetracycline, 
penicillin and metronidazole, using Stoke's method. 96
Figure 3.1 DEFT-Filter unit which was used in the 
determination of bacterial concentration and 
in adherence studies.__________________________  138
Figure 3.2 An example of a typical plot used to
determine the optical density of Aa 02. A suspe­
nsion containing 1 x 10® bacteria/ml is equivalent 
to an optical density of 0.042 at 520 nm. _________ 140
Figure 3.3 A.actinomycetemcomitans adhering to buccal 
epithelial cell in vitro, stained with acridine 
orange, examined at 1000 magnification .    152
9
Index of Figures continued
Figure 3.4 Distribution of the number of Aa 03 (NCTC-
10979) cells adhering to 150 buccal epithelial 
cells in SIB, (the data represent the combined 
results from three different experiments) .___________ 159
Figure 3.5 Distribution of the number of Aa 18 (GDH- 
1014) cells adhering to 150 buccal epithelial 
cells in SIB, (the data represent the combined 
results from three different experiments) .___________ 160
Figure 3.6 Distribution of the number of Aa 18 (GDH-
1014) cells adhering to 150 buccal epithelial cells 
in the presence of saliva, (the data represent the 
combined results from three different experiments) 167
Figure 3.7 Distribution of the number of Aa 09 (GDH-
143) cells adhering to 150 buccal epithelial cells 
in the presence of serum, (the data represent the 
combined results from three different experiments) 173
Figure 4.1 Diagrammatic representation of the
hydrophobicity assay used in this study._____________196
Figure 5.1a HL-60 cells stained by trypan blue 
after 60 minutes exposure to whole cells of 
A. actinomycetemcomitans (Aa 40)._____________________ 22 9
Figure 5.1b HL-60 cells stained by trypan blue after 
60 minutes minutes incubation in Hanks Balanced 
Salt Solutions buffer.________________________________229
Figure 5.2 An example of a graph used for measuring 
lactate dehydrogenase from PMNLs using whole 
cells of Aa 40 (GDH 1224) . The optical density 
of the pyruvate substrate (not shown) was 0.6 
at 450 nm..................................... ........2,30
Figure 5.3 Leucotoxic activity of five Type strains 
of A.actinomycetemcomitans for HL-60 cells over 
a period of 7 hours using the trypan blue 
exclusion method (figures represent the mean of 
three different experiments after subtracting the 
% dead cells in control assays .;___________________ 233
10
INDEX of TABLES
Table 1.1 Biochemical characteristics of A.actinomy­
cetemcomitans and H.aphrophilus._____________________ 29
Table 1.2 Summary of the different serogroups and
biotypes of A.actinomycetemcomitans described in
the literature. _____________________________________ £1.
Table 1.3 Potentially important pathogenic factors
produced by A. actinomycetemcomitans strains.________ 40
Table 1.4 The occurrence of A.actinomycetemcomitans in 
subgingival plaque collected from chronic 
periodontitis patients._______________________________58
Table 2.1 A.actinomycetemcomitans strains used in
the selective media study.____________________________6j4
Table 2.2 log^Q cfu/ml of 17 A.actinomycetemcomitans 
strains recovered on CBA, TSBV and MGB agar 
plates (figures represent the mean of two 
observations) . Experiment No. 1.____________________ 73
Table 2.3 log]_o cfu/ml of 17 A. actinomycetemcomitans 
strains recovered on CBA, TSBV and MGB agar 
plates (figures represent the mean of two 
observations). Experiment No. 2 . ____  74
Table 2.4 log^o cfu/ml of 17 A.actinomycetemcomitans 
strains recovered on CBA, TSBV and MGB agar 
plates (figures represent the mean of two 
observations) . Experiment No. 3.____________________ 75
Table 2.5 Summary of the mean log]_g cfu/ml of 17 
A.actinomycetemcomitans strains recovered 
on CBA, TSBV and MGB agar plates (figures 
represent the mean of three experiments) .  76.
Table 2.6 Isolation of A.actinomycetemcomitans
from mixed samples using both TSBV and MGB media. 82
Table 2.7 Antimicrobial agents used for testing the
sensitivity patterns of A. actinomycetemcomitans.____ 94.
Table 2.8 Age range and prevalence of A.actinomy­
cetemcomitans isolated from 98 patients with 
chronic periodontitis.______________________  101
Table 2.9 Age range and prevalence of A.actinomy­
cetemcomitans isolated from 55 male and female 
control subjects.___________________________ 102
Table 2.10 Isolation frequency of A.actinomycetem­
comitans in the upper posterior segments of male 
and female patients.____________________  103
11
Index of Tables continued
Table 2.11 Isolation frequency of A.actinomycetem-
comitans in the lower posterior segments of male 
and female patients. ___________________________
Table 2.12 Isolation frequency of A.actinomycetem­
comitans in the anterior segments of male and 
female patients.   1Q4
Table 2.13 Summary of the isolation frequency of
A.actinomycetemcomitans in the different oral 
segments of male and female patients.__________|_____ 105
Table 2.14 Viable counts of A.actinomycetemcomitans 
(log^o cfu/ml) on TSBV from subgingival plaque 
samples of male patients.__________________ 1Q6
Table 2.15 Viable counts of A.actinomycetemcomitans 
(log^o cfu/ml) on TSBV from subgingival plaque 
samples of female patients 107
Table 2.16 Summary of the biochemical results for the 
38 freshly isolated A.actinomycetemcomitans 
strains as determined by the API 20 A system.
Table 2.19 The prevalence of star-shaped and non-star 
shaped colonies of A.actinomycetemcomitans and
H .aphrophilus in subgingival plaque samples on 
primary isolation on TSBV medium from 31 patients. 114
Table 2.20 The effect of five antimicrobial agents 
on A .actinomycetemcomitans (results represent 
duplicate readings of inhibition zones using 
S . aureus NCTC 6571 as control) ._______________ 117
Table 3.1 List of A .actinomycetemcomitans strains
used in adherence and hydrophobicity studies. 135
Table 3.2 Dilutions made to determine the total
counts of bacteria. __________   137
Table 3.3 Summary of the optical densities at
a concentration of 10® bacteria/ml obtained 
for A .actinomycetemcomitans strains used in 
the adhesion experiments.,______ ___________  148
Table 2.17 Summary of the enzymatic characteristics 
of A.actinomycetemcomitans (26 strains) 
as determined by the API ZYM system.
Table 2.18 The prevalence of star-shaped and non­
star-shaped strains of A.actinomycetemcomitans 
in subgingival plaque samples on primary 
isolation on TSBV medium from 31 patients.____ 112
12
Index of Tables continued
Table 3.4a An example of the raw adherence data
obtained for Aa 03 (data represent the number 
of bacteria/BEC for test and control in SIB).
Experiment No. 1._____________________________________ 153
Table 3.4b An example of the raw adherence data
obtained for Aa 03 (data represent the number 
of bacteria/BEC for test and control in SIB).
Experiment No. 2.____________________________ ._________154
Table 3.4c An example of the raw adherence data
obtained for Aa 03 (data represent the number 
of bacteria/BEC for test and control in SIB).
Experiment No. 3._____________________________________ 155
Table 3.5a An example of the raw adherence data
obtained for Aa 18 (data represent the number 
of bacteria/BEC for test and control in SIB).
Experiment No. 1._____________________________________ 156
Table 3.5b An example of the raw adherence data
obtained for Aa 18 (data represent the number 
of bacteria/BEC.for test and control in SIB).
Experiment No. 2._____________________________________ 157
Table 3.5c An example of the raw adherence data
obtained for Aa 18 (data represent the number 
of bacteria/BEC for test and control in SIB).
Experiment No. 3._____________________________________ 158
Table 3.6 Summary of the adherence results for 
A.actinomycetemcomitans strains to buccal 
epithelial cells in SIB_____buffer.__________________ 161
Table 3.7a. An example of the raw adherence data
obtained for Aa 18 (data represent the number 
of bacteria/BEC in the presence of saliva for 
test and control assays) . Experiment No. 1._________ 164
Table 3.7b An example of the raw adherence data
obtained for Aa 18 (data represent the number 
of bacteria/BEC in the presence of saliva for 
test and control assays) . Experiment No. 2.  165
Table 3.7c An example of the raw adherence data
obtained for Aa 18 (data represent the number 
of bacteria/BEC in the presence of saliva for 
test and control assays) . Experiment No. 3._________166
Table 3.8 Summary of the adherence results for 
A.actinomycetemcomitans strains to buccal 
epithelial cells in the presence of saliva.___________168
13
Index of Tables continued
Table 3.9a An example of the raw adherence data
obtained for Aa 09 (data represents the number 
of bacteria/BEC in the presence of serum for 
test and control assays). Experiment No. 1. 170
Table 3.9b An example of the raw adherence data
obtained for Aa 09 (data represents the number 
of bacteria/BEC in the presence of serum for 
test and control assays) . Experiment No. 2. 171
Table 3.9c n example of the raw adherence data
obtained for Aa 09 (data represents the number 
of bacteria/BEC in the presence of serum for 
test and control assays). Experiment No. 3. 172
Table 3.10 Adherence of A .actinomycetemcomitans 
to buccal epithelial cells in SIB. 174
Table 3.11 Adherence of A .actinomycetemcomitans to
buccal epithelial cells in the presence of serum._ 175
Table 3.12 Comparison of adherence of A.actinomy­
cetemcomitans to buccal epithelial cells in 
SIB and in the presence of serum. 176
Table 3.13 Adherence of rough (fresh) strains of 
A.actinomycetemcomitans to buccal epithelial 
cells in SIB. 178
Table 3.14 Adherence of smooth (subcultured) variants 
of A.actinomycetemcomitans to buccal epithelial 
cells in SIB. 178
Table 3.15 Comparison of adherence between rough and 
smooth variants of A.actinomvcetemcomitans. 179
Table 4.1 Hydrophobicity results of 33 strains of 
A.actinomvcetemcomitans in SIB buffer. 179
Table 4.2 Hydrophobicity of the four rough (fresh) 
isolates of A.actinomycetemcomitans strains 
before subculture. 202
Table 4.3 Hydrophobicity of four A.actinomycetem­
comitans strains after 50 repeated subcultures 
over a period of 16 weeks (smooth forms). 202
Table 4.4 Comparison of the hydrophobicity of rough and 
smooth colonial forms of A.actinomycetemcomitans. 203
Table 4.5 Hydrophobicity of three strains of 
A.actinomycetemcomitans in SIB buffer. 2Q4
14
Index of Tables continued
Table 4.6 Hydrophobicity of three strains of
A. actinomycetemcomitans in PBS buffer._______________204
Table 4.7 Comparison of hydrophobicity of three strains
of A.actinomycetemcomitans in SIB and PBS buffer. 205
Table 4.8 Hydrophobicity of of A.actinomycetemcomitans
after incubation for 24 hours on CBA.________________207
Table 4.9 Hydrophobicity of A.actinomycetemcomitans
after incubation for 48 hours on CBA.________________207
Table 4.10 Comparison of hydrophobicity of
A.actinomycetemcomitans after incubation
for 24 and 48 hours on CBA.  208
Table 4.11 Comparison between A.actinomycetemcomitans 
adherence to buccal epithelial cells and hydro­
phobicity.____________________________________________ 216
Table 5.1 A.actinomycetemcomitans strains used
in the leucotoxicity studies .________________________ 221
Table 5.2 The constituents of the test and control
tubes in the leucotoxic assays.______________________ 22$
Table 5.3 Leucotoxic activity of five Type strains of 
A.actinomycetemcomitans for HL-60 cells at zero 
time (the data represent the mean of three 
different experiments)._____________________________
Table 5.4 Leucotoxic activity of five Type strains of 
A.actinomycetemcomitans for HL-60 cells after 7 
hours exposure (the data represent the mean of 
three different experiments). ______________________232
Table 5.5 Leucotoxic activity of five Type strains of 
A .actinomycetemcomitans for PMNLs at zero 
time (the data represent the mean of three
different experiments) .______ ______________________ 235
Table 5.6 Leucotoxic activity of five Type strains of 
A.actinomycetemcomitans for PMNLs after 7 hours 
exposure (the data represent the mean of three 
different experiments) ._________  235
Table 5.7 Summary of the leucotoxic activity on both 
HL-60 cells and PMNLs after 7 hours exposure to 
five Type strains of A. actinomycetemcomitans ._______ 236
Table 5.8 Leucotoxic activity of 12 GDH strains 
of A.actinomycetemcomitans for HL-60 cells 
at zero time (figures represent the mean of 
three different experiments) ..................   2,3.7
15
Index of Tables continued
Table 5.9 Leucotoxic activity of 12 GDH strains 
of A.actinomycetemcomitans for HL-60 cells 
after 60 minutes exposure (figures represent 
the mean of three different experiments) .____________238
Table 5.10 Leucotoxic activity of 12 GDH strains 
of A.actinomycetemcomitans for HL-60 cells 
after 120 minutes exposure (figures represent 
the mean of three different experiments) .____________239
Table 5.11 Summary of the leucotoxic activity
of 12 GDH strains of A.actinomycetemcomitans 
for HL-60 cells.______________________________
Table 5.12 Leucotoxic activity of five strains of 
A.actinomycetemcomitans for HL-60 cells after 
60 minutes exposure as determined by trypan 
blue exclusion method.________________________________242
Table 5.13 Leucotoxic activity of five strains of 
A.actinomycetemcomitans for HL-60 cells after 
60 minutes exposure as determined by lactate 
dehydrogenase release.________________________________2.4.3
Table 5.14 Leucotoxic activity of five strains of 
A.actinomycetemcomitans for PMNLs after 60 
minutes exposure as determined by trypan 
blue exclusion method.________________________________245
Table 5.15 Leucotoxic activity of five strains of 
A.actinomycetemcomitans for PMNLs after 60 
minutes exposure as determined by lactate 
dehydrogenase release.  245
Table 5.16 Summary of the leucotoxic activity of five 
strains of A.actinomycetemcomitans for PMNLs 
and HL-60 cells after 60 minutes exposure as 
determined by lactate dehydrogenase release 
and trypan blue exclusion.________________    246,
Table 5.17 Leucotoxic activity of A.actinomycetem­
comitans determined by different research groups  ...25.4.
16
ACKNOWLEDGE M E NTS
i would like io  express my sincere g ra i i fude  to Dr. T.W 
Macfar lane fo r  bis invaluable advice, guidance, cr i t ic ism  
and encouragement throughout  this study.
Special thanks are due to Mr. W.M.M Jenkins (Per io-  
dontology uni t ,  Glasgow Dental Hospital  and School) fo r  
his help in the cl inical  study in carrying out  the examin­
at ion o f  pat ients and in supplying specimens.
Many thanks are due also to  Mr. W Marshal l  and Mr. D 
Mackenzie fo r  thei r  help.
Ibrahim
17
d e c l a r a t i o n
None o f  the work presented in th is  thesis has been 
subm i t ted  in support  o f  an appi icat ion  f o r  another  
degree o f  this or  another  un ivers i ty  or in s t i tu t ion  o f  
learning.
The author,
I A A Taher
18
SUMMARY
Actinobacillus actinomycetemcomitans has been regarded as 
one of the major microbiological aetiological agents in cer­
tain types of human periodontal disease especially Localized 
Juvenile Periodontitis. However, relatively few reports are 
available concerning its prevalence in chronic periodon­
titis, and there is some doubt concerning the laboratory 
methods used to isolate and identify A.actinomycetemcomitans 
from subgingival plaque.
In the present investigation the ability of two semi-selec­
tive media (TSBV and MGB) to isolate A.actinomycetemcomitans 
from dental plaque samples was examined. TSBV medium was 
found to be less inhibitory with pure cultures and more sel­
ective in mixed cultures than MGB. In the laboratory, the 
presence of star-shaped colonies on primary culture plates 
is commonly used to differentiate A .actinomycetemcomitans 
from other bacteria, even although non-star-shaped variants 
are known to occur. Since there is no information concer­
ning the presence of star-shaped and non-star-shaped colon­
ies on primary isolation by A .actinomycetemcomitans in the 
literature, the prevalence of both colonial forms of 
A .actinomycetemcomitans on primary culture on TSBV medium 
was investigated in a subgroup of samples collected from 
patients with chronic periodontitis (see below) . Surpri­
singly more than half of the isolates (52%) produced non- 
star-shaped colonies, the remainder having the star-shaped 
format. As a result if only star-shaped colonies had been 
selected for identification in this thesis, the prevalence
19
data for the chronic periodontitis patients would have been 
reduced from 38 to 19 patients. Since no standard method 
for identifying A.actinomycetemcomitans was available, the 
API 20 A system was used in this thesis. Four different 
biochemical profiles were obtained, and the system was found 
to be simple to use and gave reproducible results.
In a clinical study of the prevalence of A .actinomycetem­
comitans in 98 patients with chronic periodontitis (302 sub­
gingival samples), the organism was isolated from 39% of 
patients and from 27% of the total samples collected. Howe­
ver, in a healthy control group of 55 volunteers only one 
(2%) of the subjects possessed A.actinomycetemcomitans. In 
the chronic periodontitis group there were 55 females and 43 
males, and although A.actinomycetemcomitans was isolated 
overall from more sites in male patients (60%) compared to 
female patients (40%), the distribution of A.actinomycetem­
comitans was found to be similar in both groups. In general 
there were no clear differences between the prevalence of 
A.actinomycetemcomitans in the six different segments samp­
led in the 98 patients.
Although adherence and hydrophobicity are believed to play 
an important role in the pathogenicity of a number of bact­
eria, little is known about these properties with regard to 
A.actinomycetemcomitans. In addition, previously published 
studies have used small numbers of strains. In the present 
investigation the ability of 33 strains of A.actinomycetem­
comitans to adhere to human buccal epithelial cells in the 
presence of Saliva Ions Buffer (SIB), clarified mixed saliva
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and serum, using an epifluorescence technique was assessed 
in vitro. The hydrophobicity of the same 33 strains was 
assessed using adsorption to xylene. The adherence results 
clearly showed that overall A.actinomycetemcomitans can adh­
ere well to buccal epithelial cells in vitro and in compara­
ble numbers when experiments were performed in mixed saliva 
and in SIB. The adherence values were 12.7 and 12.0 adher­
ent bacteria per buccal epithelial cell respectively. Simi­
larly there was no significant difference between the adher­
ence of fresh isolates (mean 13.3 bacteria) compared to the 
Type strains' (10.7) . The addition of human serum to the 
adherence assay system significantly inhibited the adherence 
of A.actinomycetemcomitans strains to buccal cells (p 
<0.0005). All isolates of A.actinomycetemcomitans were hyd­
rophobic and produced a reduction in absorbance which ranged 
from 39% to 82% (mean 67%) . No significant difference 
between the hydrophobicity of fresh and Type strains of 
A.actinomycetemcomitans was found. When the adherence to 
buccal epithelial cells and hydrophobicity results for each 
strain were compared a significant overall correlation (p 
<0.05) was found. These results tend to confirm the view 
that hydrophobicity and adherence to buccal cells are 
related.
The pathogenicity of A.actinomycetemcomitans has been rela­
ted to its ability to produce a number of toxic factors, 
especially leucotoxin. The leucotoxic activity of twelve 
fresh isolates and six Type strains of A.actinomycetemcomi­
tans against human polymorphonuclear leucocytes (PMNLs) or a
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promyelocyte cell line (HL-60) was investigated using the 
trypan blue exclusion or lactate dehydrogenase release (LDH) 
methods, in vitro. Only one of the fresh isolates of 
A.actinomycetemcomitans (Aa 40) was found to be leucotoxic 
for both HL-60 cells and PMNLs as monitored by both detect­
ion methods. The other fresh isolates failed to show any
definite toxic activity. The Type strains were leucotoxic
negative for both PMNLs and HL-60 cells. In view of the
previous literature these results were unexpected and the 
possible reasons for the discrepancies between this study 
and that of previous workers are discussed in full. There 
is no agreed method of testing strains of A.actinomycetem­
comitans for leucotoxicity, and no criteria for categorizing 
strains as leucotoxic positive or negative. In view of the 
apparent importance of this organism in some types of perio­
dontal disease, appropriate methods and criteria should be 
developed in the near future.
In conclusion, although it appears that much is known about 
the ecology and pathogenicity of A.actinomycetemcomitans in 
the human mouth, the results of this study suggest that the 
current state of knowledge is far from complete, and that a 
substantial effort is needed, initially in relation to meth­
odology, and later in linked clinical-laboratory studies, 
before this area will become clear.
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ABBREVIATIONS
Aa: Actinobacillus actinomycetemcomitans 
ABB: Anaerobic Blood Broth Supplemented 
ATCC: American Type Culture Collection 
BECs: Buccal Epithelial Cells 
CBA: Columbia Blood Agar
cfu/ml: Colony forming units per millilitre
DST: Diagnostic Sensitivity Agar
HBSS: Hanks Balanced Salt Solutions
LDH: Lactate dehydrogenase
LJP: Localized Juvenile Periodontitis
MGB: Malchite Green Bacitracin Agar
NCTC: National Collection of Type Cultures
O.D: Optical Density
p: Probability
±SEM: Standard error of mean
PBS: Phosphate Buffered Saline
PMNLs: Polymorphonuclear leucocytes
SIB: Saliva Ions Buffer
TGB: Thioglycollate Broth
TSBV: Tryptic Soy-Serum-Bacitracin-Vancomycin Agar
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CHAPTER 1
LITERATURE REVIEW
1.1 Historical Review
Actinobacillus actinomycetemcomitans was first described in 
1912 by the German microbiologist Klinger who isolated the 
organism from a case of cervicofacial actinomycosis. A.act- 
inomycetemcomitans has been closely associated and frequ­
ently present with Actinomyces israelii in actinomycotic 
lesions (Klinger, 1912; Colebrook, 1920) and Holm (1951) 
proposed that actinomycosis should be regarded as a mixed 
infection of these two microorganisms. The original name 
given to the A .actinomycetemcomitans was Bacterium actinomy- 
cetum comitans (Klinger, 1912). This was changed to Bact­
erium comitans (Lieske, 1921) and later to Actinobacillus 
actinomycetemcomitans (Topley and Wilson, 1929). However, 
in view of genetic and serological relationships and pre­
vious inclusion of X and V factor independent bacterial spe­
cies in the genus Haemophilus, A .actinomycetemcomitans was 
reassigned to the genus Haemophilus actinomycetemcomitans by 
Potts, Zambon and Genco (1985). However, this has not been 
widely accepted and both terms are in use at present.
Until recently little was known about the pathogenicity of 
A .actinomycetemcomitans, although it was described as non- 
pathogenic for laboratory animals (Buchanan and Gibbons, 
1974) . Pathogenicity for man was thought to be doubtful, 
since it occurs usually in combination with A. israelii 
(Heinrich and Pulverer, 1959 b; Buchanan and Gibbons, 1974).
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Thus A . actinomycetemcomitans was regarded as a harmless 
member of the oral microflora which could occasionally cause 
pyogenic infections either alone (Thjotta and Sydnes, 1951) 
or in mixed culture with A.israelii (Heinrich and Pulverer, 
1959b) . The organism has also been recovered from severe 
non-oral infections (see section 1.6.1).
Kilian and Schiott (1975) reported that A .actinomycetemco­
mitans was indigenous to dental plaque, whereas, studies by 
Slots, Reynolds and Genco (1980a) indicated that subgingival 
dental plaque (especially from periodontal pockets) and the 
buccal mucosa were the organism's main oral ecological nic­
hes . During the past ten years studies have demonstrated a 
close association between juvenile periodontitis and the pr­
esence of A .actinomycetemcomitans (see review by Zambon, 
1985, and section 1.7.3).
1.2 Morphological Characteristics
1.2.1 Colonial morphology
Fresh isolates cultured on solid media form small colonies 
about 0.5-1.0mm in diameter. Colonies are usually convex, 
circular, translucent and glistening with a slightly irreg­
ular edge (Slots et al., 1980a; Slots, 1982a; Zambon, 1985). 
In addition, the internal shape of colonies is often descri­
bed as "star-shaped" (Colebrook, 1920) or as "crossed- 
cigars" (Heinrich and Pulverer, 1959a). Other studies have 
also reported similar findings (Mandell and Socransky, 1981; 
Slots, 1982b). However, not all isolates of A .actinomy­
cetemcomitans possess this cultural morphology, since non­
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star-shaped variants have also been observed (Mandell and 
Socransky, 1981; Slots, 1982b). On primary isolation 
colonies tend to adhere to the agar surface and are diffi­
cult to emulsify, but become mucoid and non-adherent after 
repeated subculturing (Buchanan and Gibbons, 1974; Slots, 
1982a). Rosan et al., (1988) reported similar observations 
where some freshly isolated A .actinomycetemcomitans strains 
showed a "cross" or "star-shaped1 interior structure which 
was lost after repeated subculturing in vitro. In addition 
these non-star-shaped strains, adhered weakly to the agar 
surface, grew rapidly in broth cultures and formed uniform 
suspensions (Rosan et al., 1988).
1.2.2 Light microscopy
A .actinomycetemcomitans cells are Gram-negative, non motile, 
spheres or rods. They measure about 1.0-1.5 by 0.4-0.5|lm in 
size (Slots, 1982a). Cells may occur singly, in pairs or in 
small clumps (Zambon, 1985) . In older cultures or after 
repeated subculturing longer cells may be produced by some 
strains (Slots, 1982a).
1.2.3 Electron microscopy
The ultrastructure of A.actinomycetemcomitans using transmi­
ssion electron microscopy is similar to that of other Gram- 
negative bacteria consisting of an outer cytoplasmic memb­
rane, a periplasmic space and an inner cytoplasmic membrane 
(Holt, Tanner and Socransky, 1980) . The outer membrane is 
covered by a ruthenium staining polymeric material (Holt et 
al., 1980) which is said to be a possible carbohydrate
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microcapsule (Zambon, Slots and Genco, 1983a). In addition 
membrane vesicles, ("blebs") are present in large numbers 
which are probably derived from the outer cytoplasmic memb­
rane. Morphologically these structures are identical to 
lipopolysaccharide vesicles being released into the external 
environment during growth (Holt et al., 1980; Lai, Listga-
rten and Hammond, 1981; Nowotny et al., 1982) . Scanning
electron microscopy has also revealed the presence of surf­
ace projections and amorphous surface material which cover 
and connect adjacent cells (Holt et al., 1980) . Further
studies have revealed the presence of fimbriae on freshly 
isolated A.actinomycetemcomitans strains (Scannapieco, Korn- 
man and Coykendall, 1983; Scannapieco et al., 1987; Preus,
Namork and Olsen, 1988; Rosan et al., 1988).
1.3 Biochemical Characteristics
The biochemical characteristics of A . actinomycetemcomitans 
are summarized in (Table 1.1). Members of the species are 
fermentative, non-haemolytic, indole negative and produce 
catalase. Although many sugars and carbohydrates have been 
tested, A.actinomycetemcomitans is limited in its saccharo- 
lytic activity. However, the results in Table 1.1 highlight 
the sugar fermentation reactions which are useful in identi­
fication. A.actinomycetemcomitans can be distinguished from 
other bacteria such as, Haemophilus species by its ability 
to grow in the absence of X (haemin) or V (nicotinamide ade­
nine dinucleotide). Using biochemical tests it can also be 
differentiated from other X and V factor independent organi­
sms like Haemophilus aphrophilus (see Table 1.1). Most wor-
28
Table 1.1 Biochemical characteristics of A. actinomy­
cetemcomitans and H.aphrophilus
Test A.actinomycetemcomitans H.aphrophilus
Catalase + -
Nitrate + +
Glucose + +
Galactose V +
Lactose - +
Maltose V +
Mannitol V -
Xylose V
Sucrose - +
Trehalose - +
Raffinose - +
Glycerol - +
Starch V +
|2-glucosidase - +
(3 -galactosidase - +
Sodium fluoride _ +
+: Positive reaction 
Negative reaction 
V: Variable reaction
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kers have reported similar biochemical profiles for A.actin- 
omycetemcomitans (King and Tatum, 1962; Sneath and Johnson, 
1973; Buchanan and Gibbons, 1974; Kilian and Schiott, 1975; 
Kilian and Frederisken, 1981; Slots, 1982a). However, 
Tanner et al., (1982) reported that three (16%) of their 
A . actinomycetemcomitans strains did not decompose hydrogen 
peroxide.
1.4 Serological Characteristics
Most studies have found 3 different serogroups using a vari­
ety of techniques including tube precipitation (Slots et 
al., 1980a), immunodiffusion and indirect immunofluoresence 
(Zambon et al., 1983a) and monoclonal antibodies (McArthur, 
Stroup and Wilson, 1986) (see Table 1.2) . Some of these 
groups were said to be similar eg. the serogroups a, b and c 
of Zambon et al., (1983a) and those of King and Tatum 
(1962). A.actinomycetemcomitans serogroups a and b are most 
commonly found in the human oral cavity, while serotype c 
accounts for only 10% of oral isolates. However, serotype a 
is mainly present in samples from patients with localized 
juvenile periodontitis suggesting that this serotype may be 
important in the pathogensis of this disease (Zambon et al., 
1983a). Zambon and Jones (1987) indicated that all 3 sero­
types described above (a, b and c) are predominantly mannose 
containing polysaccharide antigens.
A .actinomycetemcomitans possess at least one common antigen 
(King and Tatum, 1962 ; McArthur et al., 1982), which is
shared with other members of the Actinobacillus genus eg. A.
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suis and A .equuli (Zambon et al . , 1983a) and one other
antigen shared with H .aphrophilus (McArthur et al., 1982;
Zambon et al., 1983a).
1.5 Isolation and Selectivity
A useful approach to help determine the role of an organism 
in the aetiology of a particular disease is to study its 
prevalence and numbers in diseased and healthy sites. It is 
very difficult using non selective culture media such as 
blood agar to isolate and enumerate A.actinomycetemcomitans 
from subgingival plaque samples. Therefore two different 
semi-selective media have been developed.
The medium developed by Slots et al., (1980a) contained try- 
pticase soy agar, supplemented with 75|lg/ml bacitracin, 10% 
heat-inactivated horse serum, 0.1% yeast extract and 0.2% 
glucose. This medium was later improved by Slots (1982b) by 
the addition of 5 mg/ml vancomycin and removal of glucose 
(TSBV). Slots (1982b) showed that at least as many colonies 
of A.actinomycetemcomitans were isolated from subgingival 
plaque samples on this semi-selective medium compared with 
enriched brain heart infusion blood agar. The new selective 
medium (TSBV) also suppressed the growth of most other 
bacteria present in plaque and it was possible for A .actino­
mycetemcomitans to be distinguished from other species isol­
ated by colonial morphology and catalase activity.
In 1981 Mandell and Socransky developed a medium composed of 
tryptic soy agar 40g/litre, bacitracin 128|lg/ml, malachite 
green 8 jig/ml and 5% defibrinated sheep blood (MGB) . The
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MGB when incubated in air plus 10% CO2 gave a recovery rate 
of 83-99% of pure cultures of A.actinomycetemcomitans when 
compared to non selective media. The efficacy of both MGB 
and TSBV media in recovering A .actinomycetemcomitans from 
periodontal pockets and the ability of laboratory strains to 
grow on both media were compared by Van Steenbergen et al., 
(1986). The results showed that the highest colony forming 
units/ml were obtained on Blood agar, TSBV and MGB media 
respectively. Low counts were detected on MGB and six str­
ains of A .actinomycetemcomitans did not grow on this medium 
(Van Steenbergen et al., 1986) . In addition the colony 
characteristics of A .actinomycetemcomitans were easily reco­
gnized and colonies appeared larger on TSBV than on MGB 
medium. Further attempts were made to improve the selecti­
vity of both TSBV and MGB media by adding other drugs such 
as spiramycin, carbenicillin and fusidic acid to TSBV (Holm 
et al., 1987), or penicillin to both MGB and TSBV (Riches
and Marsh, 1987). However, the addition of these agents to 
both media did not significantly improve their selectivity 
(Holm et al., 1987; Riches and Marsh, 1987).
1.6 Oral Ecology
The mouth contains several ecological niches available for 
bacterial growth, these include the buccal mucosa, tongue, 
hard and soft palate, gingiva, gingival crevice, teeth and 
saliva, as well as dentures and various filling materials 
(Gibbons, 1984). The oral cavity contains very few organ­
isms at birth but shortly thereafter, various bacteria colo­
nize these oral sites (Christersson et al., 1985) . After
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tooth eruption, additional bacterial species are acquired 
from the mother and other family members and colonize the 
tooth surface and newly formed gingival sulcus (Socransky 
and Manganiello, 1971; Berkwoitz and Jordan, 1975). Howe­
ver, for a microorganism to colonize the human mouth, cert­
ain requirements have to be met, such as variation in tempe­
rature, oxidation-reduction potential, pH and nutrition 
(Slots and Genco, 1984) . Other factors include serum or 
saliva components (Gibbons, 1980), growth conditions (Peros 
and Gibbons, 1981) and salivary enzymes of bacterial origin 
(Nakamura and Slots, 1983). In addition persistent coloni­
zation in the mouth requires the bacteria to become suffi­
ciently attached to oral surfaces to avoid removal by the 
mechanical washing action of saliva and the crevicular fluid 
together with other cleansing mechanisms (Van Houte, 1983).
Dental plaque can be defined as a complex mixed microbial 
community which forms on hard surfaces within the mouth con­
sisting predominantly of extracellular polymers synthesized 
by bacteria and macromolecules derived from saliva, crevi­
cular fluid and dietary sources in the mouth (Fitzgerald, 
1985) . Saliva is believed to play a central role in the 
microbial ecology of the mouth; it protects mucosal surfaces 
from desiccation (Tabak et al., 1982), and may modulate
bacterial adhesion and aggregation to oral surfaces (Stinson 
et al., 1982). It can also be an important source of nutri­
ents for bacterial growth (Van der Hoeven et al.f 1984) . 
The mouth is also supplied with crevicular fluid via the 
gingival crevice, which has a protective function due to its
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flushing action and to the presence of immune system compon­
ents such as,_ ' immunoglobulins (IgG, IgA & IgM) , com­
plement, neutrophils, lymphocytes and monocytes (Cimasoni, 
1983).
1.7 Pathogenicity of A .actinomycetemcomitans
The role of specific Gram-negative bacteria in the aetiology 
of human periodontal disease has been increasingly appre­
ciated in recent years (Slots, 1984). However, periodontal 
disease activity has not been fully investigated and it rem­
ains difficult to associate a specific bacterial species 
with active periodontal destruction (Slots and Dahlen,
1985) . A .actinomycetemcomitans for a number of years has 
been considered a pathogen mainly in LJP and to a lesser 
extent in adult periodontitis (Slots and Dahlen, 1985). In 
general for an organism to cause periodontal disease, it 
must possess virulence factors to (a) allow it to initially 
colonize and grow in the periodontal environment (b) resist 
the host defence mechanism and (c) to produce tissue damage 
(Smith, 1975). A .actinomycetemcomitans has been shown to 
produce various factors which may play an important role in 
the pathogenicity of this organism (see Table 1.3).
1.7.1 Leucotoxic activity of A . actinomycetemcomitans
Polymorphonuclear leucocytes (PMNLs) are commonly present in 
periodontal pockets constituting >90% of the leucocyte popu­
lation (Slots, 1986). They probably play a central role in 
the host defence against periodontal infection due to their 
ability to phagocytose and destroy microorganisms (Van Dyke,
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Levine and Genco, 1982a). During the last 10 years investi­
gators have studied the interaction between PMNLs and bact­
eria present in human dental plaque (Taichman and McArthur, 
1976; Taichman et al., 1977; Tsai et al., 1978; Baehni et
al., 1978). Although the majority of certain Gram-negative
bacteria (eg. Capnocytophaga, Bacteroides and Leptotrichia 
species) as well as whole plaque, triggered the release of 
certain lysosomal constituents present in PMNLs (eg. lyso- 
zyme, (3-glucuroindase or myeloperoxidase), there was no evi­
dence of PMNL death in these experiments (Taichman et al., 
1977; Baehni et al., 1978; Tsai et al., 1978). More inter­
estingly Tsai et al., (1978) reported that a Bacteroides
like Gram-negative microorganism designated Y4 failed to 
stimulate PMNLs lysosomal release and showed no cytotoxic 
activity. In 1979, Baehni et al., presented the first study 
which demonstrated the cytotoxic activity of A.actino­
mycetemcomitans Y4 for human PMNLs. The reason for the lack 
of toxicity of Y4 in the previous study (Tsai et al., 1978) 
is not understood (Baehni et al., 1979), although it may be 
related to the fact that different growth conditions and a 
fresh stock culture of Y4 were used in later experiments. 
In addition, it was suggested that reculturing of A.actino­
mycetemcomitans Y4 in vitro may result in the loss of 
leucotoxic activity (Baehni et al., 197 9) . Similar experi­
ments were carried out later by a number of investigators 
and all agreed that A.actinomycetemcomitans Y4 possessed 
cytotoxic activity (Tsai et al., 1979; McArthur et al., 
1981; Baehni et al., 1981).
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The toxin produced by A .actinomycetemcomitans is widely 
described as a leucotoxin which kills human PMNLs and 
monocytes (Tsai et al., 1979; Taichman, Dean and Sanderson, 
1980; Taichman et al., 1982; Simpson, Berthold and Taichman, 
1988) . The toxin is known to be heat-labile, active at 37°C 
but inactivated at 56°C for 30 minutes and trypsin sensitive 
(Taichman et al., 1980; McArthur et al., 1982; Ohta et al.,
1987). The leucotoxin is found in both viable as well as in 
soluble sonic extracts or in the membrane vesicles of A.act­
inomycetemcomitans cells (Tsai.et al., 197 9; Nowotny et al., 
1982). The cytotoxic activity of A .actinomycetemcomitans 
leucotoxin is described to be dose, time and temperature 
dependent. As the number of bacteria per PMNL is increased 
more PMNLs were killed, reaching a maximum after 45 to 60 
minutes exposure, as monitored by either trypan blue stai­
ning or lactate dehydrogenase release (Baehni et al., 1979; 
Tsai et al., 1979; McArthur et al., 1981; Zambon et al., 
1983c) .
There is some evidence that the addition of fresh human sera 
(Baehni et al., 1979; McArthur et al., 1982; Zambon et al., 
1983c) as well as sera from patients with other types of 
periodontal or systemic diseases (Tsai et al., 1981; Taich­
man and Wilton, 1981) enhances the cytotoxicity of A.actino­
mycetemcomitans in vitro. However, sera from juvenile peri­
odontitis patients or pooled sera from rabbits immunized 
with A .actinomycetemcomitans, neutralized the leucotoxin and 
no killing of PMNLs occurred (Tsai et al., 1979; McArthur et 
al., 1981) . It appears that this protective activity was
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due to the presence of antibodies to the leucotoxin, since 
Ebersole et al., (1982) and Tsai et al., (1981) found that
LJP patients had high serum IgG levels to A .actinomycetemco- 
mitans Y4 . Microbiological and immunological studies have 
demonstrated that specific IgG was later identified as the 
inhibitor of A.actinomycetemcomitans leucotoxin activity 
(McArthur et al., 1981). While the leucotoxin produced by 
A.actinomycetemcomitans Y4 has been most extensively stud­
ied, Baehni et al., (1981) examined a number of A.actinomy­
cetemcomitans strains including some dental plaque isolates, 
and found that not all strains tested exhibited leucotoxic 
activity for PMNLs. The leucotoxic strains were found to 
possess specific antigens which were absent from the non- 
leucotoxic strains (Baehni et al., 1981).
A.actinomycetemcomitans leucotoxin can kill gingival crevice 
PMNLs (Taichman and Wilton, 1981; Taichman et al., 1982), 
promyelocytic tissue cell lines HL-60, U937 and KG-I as well 
as T and B-cell lines (Zambon et al., 1983c; Simpson et al., 
1988). Furthermore, A.actinomycetemcomitans leucotoxin was 
found to be cytotoxic for other non human PMNLs and mono­
cytes including those of monkeys and other primates which 
varied significantly in their sensitivity to the A. actinomy­
cetemcomitans leucotoxin (Taichman et al., 1984; Taichman et 
al., 1987a). The ability of A.actinomycetemcomitans to pro­
duce leucotoxin appears to be correlated with virulence 
(Slots and Genco, 1984; Slots, 1986). This is evident from 
a study by Zambon et al., (1983c) who showed that 55% of 
A.actinomycetemcomitans isolates from LJP patients were leu-
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cotoxic, whereas, only 16% of A.actinomycetemcomitans isola­
tes from healthy subjects possessed cytotoxic activity. 
However, Taichman et al., (1982) hypothesized that infection
by A.actinomycetemcomitans may occur during the early stages 
in the development of juvenile periodontitis and that leuco­
toxin production in the gingival crevice may deplete the 
area of an essential host defence mechanism. In addition, 
Tsai and Taichman (1986) suggested that the ability of 
A.actinomycetemcomitans to destroy human PMNLs could be alt­
ered during the course of infection since leucotoxic produ­
cing A.actinomycetemcomitans were only found in isolates 
obtained from young patients (6-12 years) but not in older 
patients (13-25) years old.
Although some A.actinomycetemcomitans strains possess plas­
mids (Hammond, Peindl and Socransky, 1975) and are infected 
with bacteriophage (Stevens, Hammond and Lai, 1982; Preus, 
Olsen and Namork, 1987), there seems to be no correlation 
between these factors and leucotoxin production (Stevens et 
al., 1982). Moreover, leucotoxin-producing A.actinomycetem­
comitans strains may be more resistant to the hydrolytic 
enzymes of PMNLs than non-producing strains, since enzymatic 
extracts from human PMNLs cause greater damage to the cell 
wall and cytoplasmic membrane of non-leucotoxic A.actinomyc­
etemcomitans strains than to leucotoxic A.actinomycetemco­
mitans Y4 (Sela, 1983; Sela and Romano, 1983) .
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Table 1.3 Potentially important pathogenic factors 
produced by A .actinomycetemcomitans strains.
FACTORS PRODUCED EFFECT on HOST
Leucotoxin kill PMNLs and monocytes
Endotoxin platelet aggregation, 
macrophage killing
Lipopolysaccharide (LPS) Lymphocyte activation
LPS Bone resorption
Epitheliotoxin Periodontal tissues damage
Collagenase ~
Catalase ~
Fibroblast growth inhibitor ~
Acid phosphatase ~
Alkaline phosphatase ~  ~
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1.7.2 Chemotaxis suppression
With regard to the immune system, defective neutrophil chem­
otaxis has been reported in patients with juvenile or rapidly 
Progressive periodontitis (Cian cola et al., 1977; Lavine et al., 
1979; Clark, Page and Wilde, 1977; Van Dyke et al., 1980) as 
well as defective phagocytosis (Van Dyke et al., 1986) . 
However, Kinane et al., (1989a, b) could not confirm the 
presence of depressed PMNL chemotaxis in juvenile or rapidly 
progressive periodontitis patients using the Boyden chamber 
method. Differences in techniques were thought to account 
for much of the variation with respect to PMNL chemotaxis in 
periodontal disease (Kinane et al., 1989b).
A reduced level of complement-derived chemotactic activity 
has been demonstrated in serum from patients with LJP (Clark 
et al., 1977). This may play a role in periodontal infect­
ion in that defects in PMNLs may predispose individuals to 
infection (Van Dyke et al., 1980). For instance, Van Dyke
et al., (1982b) showed that A.actinomycetemcomitans can inh­
ibit human neutrophil chemotaxis and Sundqvist and Johansson 
(1982) demonstrated that A.actinomycetemcomitans was not 
killed by a pooled human serum with known active complement. 
Other workers have shown that A.actinomycetemcomitans stra­
ins were resistant to killing by complement alone or by com­
plement and serum containing IgG and IgM antibodies to 
A.actinomycetemcomitans (Evans and Genco, 1983). However, 
in the presence of neutrophils (PMNLs), complement and anti­
bodies, killing did occur indicating the importance of these 
cells in the immune system (Genco and Slots, 1984),
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1.7.3 Lymphocyte suppression
Despite the fact that sonic extracts of A.actinomycetem­
comitans do not appear to be cytotoxic for human lymphocytes 
(Tsai et al., 1979), it is known that such extracts can sup­
press the responsiveness of human lymphocytes to mitogens 
and antigens affecting DNA, RNA, and protein synthesis (She- 
nker, McArthur and Tsai, 1982a). Sonic extracts also supp­
ress both B and T-cell functions (Shenker, Tsai and Taich­
man, 1982b). I-n addition a lipopolysaccharide from A . acti­
nomycetemcomitans was shown to enhance human lymphocyte kil­
ling of the natural killer cell-sensitive human erythroleu- 
kaemia cell line K562 (Lindemann, Miyasaki and Wolinsky, 
1988; Lindemann, 1988) . Moreover, using animal models Bick 
et al., (1981) and Yoshie et al., (1985) found that A.acti­
nomycetemcomitans possessed a potent B-cell activator which 
may contribute to A.actinomycetemcomitans pathogenicity by 
inducing B lymphocytes to produce antibodies and possibly 
other mediators of inflammation (Carpenter et al., 1984). 
More recent studies have also shown that A.actinomycetemco­
mitans can strongly induce interleukin-1 (IL-1) production 
by mouse macrophages or human monocytes which may be impor­
tant in the development of periodontal disease, since IL-1 
may express a range of biological activities eg. alteration 
of gingival connective tissues during the development of 
periodontal disease (Ohmori et al., 1988; Lindemann and 
Economou, 1988).
Finally A.actinomycetemcomitans is reported to be resistant 
to killing by physiological concentrations of (85 - >1000|1M)
42
hydrogen peroxide (H2O2). This property could be sufficient 
to protect it from direct H202~mediated killing by host pha­
gocytes (Miyasaki et al., 1984). However, the addition of
sodium azide, which inhibits cell-associated catalase acti­
vity did not affect the resistance of A.actinomycetemcomi­
tans to H2O2 • Thus catalase activity may not be important 
in the resistance of A.actinomycetemcomitans to H2O2 • None­
theless, A.actinomycetemcomitans was found to be sensitive 
to killing by myeloperoxidase-hydrogen peroxide-chloride 
system in vitro under aerobic and anaerobic conditions 
(Miyasaki, Wilson and Genco, 1986b). In addition most 
oxygen-dependent killing requires myeloperoxidase activity 
which is essential but not alone sufficient to kill A.acti­
nomycetemcomitans (Miyasaki et al., 1986a; Miyasaki et al.,
1987). This may suggest a possible role for oxidative inac­
tivation of A.actinomycetemcomitans leucotoxin by secretory 
products of neutrophils (Clark, Leidal and Taichman, 1986). 
Another possibility is that lactoferrin contributes to the 
killing of A.actinomycetemcomitans by human neutrophils and 
may thus play a significant role in the innate secretory 
defenses against A.actinomycetemcomitans (Kalmar and Arnold,
1988) .
1.7.4 Tissue destruction by A . actinomycetemcomitans 
Endotoxin:
Bacteria and their products may lead to the destruction of 
the periodontal tissues by direct action or indirectly by 
inducing reactions that are partly unfavorable to the host
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(Slots and Genco, 1984). A.actinomycetemcomitans produces 
endotoxic lipopolysaccharide (LPS) which can cause tissue 
destruction in animals and appears to be similar in struct­
ure to the LPS from other Gram-negative bacteria, ie. a pol­
ysaccharide chain with a hydrophobic lipid-A which is coval­
ently joined by an inner core and an outer carbohydrate 
layer (Kiley and Holt, 1980; Hammond and Stevens, 1982). 
The LPS of A.actinomycetemcomitans appears to possess a range 
of biological activities which include the Schwartzman reac­
tion, macrophage activation, platelet aggregation and limu- 
lus amoebocyte activity (Kiley and Holt, 1980; Nowotny et 
al . , 1982; Nishihara et al . , 1986; Koga et al., 1987;
Nishihara, Koga and Hamada, 1987; Hamada et al., 1988). The 
LPS material from A.actinomycetemcomitans can exert potent 
bone resorption activity as demonstrated by the in vitro 
release of calcium from mouse calvaria similar to that obta­
ined with 'capsular' material under the same conditions 
(Kiley and Holt, 1980; lino and Hopps, 1984;. Wilson, Kamin 
and Harvey, 1985) . Also significant increase in bone 
resorption has been seen in rats who received T-cells 
sensitized to A.actinomycetemcomitans LPS compared with a 
non-sensitized control group (Yoshie et al., 1987) . These 
results tend to suggest that the LPS activity of A.actinomy­
cetemcomitans may be important in mediating bone loss in 
chronic periodontitis. A.actinomycetemcomitans also produ­
ces acid and alkaline phosphatases (Slots, 1981), and the 
former has been implicated in bone destruction which may 
enable A.actinomycetemcomitans to cause tissue destruction 
(Slots, 1986).
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Collagenase:
Collagen is an important component of the periodonitum which 
is mainly composed of Type I and III. It is arranged in the 
tissues as precisely ordered aggregates of many similar 
molecules (Gross, 1970) . The amino acid composition of 
collagen is made up of glycine, proline and hydroxyproline 
(Fietzek and Kuhn, 1976) and fibres are generally resistant 
to enzymatic degradation. However, it is sensitive to 
certain bacterial enzymes such as collagenase which has been 
defined as an enzyme capable of degrading native collagen at 
physiological pH and temperature (Gross, 1970). Collagenase 
is produced by most A.actinomycetemcomitans strains (Slots, 
1982a; Robertson et al., 1982; Rozanis et al., 1983) and
this enzyme may play an important role in collagen loss in 
destructive disease of the periodontium (Kamin et al.,
1986) . However, not all A .actinomycetemcomitans strains 
produce collagenase and while Rozanis and Slots (1982) found 
11 of 140 (8%) strains possessed collagenolytic activity, Uitto 
et al., (1988) found that 5 out 5 A.actinomycetemcomitans 
strains did not produce collagenase. It has been suggested 
that if collagenase derived from A.actinomycetemcomitans was 
combined with collagenase released from leucotoxin-damaged 
PMNLs then the mixture may produce a significant level of 
tissue destruction (Zambon, 1985). From these results it is 
not clear if collagenase produced by A.actinomycetemcomitans 
is important in pathogenicity, since only very small perce­
ntage (8%) of A.actinomycetemcomitans isolates produced col-
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lagenase. In addition very little data is available and 
more studies should be carried out in this field.
Fibroblasts:
Fibroblasts are the predominant cells in connective tissues 
and show morphological changes at sites of inflammation 
(Stevens, Gatewood and Hammond, 1983). A .actinomycetem­
comitans was found to produce a dose-dependent inhibition of 
both human and murine fibroblast proliferation as assessed 
by DNA and RNA synthesis with an overall decrease in cell 
growth but not viability (Shenker, Kushner and Tsai, 1982c; 
Stevens et al., 1983; Kamin et al., 1986; Stevens and Hamm­
ond, 1988) .
Epitheliotoxin:
Epitheliotoxin is another pathogenic factor capable of 
directly causing tissue destruction (Birkedal-Hansen et al., 
1982; Kamen, 1983) and which may assist A . actinomycetem­
comitans to penetrate the sulcular epithelium and invade the 
underlying connective tissues. There is little information 
known about this factor, though it has been suggested that 
the epitheliotoxin of A.actinomycetemcomitans may destroy 
the epithelial lining of the periodontal pocket and inter­
fere with healing (Slots, 1986).
More recently Christersson et al., (1987a) using immuno-
fluoresence and electron microscopic studies reported the 
presence of A.actinomycetemcomitans in the connective tissue 
of humans. A positive correlation was found between the
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presence of A.actinomycetemcomitans in gingival biopsies and 
the number of A.actinomycetemcomitans colonies cultured from 
minced tissues and from plaque collected from periodontal 
pockets (Christersson et al., 1987a,b). It is possible that 
the production of epitheliotoxin played a role in the invas­
ion of these tissues by A.actinomycetemcomitans.
1.7.5 Adherence
It is clear that the ability of an organism to adhere to 
host surfaces or commensal bacteria is important in the 
colonization of the mouth. The literature contains only 
three studies which have dealt with the adherence of 
A.actinomycetemcomitans to different oral surfaces, namely, 
buccal epithelial cells, tissue culture cells, tooth enamel 
and hydroxyapatite. Unfortunately different methods have 
been used to study the adherence of A.actinomycetemcomitans 
to these surfaces which makes a comparison of the results 
difficult. Gibbons and Etherden (1983) examined two A.acti­
nomycetemcomitans strains (ATCC 29523 and Y4) which were 
both found to adhere in low numbers to saliva treated hydro- 
xyapatite. For example when both strains were tested at a 
concentration of 10^/ml, only 0.3% of cells adhered to hydr- 
oxyapatite (HA) . Nonetheless, Kagermeier and London (1985) 
reported that A.actinomycetemcomitans strains Y4 and N27 
adhered to hydroxyapatite in approximately the same numbers. 
The percentages of A .actinomycetemcomitans cells which adhe­
red to the HA was higher than that reported earlier by 
Gibbons and Etherden (1983), although in Kagermeier's study 
the concentration of bacteria was less than that used by
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Gibbons and Etherden (1983) . Sweet (1986) examined the 
adherence of one A.actinomycetemcomitans strain (NCTC 9710) 
and showed that this isolate adhered in high numbers to 
buccal epithelial cells, tooth enamel and Hela tissue cult­
ure cells.
The ability of A.actinomycetemcomitans to adhere to oral 
surfaces is thought to be related to a number of bacterial 
cell surface structures, such as a 'capsule', membrane vesi­
cles or fimbriae (Holt et al., 1980; Lai et al., 1981;
Zambon et al., 1983a) . A preliminary study by Rosan et al., 
(1988) showed that two fimbriated A.actinomycetemcomitans 
strains adhered to hydroxyapatite about 3 to 4-fold times 
higher than non-fimbriated variants which were obtained aft­
er repeated subculturing. However, results obtained with a 
third strain showed no difference in adherence. Other fact­
ors which may affect adherence, eg. the composition of the 
growth medium appear to have little or no effect on the 
adherence of A.actinomycetemcomitans to HA in vitro (Kager- 
mier and London, 1985), whereas repeated subculturing over a 
period of one year did reduce the ability of A.actinomy­
cetemcomitans to adhere to HA (Kagermeier and London, 1985). 
There seems to be different views on the effect of serum or 
saliva on the adherence of A.actinomycetemcomitans to oral 
surfaces. Kagermeier and London (1985) have shown that the 
ability of A.actinomycetemcomitans to adhere to HA was redu­
ced when the hydroxyapatite was coated with either saliva or 
serum in vitro. However, Rosan et al., (1988) reported that 
the addition of saliva had no effect on the adherence of two
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fimbriated A.actinomycetemcomitans strains compared to the 
results obtained using hydroxyapatite alone. Finally 
A.actinomycetemcomitans adhered in high numbers to Hela cell 
monolayers which were pretreated with both saliva and serum 
as compared to the results obtained when the assays were 
performed in buffer alone (Sweet, 1986).
1.7.6 Hydrophobicity
Hydrophobicity is described as the free energy change asso­
ciated with the process of bringing two entities from infin­
ite separation to distances of the order of magnitude of 
molecular dimensions (Ben-Naim, 1977). The outcome of many 
in vitro studies suggest that hydrophobic interactions are 
important in mediating the adherence of most oral bacteria 
to various oral surfaces eg. tooth surfaces and buccal epit­
helial cells (Rosenberg et al., 1981; Rosenberg et al., 
1983a). A number of laboratory methods have been developed 
to measure bacterial hydrophobicity including, hydrophobic 
interaction chromatography, salting out of bacteria by 
increasing the concentration of ammonium sulphate, adhesion 
to solid surfaces (eg. polystyrene, plastic or glass), bind­
ing of radiolabelled hydrocarbons, two phase partioning, 
contact angle measurements and bacterial adhesion to hydro­
carbons (for review see Rosenberg and Kjelleberg, 1986).
A number of factors appear to affect hydrophobicity and 
therefore bacterial adhesion, which include fimbriae as well 
as other surface projections such as fibrils (Marshall and 
Cruickshank, 1973; Rosenberg et al., 1982). In general, the
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structure and chemical composition of the bacterial cell 
surface may vary due to differences in culture conditions 
such as the composition of the growth medium, the degree of 
aeration, the incubation temperature and the age of the mic­
robial cells, all of which may affect cell surface hydro- 
phobicity (review Rosenberg and Kjelleberg, 1986). The 
presence of plasmids may similarly affect hydrophobicity by 
allowing the expression of fimbriae or other surface compon­
ents (Martinez, 1983). Moreover, hydrophobicity varies not 
only from species to species but also from strain to strain 
(Rosenberg, 1982; Olsson and Westergren, 1982). While there 
is some information about the effect of saliva and serum on 
the adherence of bacteria to oral surfaces, there is very 
little data concerning the effect of either saliva or serum 
on bacterial hydrophobicity in vitro.
Relatively little is known about the hydrophobicity of 
A .actinomycetemcomitans in vitro or about the role of this 
property in the colonization of the dentogingival area 
(Kozlovsky, Metzger and Eli, 1987). Nonetheless, Gibbons 
and Etherden (1983) reported that two A.actinomycetem- 
comitans strains (ATCC 29523 and Y4) were hydrophilic as 
assessed by their lack of ability to adsorb to hexadecane and because 
they adhered in only low numbers to saliva coated hydroxy- 
apatite. However, these results were not supported by the 
finding of Kozlovsky et al ., (1987) who reported that
A . actinomycetemcomitans strain Y4 was hydrophobic when meas­
ured using adherence to the hydrocarbon, octane. They also 
noted that hydrophobicity could be varied from 60 to 90%,
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depending on the medium in which the organism was grown, age 
of culture and the buffer in which the assay was carried 
out. One possible explanation for the discrepancies found 
in these two studies is the difference in growth conditions 
used in the two studies (Kozlovsky et al., 1987) . Another
reason for the differences may be due to the use of diff­
erent hydrocarbons (ie hexadecane and octane). Since 
Rosenberg, Gutnick and Rosenberg (1980) have reported that 
the hydrophobicity of the same bacterial strain showed 
slight variations depending on the hydrocarbon used (hexade­
cane, octane and xylene) . In another study the hydropho­
bicity of supragingival dental plaque was found to be higher 
in the presence of xylene than in octane or hexadecane resp­
ectively (Rosenberg, Judes and Weiss, 1983b). More recently 
Sweet (1986) investigated the hydrophobicity of one Type 
strain of A . actinomycetemcomitans (NCTC 9710) and found it 
hydrophobic when measured using adherence to xylene. Appar­
ently neither saliva nor the type of buffer used (SIB or 
PBS) had any affect on the hydrophobicity of A. actinomy­
cetemcomitans NCTC 9710.
1.8 General Infections Related to A . actinomycetem­
comitans
A .actinomycetemcomitans can cause severe medical infections 
throughout the body. It has been associated with abscess of 
the abdomen, brain, face, hand, thyroid gland, actinomy­
cosis, endarteritis, endocarditis, meningitis, pneumonia, 
septicaemia, urinary tract infection, vertebral osteomye­
litis and more recently from a case of endophthalmitis
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(Garner, 197 9; Page and King, 1966; Mauff et al., 1983;
Burgher, Loomis and Ware, 1973; Colebrook, 1920; Symbas et 
al., 1967; AhFat, Patel and Pickens, 1983; Meyers et.al, 
1971; Townsend and Gillenwater, 1969; Muhle, Rau and Ruskin, 
1979; Ishak, Zablit and Dumas, 1986) . Infective endocar­
ditis is probably the most common type of extra-oral infec­
tion with A.actinomycetemcomitans and approximately two- 
thirds of these cases occur in subjects with a history of 
rheumatic heart disease or prosthetic valve replacement 
(Zambon, 1985) .
1.9 Periodontal Infections Related to A . a c t i n o m y ­
cetemcomitans
Microbiological studies have strongly associated A.actinomy­
cetemcomitans with localized juvenile periodontitis (Slots 
et al., 1980a), since it tends to be found in only small 
numbers of healthy subjects or patients with other types of 
periodontal disease (Slots et al., 1980a; Zambon, Chister-
sson and Slots, 1983b). More recently the role of A .actino­
mycetemcomitans in chronic periodontitis has been investig­
ated and reports have yielded conflicting results (Wolff et 
al., 1985; Dahlen et al., 1989).
1.9.1 Prepubertal periodontitis
Localized prepubertal periodontitis (LPP) is described as a 
host-defect mediated form of bacterially induced periodon­
titis with an early onset and rapid progression around a few 
teeth in children prior to puberty (Delaney and Kornman, 
1987) . Although the number of studies in 'this field are
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limited, it has been shown that subjects with LPP harbour 
high levels of several suspected pathogens including A.acti­
nomycetemcomitans , Bacteroides intermedius and Capnocyto- 
phaga species (Delaney and Kornman, 1987; Sweeney et al.f 
1987; Alaluusua and Asikainen, 1988; Frisken et al., 1987). 
It has been suggested that these results indicate that 
localized prepubertal periodontitis may be more common than 
previously realized and associated with bacteria generally 
regarded as periodontal pathogens particularly A.actinomy- 
cetemcomitans (Sweeney et al., 1987; Preus and Gjermo, 
1987) .
More recently Preus and Gjermo (1987) presented two clinical 
cases of Papillon-Lefevre Syndrome (PLS) in two siblings 
with prepubertal periodontitis. Although no microbiology 
was performed the authors postulated that the microorganisms 
responsible for the extreme tissue destruction in PLS perio­
dontitis must be virulent. Preliminary studies have indic­
ated elevated serum titers of antibodies against A. actinomy- 
cetemcomitans in both siblings, and later A.actinomycetem­
comitans was isolated from one of the patients (Preus et 
al., 1987).
1.9.2 Juvenile periodontitis
Juvenile periodontitis is described as a disorder of the 
supporting apparatus of the teeth which occurs in adolesc­
ents (Baer, 1971) . It is characterized by the early loss of 
alveolar bone around the permanent first molar and incisor 
teeth (Liljenberg and Lindhe, 1980; Listgarten, Lai and
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Evian, 1981) . This form of disease is known as Localized 
Juvenile Periodontitis (LJP). However, the extent of peri­
odontal destruction in these patients is generally dispro- 
portional to the minimal amounts of dental plaque and gingi­
val inflammation which are found clinically (Zambon, 1983). 
The disease tends to occur with higher frequency in certain 
families (Zambon, 1983).
Although the precise aetiology of juvenile periodontitis is 
unknown, many theories have been suggested, including a 
genetic or immunological defect of the host with or without 
specific microbial infection (Lindemeyer, 1986). An associ­
ation between juvenile periodontitis and certain bacterial 
species especially Gram-negative rods has been reported 
(Newman et al., 1976; Slots, 1976; Newman and Socransky,
1977) . A.actinomycetemcomitans is believed to be the most 
important Gram-negative rod present in plaque from these 
patients (Tanner et al., 1979). Capnoytophaga has also been 
commonly isolated from LJP patients (Newman et al., 197 6; 
Newman and Socransky, 1977; Holt, Leadbetter and Socransky, 
1979; Socransky et al., 1979) . However the relationship of 
Capnocytophaga with periodontal disease is still unclear 
(Genco, Christersson and Zambon, 1986) .
The recent evidence implicating A.actinomycetemcomitans as 
an important organism in the aetiology of juvenile periodo­
ntitis is as follows: (a) The increased prevalence of
A.actinomycetemcomitans in almost all juvenile periodontitis 
patients, while subjects with a healthy periodontium harbour 
very few if any A.actinomycetemcomitans (Slots et al.,
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1980a); (b) the presence of high titers of antibodies agai­
nst A.actinomycetemcomitans in the serum, saliva and gingi­
val crevicular fluid of patients with this disease 
(Listgarten et al.r 1981); (c) the capability of A.actinomy­
cetemcomitans to produce a range of virulence factors which 
can depress defence mechanisms; eg. inhibition of human 
fibroblast proliferation and leucotoxin production (Review 
Zambon, 1985); (d) and finally clinical studies have shown
that juvenile periodontitis can be treated by eliminating 
A.actinomycetemcomitans from periodontal pockets in diseased 
subjects using tetracycline therapy (Lindemeyer, 1986).
Studies by Slots et al., (1980a); Mandell and Socransky 
(1981) and Slots (1982b) reported that A.actinomycetem­
comitans was present in high numbers in almost all localized 
juvenile periodontitis lesions, whereas, it was less frequ­
ently detected in healthy periodontal sites, normal juveni­
les, normal adults or adult periodontitis patients. In a 
study involving 403 healthy and diseased subjects, A .actino­
mycetemcomitans was detected in 97% of subgingival dental 
plaque samples from LJP patients (Zambon et al., 1983b), but 
in very small numbers from only 15% of other individuals 
which included healthy adults, chronic periodontitis patie­
nts and insulin-dependent juvenile diabetics. Similar find­
ings were reported by Slots et al., (1982) and Genco et al., 
(1986) where 95% of LJP patients samples yielded A.actinomy­
cetemcomitans .
Moore (1987) summarized a number of recent studies on 
A.actinomycetemcomitans and concluded that the subgingival
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plaque from about 17% of 137 affected juvenile periodontitis 
sites contained 10% to 99% A.actinomycetemcomitans, 20% con­
tained 1% to 10% and 64% of affected sites contained less 
than 1% A.actinomycetemcomitans. He concluded that if at 
least 1% A.actinomycetemcomitans is required for tissue des­
truction, then A.actinomycetemcomitans could be the destruc­
tive agent in about one-third of the sites examined (Moore,
1987). The relationship between A.actinomycetemcomitans 
proportions and disease progression was evaluated by Bragd 
et al., (1987) using multiple-regression analysis. A rec­
overy rate below 0.01% for A.actinomycetemcomitans disting­
uished non-progressing from progressing periodontal sites 
with a sensitivity and specificity of about 85% for both 
variables.
The prevalence of A.actinomycetemcomitans was also reported 
in 17 Finnish LJP patients with 89% positive (Asikainen et 
al . , 1986), in 12 Panamanian LJP patients 100% positive
(Eisenmann et al., 1983) and in 5 Korean LJP patients again 
100% positive (Chang et al., 1984).
Further evidence of a close association between A.actino­
mycetemcomitans and LJP comes from immunological studies. 
Genco et al., (1980) and Tsai et al., (1981) found that 69
to 94% of LJP patients had specific serum antibodies to 
A.actinomycetemcomitans. In other investigations, only 3% 
to 19% of gingivitis subjects were positive and 15% to 30% 
of adult periodontitis patients exhibited any antibody resp­
onse (Genco et al., 1980; Tsai et al., 1981; Ebersole et
al., 1982; Ranney et al., 1982).
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Finally a number of clinical studies have also associated 
A . actinomycetemcomitans with the following groups of pati­
ents: generalized juvenile periodontitis (Tanner et al.,
1979), insulin-dependent juvenile diabetics with periodon­
titis (Mashimo et al., 1983) and rapidly progressing perio­
dontitis (Moore et al., 1982; Page et al., 1983).
1.9.3 Chronic periodontitis
While the aetiology of A.actinomycetemcomitans in juvenile 
periodontitis is well documented, there is much less inform­
ation regarding a possible association between A.actinomy­
cetemcomitans and chronic periodontitis. However, the resu­
lts summarized in Table (1.4) clearly show that A.actinomy­
cetemcomitans is not infrequently isolated from patients 
with chronic periodontitis, although the clinical signifi­
cance of the data is not clear. Past reports suggest that 
A.actinomycetemcomitans is less frequently isolated from 
chronic periodontitis patients compared to LJP patients. 
For example Slots et al., (1980a) found 50% of chronic peri­
odontitis patients harboured A.actinomycetemcomitans comp­
ared to 90% of the LJP patients. A.actinomycetemcomitans 
was mainly isolated from subgingival plaque samples and 
lesions which were described as progressing compared to non­
progressing lesions (Slots et al., 1986). Since subgingival 
plaque samples exhibited higher recovery rates than supra- 
gingival samples, the presence of A.actinomycetemcomitans in 
these sites was found to correlate with high plaque index 
and pocket depths of 3 to 5mm (Wolff et al., 1985).
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1.10 Aims of this study
As cited in Section 1.5 that there are different views on 
the suitability of the two semi-selective media TSBV and MGB 
in the isolation of A.actinomycetemcomitans from subgingival 
plaque samples. Therefore the first series of experiments 
in this thesis were designed to compare these two media for 
their inhibitory action against pure isolates of A.actinomy­
cetemcomitans and their ability to differentiate this organ­
ism from other bacterial species present in mixed plaque 
samples.
Due to the variation in prevalence data associated with the 
recovery of A.actinomycetemcomitans from healthy volunteers 
and chronic periodontitis patients, a group of Scottish pat­
ients were investigated. Since there is no information 
concerning the prevalence of both star-shaped and non-star- 
shaped colonies of A .actinomycetemcomitans on primary isola­
tion, it was decided to investigate this phenomena in the 
subgingival plaque cultures on semi-selective media. While 
previous workers have employed different identification 
methods, the commercially provided kit (API 20 A) was used 
throughout this study for the identification of suspected 
A .actinomycetemcomitans isolates.
It is clear from the earlier review of the literature that 
little information is available concerning the adherence of 
A.actinomycetemcomitans to oral surfaces (especially buccal 
epithelial cells). In addition the small amount of info­
rmation concerning hydrophobicity which is available tends
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to be conflicting. Thus it was decided to study the adhere­
nce of 33 strains of A .actinomycetemcomitans to buccal 
cells, and to examine the effect of both saliva and serum on 
adherence. The hydrophobicity of A.actinomycetemcomitans to 
xylene was also investigated with the same strains.
Finally the pathogenicity of A.actinomycetemcomitans has 
been related to the ability of this organism to produce leu- 
cotoxin capable of killing human PMNLs and other target 
cells such as HL-60 in vitro. Freshly isolated strains of 
A.actinomycetemcomitans were included in leucotoxicity expe­
riments in this thesis to provide further information conc­
erning toxin production by A.actinomycetemcomitans.
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CHAPTER 2
THE PREVALENCE OF A . ACTINOMYCETEMCOMITANS IN CHRONIC 
PERIODONTITIS (MICROBIOLOGICAL AND CLINICAL STUDIES)
2.1 Introduction
This chapter is divided into two parts, the first part deals 
with a preliminary study in which a comparison of semi- 
selective media for the isolation of A.actinomycetemcomitans 
was carried out. The other part deals with a clinical study 
in which the prevalence of A.actinomycetemcomitans in subgi­
ngival plaque samples from 98 patients and 55 control subj­
ects was investigated.
2.2 Comparison of selective media
2.2.1 Introduction
The isolation and identification of A.actinomycetemcomitans 
has become increasingly important because of its suspected 
role in certain types of human periodontal disease, eg. 
patients with Localized Juvenile Periodontitis (LJP) , (Slots 
et al., 1980a; Slots, 1982b). Development of a fully selec­
tive medium for the specific recovery of A.actinomycetem­
comitans from subgingival plaque would of particular value, 
as the organism forms small translucent colonies on primary 
cultures and may be easily overlooked due to the presence of 
other microorganisms.
Two semi-selective media have been developed for the isola­
tion of A.actinomycetemcomitans from subgingival plaque 
(Mandell and Socransky, 1981; Slots 1982b). However, there
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seems to be some confusion about the suitability of using 
these two media (Riches and Marsh, 1987). In this study the 
two semi-selective media were compared with respect to (I) 
their ability to inhibit the growth of pure strains of 
A.actinomycetemcomitans, and (II) their effectiveness in the 
isolation of A.actinomycetemcomitans from mixed subgingival 
plaque samples. The medium which performed best in these 
tests was subsequently used for the isolation of A.actinomy­
cetemcomitans from both patients and control subjects in the 
follow-up clinical study.
2.2.2 Materials and methods
2.2.3 Bacteria used to compare the selective media
A total of 17 A.actinomycetemcomitans strains were used in 
this study, 4 Type strains, (NCTC 9709, NCTC 9710, NCTC 
10979 and NCTC 10982) obtained from the National Collection 
of Type Cultures, London, UK, and 13 freshly isolated A.act­
inomycetemcomitans strains from subgingival sites in chronic 
periodontitis patients who attended Glasgow Dental Hospital 
and School (see Table 2.1) . All the freshly A.actino­
mycetemcomitans strains were isolated as described in sect­
ion 2.3.3. Both the Type strains and the fresh isolates 
were identified according to the procedures described below.
2.2.4 Identification of A . actinomycetemcomitans str­
ains 
Microscopic examination (Gram-stain)
All bacterial isolates were stained by Gram's method using a 
similar technique to that described by Preston and Morrell
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(1962). A bacterial smear was prepared by removing 2-3 
colonies using a sterile loop and emulsifying them in a 
loopful of sterile distilled water on a glass microscope 
slide. The smear was dried by passing it over a Bunsen 
flame and stained with a 0.5% w/v crystal violet solution 
for 60 seconds. The crystal violet was poured off and the 
slide was flooded with Gram's iodine solution which was left 
to act for a further 60 seconds. The smear was then decolo­
urized using acetone (M & A, Pharmchem Ltd., Bolton, Eng­
land) which was left to act for about 5 seconds. Next the 
smear was washed with running tap water and counterstained 
with 5% v/v carbolfuchsin solution for two minutes. Finally 
the counterstain was washed off, and the smear dried and 
examined at 1000X magnification using an Olympus microscope 
(Tokyo, Japan) . With the exception of acetone all the 
chemicals used in the Gram-stain were supplied by Clin-Tech 
Ltd., London, England.
CO2 requirement
The requirement of each strain for CO2 was examined by comp­
aring the growth of A.actinomycetemcomitans on Columbia 
Blood Agar plates (CBA) (Gibco-Europe, Paisley, Scotland) , 
(Appendix I) after incubation for 48 hours at 37°C in air 
(LEEC Ltd., Nottingham, England) with that obtained from 
growth in 5% CO2 in air using a Qualitemp 80 MI incubator
(Laboratory Terminal Equipment Ltd., Oldham, UK). Results 
were recorded on the basis of either a light, medium or 
heavy growth obtained under the two different atmospheric 
conditions.
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Table 2.1 A . actinomycetemcomitans strains used in 
the selective media study.
Strain
Number Source
Site of 
Isolation
API 20 A 
Profile
Aa 01 NCTC 9709 Abscess (site not given) 4110404
Aa 02 NCTC 9710 Abscess (site not given) 4110405
Aa 03 NCTC 10979 Mandibular abscess 4150404
Aa 06 NCTC 10982 Chest aspirate 4050505
Aa 07 GDH 310 Juvenile periodontitis 4110404
Aa 08 GDH 312 Chronic periodontitis 4110404
Aa 09 GDH 143 ~ 4110404
Aa 10 GDH 216 ~ 4110404
Aa 11 GDH R8529 ~ 4150404
Aa 12 GDH 156 ~ 4110404
Aa 13 GDH 471 ~ 4110404
Aa 14 GDH 1954 4050404
Aa 34 GDH 1116 ~ 4050404
Aa 35 GDH 1123 ~ 4050404
Aa 36 GDH 2 8 ~ 4110404
Aa 37 GDH 33 ~ 4110404
Aa 38 GDH 3 9 Juvenile periodontitis 4110404
NCTC: National Collection of Type Cultures 
ATCC: American Type Culture Collection 
GDH: Glasgow Dental Hospital
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Catalase test
Catalase production by A.actinomycetemcomitans was tested on 
a glass slide. One drop of 3% H2O2 from a pasteur pipette
was dispensed onto a clean glass slide. Three to four colo­
nies were selected from a Tryptic Soy-Serum-Bacitracin-Van- 
comycin Agar (TSBV) (Appendix I) using the edge of a clean 
glass coverslip and smeared near the drop of H2O2 . A cover-
slip was then carefully placed over the slide and the form­
ation of bubbles within,10 seconds was recorded as a posi­
tive result.
X and V requirements
The requirement of A.actinomycetemcomitans for either X or V 
growth factors was examined by emulsifying the growth from 
one CBA plate in 3.0 ml sterile distilled water. This was 
then inoculated onto Peptone Agar (Mast Lab., Merseyside, 
England), (Appendix I) with a sterile cotton swab (Medical 
Wire & Equipment Co., Wiltshire, England). Using a sterile 
needle X, V and XV discs (Mast Lab., Merseyside, England) 
were applied to the agar surface and plates were incubated 
for 48 hours at 37°C in a Qualitemp 80 MI incubator with an 
atmosphere of 5% CO2 in air. The presence or absence of 
growth around the discs was then recorded.
API 20 A System
The API 20 A system (API Laboratories, La Balme, Les Grot- 
tes, France) which consists of 20 biochemical tests in pre­
prepared plastic microtubes, was used as the standard method
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for the identification of A.actinomycetemcomitans (Figure 
2.1) . The inoculum for the test was collected by removing 
the pure heavy growth from a CBA plate using a sterile 
cotton swab. This was then emulsified in -the broth medium 
supplied with the API kit. The microtubes were inoculated 
with the bacterial suspension to the recommended level using 
a pasteur pipette and then incubated for 48 hours at 37°C in 
5% CO2 in air. At the same time a drop from the test suspe­
nsion was inoculated onto a fresh CBA to check for purity 
and incubated under the same conditions used for the API 
strips.
The results were recorded as indicated by colour changes of 
the inoculated API strips after 48 hours of incubation (see 
Figure 2.1) The results were recorded on the report sheet 
supplied and the biochemical reactions obtained for each 
test organism were then compared to the four different API 
20 A profiles for A.actinomycetemcomitans. As the API comm­
ercial system has no database for A.actinomycetemcomitans, 
these profiles were produced by testing five different NCTC 
strains of A.actinomycetemcomitans on three different occas­
ions. The profiles were 4110, 4150, 4050 and 4010.
2.2.5 Inoculation procedure
Due to the difficulty in growing the majority of the freshly 
isolated strains of A.actinomycetemcomitans in broth culture 
without homotypic aggregation occurring (Figure 2.2), each 
of the test strains was grown on two .CBA plates for 48 hours 
in. 5% CC>2 plus air in a Qualitemp 80MI incubator (Laboratory
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Figure 2.1 API 20 A (System) used for the biochemi­
cal identification of A.actinomycetemcomitans. The 
control test (E) shows no change in colour, while 
the four test strips (A, B, C & D) show different 
biochemical profiles.
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Figure 2.2 Strains of A .actinomycetemcomitans cult­
ured in thioglycollate broth; the type strain Y4 
shown here produces uniform turbidity while the the 
fresh isolates GDH 87034 & GDH 114 show marked aggr­
egation .
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Terminal Equipment Ltd., Oldham, UK) . At the end of this
time, growth was harvested using a sterile cotton swab and
transferred into 5 ml Anaerobic Blood Broth (ABB, Appendix
I) (Gibco-Europe Ltd., Paisley, Scotland), vortex mixed for
60 seconds (Fisons Scientific Apparatus, Leicestershire,
England) and 10-fold serial dilutions then made in Phosphate
Buffered Saline, pH 7.2 (PBS, Appendix II) (Flow Laborat-
4 5ones, Rickmansworth, England) . A dilution of 10 to 10 
was used to inoculate the following media; TSBV, Malachite 
Green Bacitracin Agar (MGB) , and CBA (Appendix I) . Using a 
spiral plater (Model D, Spiral Systems, Clough Pike, Cincin­
nati, USA) , 50 |ll aliquots were inoculated onto each agar
medium in duplicate and incubated in an atmosphere of 5% CO2
in air for 5 days at 37°C. The spiral plater operates by 
dispensing 50 fll onto the surface of the agar plate at a 
constant rate in a spiral pattern from the centre outwards 
(Figure 2.3). Therefore, the concentration of the sample 
per surface area becomes progressively less on moving from 
the centre to the periphery of the culture plate.
2.2.6 Colony counting
The colony forming units (cfu/ml) on each plate were counted 
by using a 10 cm, Spiral Systems, manual counting grid. The 
grid divides the surface of the agar plate into zones which 
represent known volumes of the inoculum (Figure 2.4). Areas 
containing 30-50 colonies were chosen and the number of col­
onies present on sectors on contralateral sides of the plate 
were counted to obtain more accurate results. The mean 
number of colonies on duplicate plates was then calculated.
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Figure
ating
2 .3 Spiral plater model D used for inocul- 
agar plates.
H H H M i
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Figure 2.4 A manual grid used in conjunction with 
the spiral plater for counting bacterial colonies in 
different zones on agar plates.
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2.2.7 Statistical analysis
All assays were performed on three different occasions for 
each bacterial strain under study. Results were analysed 
using STAT-WORK software (Apple Macintosh computer) ,• and 
Significant differences were determined using the paired t- 
Test.
2.2.8 Results: 
Comparison of selective media
The log^Q counts of the colony forming units (cfu/ml) of
pure cultures of A.actinomycetemcomitans recovered on each 
of the three tested media (CBA, TSBV and MGB) are shown in 
Tables 2.2, 2.3 & 2.4 and a summary of these results is
presented in Table 2.5. There was a clear evidence that 
both of the semi-selective media TSBV and MGB suppressed the 
growth of A.actinomycetemcomitans to a different degree 
compared to growth on CBA. As shown in Table 2.5, the over­
all mean number of A.actinomycetemcomitans was, highest on 
CBA plates followed by TSBV while MGB gave the lowest number 
of A.actinomycetemcomitans recovered. The growth of 
A.actinomycetemcomitans was significantly inhibited on MGB 
and TSBV agar plates as compared to CBA plates (p <0.005) . 
In addition, MGB was significantly more inhibitory to the 
growth of A.actinomycetemcomitans compared to TSBV medium (p 
<0.01) . Furthermore, the colony characteristics of A.acti­
nomycetemcomitans strains were more easily recognized on the 
TSBV than on the MGB agar plates, while colony size was 
maximal on CBA followed by TSBV and MGB respectively.
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Table 2.2 log^Q cfu/ml of 17 A . actinomycetemcomitans
strains recovered on CBA, TSBV and MGB agar plates 
(figures represent the mean of two observations). 
Experiment N o . 1
Strain
number
logiO cfu/ml 
CBA
of A.actinomycetemcomitans 
TSBV MGB
Aa 01 10.04 9.18 10.08
Aa 02 10.0 9.36 9.93
Aa 03 10 .11 9.54 10.18
Aa 06 9.83 9.20 9.81
Aa 07 9.65 9.90 9.70
Aa 08 9.86 9.71 9.52
Aa 09 9.23 8.40 4.0
Aa 10 8.59 8.20 3.86
Aa 11 9.85 9.59 5.65
Aa 12 8.94 8.61 4.55
Aa 13 9.11 8.23 4.73
Aa 14 9.70 9.43 5.32
Aa 34 10.15 10.08 9.63
Aa 35 9.63 10.08 9.57
Aa 36 9.76 9.84 9.50
Aa 37 9.94 9.65 9.72
Aa 38 9.77 9.77 9.59
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Table 2.3 log^Q cfu/ml of 17 A .actinomycetemcomitans
strains recovered on CBA, TSBV and MGB agar plates 
(figures represent the mean of two observations). 
Experiment N o . 2
Strain
number
log^Q cfu/ml 
CBA
of A.actinomycetemcomitans 
TSBV MGB
Aa 01 9.82 9.77 10 .04
Aa 02 9.84 9. 60 9.81
Aa 03 10.15 9.96 10 .20
Aa 0 6 9.81 9.86 9. 98
Aa 07 9.84 9.86 9. 67
Aa 08 9.72 9.54 9. 62
Aa 09 9.46 9.34 6.20
Aa 10 9.18 8.81 3.80
Aa 11 10.04 10.0 5.65
Aa 12 8.0 9.0 7.04
Aa 13 9.28 8.81 3.85
Aa 14 9.23 9.0 5.0
Aa 34 9.89 9.71 9.79
Aa 35 9.18 9.84 9.74
Aa 36 9.72 9.83 9.45
Aa 37 9.99 9.71 9.78
Aa 38 9.94 9.75, ___ 9.62
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Table 2.4 log^Q cfu/ml of 17 A .actlnomycetemcomltans
strains recovered on CBA, TSBV and MGB agar plates 
(figures represent the mean of two observations). 
Experiment N o . 3
Strain
number
logiO cfu/ml 
CBA
of A.actlnomycetBmcomitans 
TSBV MGB
Aa 01 10.32 10 .04 10.08
Aa 02 9.87 9.57 9.94
Aa 03 10.25 9.38 9. 90
Aa 06 9.96 9.54 9.97
Aa 07 9.81 9.89 9.84
Aa 08 9.68 9.81 9.71
Aa 09 9.48 9.45 4 .30
Aa 10 9.38 8. 98 3.85
Aa 11 10.15 9. 96 5.50
Aa 12 9.25 9.08 3.90
Aa 13 9.15 8.82 3.82
Aa 14 NT NT NT
Aa 34 10.20 9.86 9.96
Aa 35 10.25 9.92 9.77
Aa 36 9.83 9.93 9.65
Aa 37 10.20 10.20 10.20
Aa 38 9.86 9.87 9.54
NT: Not tested
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Table 2.5 Summary of the mean log^Q cfu/ml of 17
A .actinomycetemcomltans strains recovered on CBA, 
TSBV and MGB agar plates (figures represent the mean 
of three different experiments).
Strain Mean log^Q cfu/ml of A .actinomycetemcomltans 
number_______ CBA (±SEM)_____ TSBV (±SEM) MGB (±SEM)
Aa 01 10.06 (0.14) 9.66 (0.25) 10.07 (0.01)
Aa 02 9.90 (0.05) 9.51 (0.07) 9.89 (0.04)
Aa 03 10 .17 (0.04) 9.63 (0.17) 10.09 (0.1)
Aa 06 9.87 (0.05) 9.53 (0.2) 9.92 (0.1)
Aa 07 9 .77 (0.06) 9.88 (0.01) 9.74. (0.05)
Aa 08 9.75 (0.05) 9.69 (0.08) 9.62 (0.05)
Aa 09 9.39 (0.08) 9.06 (0.33) 4 .83 (0.69)
Aa 10 9.05 (0.24) 8.66 (0.24) 3.84 (0.02)
Aa 11 10.0 (0.09) 9.85 (0.13) 5. 60 (0.05)
Aa 12 8 .73 (0.38) 8.89 (0.14) 5.16 (0.96)
Aa 13 9.18 (0.05) 8.62 (0.19) 4 .13 (0.3)
Aa 14 9.46 (0.23) 9.21 (0.21) 5.16 (0.16)
Aa 34 10 .08 (0.1) 9.88 (0.11) 9.79 (0.09)
Aa 35 9.69 (0.31) 9.95 (0.07) 9.69 (0.06)
Aa 36 9.77 (0.03) 9.87 (0.03) 9.53 (0.06)
Aa 37 10.04 (0.08) 9.85 (0.17) 9. 90 (0.15)
Aa 38 9.86 (0.05) 9.80 (0.04) 9.58 (0.04)
Over all 9.69 (0.09) 9.50 (0.11) 8.03 (0.61)
±SEM: Standard error of mean
Comparisons: determined by paired t-Test 
CBA v TSBV= < 0.005 
CBA v MGB= < 0.005 
TSBV v MGB= <0.01
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2.2.9 Discussion:
The selectivity and sensitivity of the two semi-selective 
media TSBV and MGB for the isolation of A . act inomy- 
cetemcomitans have been examined by few researchers. In 
1981 Mandell and Socransky investigated the ability of MGB 
medium to grow 9 strains of A .actinomycetemcomitans (4 Type 
strains and 5 fresh isolates), and reported that using MGB, 
a range of 83% to 99% (mean 90%) of A.actinomycetemcomltans 
cells were recovered compared to the number which grew on a 
trypticase soy agar plates. In the present investigation, 
17 strains of A.actinomycetemcomltans were examined inclu­
ding 4 Type strains, and a range of 42% to 100% (mean 83%) 
of A.actinomycetemcomitans cells were recovered on MGB comp­
ared to the number obtained on CBA plates. Only one of the 
Type strains of A.actinomycetemcomltans (ATCC 29522) exam­
ined by Mandell and Socransky (1981) was included in the 
present investigation. While Mandell and Socransky (1981) 
showed that 94% of ATCC 2 9522 cells were recovered on MGB, a 
figure of 99% was obtained in this study. However, a marked 
difference was found between the two studies in relation to 
the inhibitory activity of MGB. The lowest recovery rate 
reported by Mandell and Socransky (1981) was 83%, whereas a 
figure of 42% was obtained in this study. The importance of 
this difference is doubtful since it could be related to the 
fact that different A.actinomycetemcomltans strains and 
blood agar plates were used in both studies. VAN Steen- 
bergen et al., (1986) who examined 21 isolates of A.actino­
mycetemcomitans including three Type strains reported low
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recovery rates on MGB which ranged from approximately 10% to 
100% giving an overall mean of 55%, which agrees with the 
results of the present study, and confirms that MGB medium 
significantly inhibits the growth of pure cultures of 
A.actinomycetemcomltans compared to growth on blood agar 
plates. Riches and Marsh (1987) reported that the growth of 
three Type strains of A .actinomycetemcomitans ranged between 
61% to 73% on MGB medium. Although two of the strains exam­
ined by Riches and Marsh (1987) were included in the present 
study, comparison of results is not possible because there 
was no data reported for these strains by these workers.
The other semi-selective medium TSBV has been used by a num­
ber of workers. Slots (1982b) has reported a mean recovery 
rate of 96% for 12 pure cultures on TSBV compared to the 
number on blood agar plates, but no information was given 
about the individual strains. However, VAN Steenbergen et 
al . , (1986) reported that using TSBV, a range of 50% to 
>100% (mean 85%) pure cultures of 21 strains of A.actinomy­
cetemcomitans were recovered as compared to blood agar 
plates. In the present investigation recovery rates of 94% 
to >100% (mean 98%) of pure cultures of A .actinomycetemcomi­
tans were obtained which agrees with the results of both 
Slots (1982b) and VAN Steenbergen et al., (1986). Neverthe­
less, Riches and Marsh (1987) reported the lowest recovery 
rate of 3% to 19% for three Type strains of A.actinomycetem­
comitans on TSBV. These results which disagree with the 
previously published data and that reported in this study
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may be explained by the fact that Riches and Marsh (1987) 
used only Type strains of A.actinomycetemcomitans.
In this study both TSBV and MGB significantly suppressed the 
growth of A .actinomycetemcomitans compared to CBA agar 
plates (p <0.005), but MGB was significantly more inhibitory 
than the TSBV (p <0.01) . The suppression of growth of 
A .actinomycetemcomitans strains on the these semi-selective 
media may be related to the presence of either antimi­
crobials or other agents such as malachite green. Riches and 
Marsh (1987) reported that TSBV was more inhibitory to three 
Type strains of A .actinomycetemcomitans (Y4, NCTC 10979, 
NCTC 9710) than MGB. Viable counts of A .actinomycetem­
comitans obtained ranged from 3% to 19% on TSBV, whereas MGB 
recovered a range of 61% to 73% (Riches and Marsh, 1987). 
These results disagree with the findings of the present 
investigation and those by VAN Steenbergen et al., (1986).
In the present study, MGB mainly suppressed the growth of 6 
(46%) fresh isolates of A .actinomycetemcomitans, while this 
was not observed with the Type strains of A .actinomycetem­
comitans (see Table 2.5) . On the contrary, the NCTC Type 
strains examined, grew equally well on both TSBV and MGB 
plates. In support of this findings, VAN Steenbergen et 
a l ., (1986) used three Type strains of A .actinomycetem­
comitans (Y4, ATCC 29523 and ATCC 29524) in their study 
(none of which were examined in the present investigation), 
and reported that all grew in high numbers on TSBV, MGB and 
blood agar plates. This discrepancy between Type and fresh 
isolates may possibly be explained by the fact that the Type
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strains have adapted to growing under laboratory conditions 
over a period of time (VAN Steenbergen et al., 1986). The
results of the present investigation and those by (VAN 
Steenbergen et al., 1986) highlight the importance of using 
fresh isolates as well as Type strains to examine the selec­
tivity of culture media to recover pure cultures of A.acti- 
nomycetemcomitans.
2.2.10 Isolation of A . actinomycetemcomitans from 
mixed cultures
This part of study was carried out to examine the effecti­
veness of both semi-selective media (TSBV and MGB) in recov­
ering A .actinomycetemcomitans from subgingival plaque samp­
les. Nine patients with 31 sites were examined in this 
study. One subgingival plaque sample was taken from the 
deepest pocket in each segment in which pocket depths of 6 
mm or more were found. Thus depending on the distribution 
of disease, one to 6 samples were taken from each patient. 
Samples were collected after isolating the relevant tooth 
with cotton wool rolls and drying with an air syringe. 
Supragingival plaque was collected with a sterile curette 
and discarded. One to three sterile paper points (depending 
on the space available) were inserted to the base of the 
pocket and left for 10 seconds. The paper points were then 
transferred to one ml ABB and immediately transported to the 
laboratory. All plaque samples were dispersed using a vor­
tex mixer (Fisons Scientific Apparatus, Leicestershire, Eng­
land) for 60 seconds and 10-fold dilutions were made in PBS. 
Using a spiral plater (Spiral Systems, Clough Pike, Cincin-
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nati, USA) , 50 Jil aliquots from the neat, 10 1 and 10 ^
dilutions were inoculated onto the TSBV and CBA plates. 
Incubation was carried out for 5 days at 37°C in 5% CC>2 in
air, and plates were examined daily for up to 5 days for the 
presence of * colonies resembling A .actinomycetemcomitans. 
Colonies were selected using the criteria described in 
section 2.3.5, and all isolates were identified using the 
same method described earlier in section 2.2.4.
2.2.11 Results:
A total number of 31 sites from nine patients were examined 
for the presence of A . actinomycetemcomitans using the two 
semi-selective media TSBV and MGB. Although only nine 
patients were included in this study, four patients (44%) 
and 8 sites (26%) were found to harbour A.actinomycetemcomi­
tans . However, as shown in Table 2.6 all positive cultures 
were detected only on TSBV medium since the MGB medium 
failed to recover A .actinomycetemcomitans from any of the 
mixed samples.
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Table 2.6 Isolation of A . a c t i n o m y c e t e m c o m i t a n s  from 
31 mixed samples using both TSBV and MGB media.
Patient
Number
N o . sites 
examined
N o. +ve 
sites
Medium +ve for 
A . a c t i n o m y c e t e m c o m i t a n s
01 1 1 TSBV
02 1 0 None
03 2 2 TSBV
04 2 0 None
05 3 3 TSBV
06 5 0 None
07 5 0 None
08 6 2 TSBV
09 6 0 None
Number of patients examined = 9 
Total sites examined = 31
Number of patients with A.actinomycetemcomitans = 4 (44%) 
Number of sites with A.actinomycetemcomitans = 8 (26%)
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2.2.12 Discussion:
There are only few reported studies which have investigated 
the isolation of A .actinomycetemcomitans from mixed samples 
using both TSBV and MGB media. Although only a small number 
of samples (31 sites) were included in this study, TSBV 
medium was found to be far superior to MGB medium in the 
recovery of A .actinomycetemcomitans from mixed samples obta­
ined from patients with periodontal disease. A similar 
study was carried out by VAN Steenbergen et al., (1986)
where the selectivity of both TSBV and MGB media in the rec­
overy of A.actinomycetemcomltans from 123 patients was inve­
stigated. Thirty patients (24%) were found to harbour 
A.actinomycetemcomltans as detected on TSBV medium incubated 
in air-5% C02. In comparison only 16 patients (13%) were 
positive for A.actinomycetemcomltans using MGB medium. Both 
the present investigation and the study by VAN Steenbergen 
et al., (1986) demonstrate the effectiveness of the TSBV
medium in the recovery of A.actinomycetemcomltans from mixed 
samples. However, the fact remains that A .actinomycetem­
comitans was not detected on MGB in this investigation, 
which disagree with the findings of VAN Steenbergen et al., 
(1986) . This could be due to the small number of samples 
examined, 31 compared to the 123 samples investigated by VAN 
Steenbergen et al., (1986). Certainly colonies of A.actino­
mycetemcomitans were larger, more characteristics and more 
easily recognized on TSBV compared with MGB medium, facts 
which were also noted by VAN Steenbergen et al., (1986) . 
Furthermore, TSBV medium was suitable for detecting catalase
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production unlike MGB which contains blood and can thus pro­
duce false positive results (Slots, 1982b; VAN Steenbergen 
et al., 198 6).
In conclusion, the results of the present investigation and 
those by other researchers are in agreement that TSBV medium 
is preferable to MGB for the isolation of A .actinomycetem­
comitans from subgingival plaque samples from periodontitis 
patients.
2.3 Clinical Study
2.3.1 Introduction
A .actinomycetemcomitans has been implicated in the aetiology 
of different forms of periodontitis, especially Localized 
Juvenile Periodontitis (LJP) (Zambon et al., 1983b; Mandell, 
1984) . However, it has not been frequently found in high 
proportions in patients with chronic periodontitis or in 
healthy subjects (Moore, 1987). Wolff et al., (1985) found
A.actinomycetemcomltans in 13% of of 284 people with healthy 
gingiva or moderate periodontitis, and the presence of 
A .actinomycetemcomitans was found to correlate with high 
plaque index and intermediate pocket depths of 3-5mm. Since 
there is no information about the the prevalence of A.actin­
omycetemcomitans in a Scottish population, a study was unde­
rtaken to quantify the prevalence of A.actinomycetemcomltans 
in subgingival plaque in 98 patients with chronic periodon­
titis and 55 healthy volunteers.
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The identification and enumeration of A . actinomycetemco­
mitans is important as there are close morphological and 
some biochemical similarities between A .actinomycetemcomi­
tans and the other facultative Gram-negative rods present in 
dental plaque especially H .aphrophilus. A .actinomycetem­
comitans has often been described as producing star-shaped 
colonies, and this characteristic has been heavily used in 
the isolation, identification and enumeration on primary 
selective culture plates. However, the literature lacks
information on the prevalence of both star-shaped and non­
star-shaped (SS/NSS) variants of this organism on primary 
culture. Therefore, using a number of the samples collected
from the chronic periodontitis and the healthy control
group, the prevalence of the different types of colonies (SS
and NSS) was investigated. Since systemic antimicrobial 
agents are sometimes used in the management of LJP and chro­
nic periodontitis (Slots and Rosling, 1983), it was decided 
to perform antimicrobial sensitivity tests on all isolates 
from diseased patients.
2.3.2 Material and methods 
Patients & controls
The population studied comprised 98 patients, (43 males and 
55 females), with advanced periodontitis who were referred 
to Glasgow Dental Hospital and School for specialist perio­
dontal assessment and treatment. Their ages ranged from 14- 
63 years with a mean age of 38.5 years.
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A healthy group of 55 young adults (27 males and 28 females) 
between the ages of 18-40 years with a mean age of 22.5 were 
selected to serve as a control group.
2.3.3 Clinical Assessment 
Chronic periodontitis patients
A full periodontal examination was carried out by a single 
consultant periodontologist using a WHO 621 probe (Ainamo et 
al., 1982). Each jaw was divided into 3 segments with the 
incisor and canine teeth forming one segment and the pre­
molar and molar teeth on either side the other two segm­
ents. Subgingival plaque samples were removed as described 
in section 2.2.9 and were later examined for the presence of 
A.actinomycetemcomitans as described in Figure 2.5.
Healthy volunteers
The majority of the 55 healthy volunteers were dental 
students at the Glasgow Dental Hospital and School. The 
mouths of these volunteers were examined by the same consul­
tant periodontologist who assessed the periodontitis group 
using WHO 621 probes (this was done gently to avoid any 
bleeding). All subjects were inspected to confirm that they 
had a generally healthy mouth without evidence of inflamm­
atory periodontal diseases. Samples were collected by first 
removing any supragingival plaque which was discarded. 
Using a sterile curette subgingival plaque was removed from 
one gingival sulcus/pocket in each quadrant. Due to the 
small amounts of plaque collected from each site, plaque 
samples were then immediately pooled in one ml of ABB, 
before transfer to the laboratory.
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Subgingival plaque 
(Paper points)
4-
1 ml ABB
I
Vortex mixing,
60s.
4
Culture 
Spiral Plater, 50 pi
^TSBV^
Incubation, 5% CO2 in 
air 37°C, 5 days
4-
Small adherent colonies, star shaped/non-star 
shaped, creamy in colour
______  Gram -ve rods,-------
| coccobacilli
Catalase -ve Catalase +ve
API 20A API 20A
H. aphrophilus A. actinoEycetexcoxitans
Figure 2.5 Chart for the isolation and identifi 
cation of A . actinomycetemcomitans .
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2.3.4 Culture of samples
All plaque samples were dispersed using a vortex mixer (Fis-
ons Scientific Apparatus, Leicestershire, England) for 60
seconds, then 10-fold dilutions made in PBS. Using a spiral
plater (Spiral Systems Clough Pike, Cincinnati, USA) , 50 |ll
_ 1 2aliquots of neat, 10 and 10 dilutions were inoculated 
onto the TSBV plates. Incubation was carried out for 5 days 
at 37°C in 5% CC>2 in air using a Qualitemp 80 MI incubator
(Laboratory Terminal Equipment Ltd., Oldham, UK) and using a 
manual magnifying glass the plates were examined daily for 
up to 5 days for the presence of colonies resembling A.acti- 
nomycetemcomitans. Colonies were selected using the crite­
ria described in section (2.3.5).
2.3.5 Identification of the freshly isolated A. acti­
nomycetemcomitans strains 
Colonial morphology
The colonies selected for isolation and identification were 
small, about 0.5-1.0mm diameter in size, circular, glisten­
ing with a slightly irregular edge and creamy in colour. 
Since both star-shaped and non-star-shaped colonies have 
been described previously, it was decided to examine plates 
for both variants in this study. Examples of the types of 
colonies selected are shown in Figure 2.6. A minimum of 3 
to 4 colonies from each TSBV agar plate were subcultured 
onto a fresh blood agar plate (CBA) and incubated for purity 
in 5% CC>2 in air for 48 hours. Pure isolates were then
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identified using the morphological and biochemical tests 
described earlier in section 2.2.4.
API-ZYM test
The API-ZYM (API Laboratories, La Balme, Les Grottes, 
France) is a semi-quantitative micro-method system which can 
be used to investigate the enzyme patterns produced by 
microorganisms. The API-ZYM colorimetric kit system was 
used to test the ability of 26 A.actinomycetemcomitans stra­
ins to produce different patterns of enzymes some of which 
may be involved in the pathogenicity of this organism. The 
assay was carried out by emulsifying a pure growth of 
A . act inomycetemcomitans from one CBA plate in 2 ml of 
sterile distilled water. The strips were inoculated using a 
pasteur pipette as recommended by the manufacturer and incu­
bated in an atmosphere of 5% C02, in air at 37°C for 4
hours. After incubation, the API-ZYM reagents A and B (API 
Laboratories, La Balme, Les Grottes, France) were added to 
the strips as recommended and the colour change (Figure 2.7) 
was recorded on a 0 to 5 scale according to the colour chart 
supplied with the test kit. Grade 0 was regarded as nega­
tive enzyme activity, grade 1 or 2 as a weak reaction and 
grade 3, 4 or 5 as strong activity.
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Figure 2.6 Variation in the colonial morphology of 
A . actinomycetemcomitans strains selected for isolat­
ion and identification.
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Figure 2.7 API-ZYM strip inoculated with A. actino­
mycetemcomitans (the test (A) shows change in colo­
ur, while the control (B) remains unchanged) .
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2.3.6 Antimicrobial sensitivity testing
A total of 4 6 A . actinomycetemcomitans isolates including 3 
reference strains were subjected to antimicrobial sensiti­
vity testing using Stokes method (Stokes and Waterworth, 
1972). The bacterial inoculum was prepared by growing each 
test organism on a CBA plate for 48 hours in an atmosphere 
of 5% CC>2 in air at 37°C. Five to seven colonies were
removed with a sterile loop and transferred to 2 ml of pept­
one water (Oxoid, Ltd., Basingstoke, Hampshire, England) 
then vortex mixed for 60 seconds. However, in the case of 
the control organism (Staphylococcus aureus Oxford NCTC 
6571), only one colony was removed and emulsified in 2 ml 
peptone water. For both control and test organisms a ste­
rile cotton wool swab was dipped into the bacterial suspen­
sion and the excess fluid removed by turning the swab 
against the side of the tube. The swab containing the test 
organism was then spread evenly in a broad band across the 
centre of the Diagnostic Sensitivity Test Agar .plate (DST, 
Appendix I) (Oxoid, Ltd., Basingstoke, Hampshire, England). 
The control organism was seeded evenly in two bands on 
either side of the test inoculum (see Figure 2.8) . All 
tests were run in duplicate on a single occasion. Antimi­
crobial discs (see Table 2.7) (Mast Lab., Merseyside, 
England) were applied with a sterile needle on the line bet­
ween the test and the control organisms and pressed gently 
onto the surface to ensure even contact with the medium. 
Due to the presence of a metronidazole antibiotic disc, all 
plates were incubated in an anaerobic chamber (Don Whithley
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TEST
m
CONTROL
Figure 2.8 Diagrammatic representation of an antimi­
crobial sensitivity test plate using StokeS method 
before incubation.
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Table 2.7 Antimicrobial agents used for testing the 
sensitivity patterns of A . actinomycetemcomitans .
Antimicrobial
Agent
Abbreviation Disc Potency
Amoxycillin A 10 ng
Erythromycin E 10 ng
Tetracycline T 10 ng
Penicillin PG 1.0 unit
Metronidazole MZ 2..5. m -------
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Scientific Ltd., West Yorkshire, England) at 37°C in an 
atmosphere of 85% N2, 10% H2 and 5% C02 for 48 hours.
Zones of inhibition were measured from the centre of the 
disc to the edge of the zone (Figure 2.9) and the difference 
between the test organism and control was calculated. 
Results were interpreted as follows:
Sensitive: Zone size equal to, wider than, or not more than 
3 mm smaller than the control.
Intermediate : Zone size greater than 3 mm, but smaller
than the control by more than 3 mm.
Resistant: Zone size 3 mm or less.
2.3.7 Maintenance of cultures
Due to the possibility of phenotypic variation occurring in 
strains of A. actinomycetemcomitans as a result of continuous 
subculture in vitro, freshly isolated bacteria were freeze 
dried within two to three subcultures after isolation and 
identification. Type strains supplied by NCTC or ATCC were 
also freeze dried.
Freeze dried ampoules (R and J Woods, Paisley, Scotland) 
were prepared for sterilization by placing a thin piece of 
card containing information to identify the isolate inside
the glass tube. A small piece of cotton wool was inserted
loosely into the top of the tube and the ampoule sterilized 
by dry heat at 160°C for 90 minutes. Using a cotton wool 
swab, the growth from two 48 hour CBA cultures was harvested 
and added to 3 ml of ABB. Approximately 0.5 ml of this emu-
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Figure 2.9 A DST agar plate inoculated with the test 
organism A .actinomycetemcomitans and S .aureus NCTC 
6571 as control, for sensitivity testing of amoxyci­
llin, erythromycin, tetracycline, penicillin and 
metronidazole using Stokes method.
96
lsion was added to prelabelled sterile ampoules. Freeze 
drying was subsequently performed using an Edwards EF4 
Modulyo freeze drier (Edwards High Vacuum, Crawley, 
England). Freezing was carried out on two stages, firstly 
during centrifugation and secondly when the vials had 
stopped spinning. This secondary freezing was continued 
until a pressure of 1.3 x 10 ^m bar or below was achieved. 
The vials were then constricted using an Edwards Ampoule 
constricter and subjected to the final stage of freeze dry­
ing under a vacuum for 60 to 90 minutes . After this 
procedure the ampoules were sealed using an Edwards Flame- 
master hand torch and stored at room temperature until req­
uired. Fresh ampoules were opened after the strains in use 
had been subcultured on more than five occasions. During 
experimental work, cultures were maintained on blood agar 
plates at 4°C.
When required, ampoules were opened by making a mark around 
the top half of the glass vial with a diamond marker. A 
clean paper napkin was placed around the ampoule and the top 
of the ampoule was broken off. Two to three drops of ABB 
were added to the culture using a pasteur pipette. The 
bacterial suspension was then inoculated onto a fresh CBA 
plate and incubated, at 37°C in an atmosphere of 5% C02 in 
air for 48-72 hours, each culture was then checked for pur­
ity as described in section 2.2.4 before use.
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*• 2.4 Results:
2.4.1 Isolation of A . a  c t  i n omy cetemcomi'tans from 9  8  
patients with chronic periodontitis
Ninety eight patients with chronic periodontitis were exami­
ned in this study. The male group consisted of 43 patients 
aged from 20 to 63 years (mean 41); and the female group of 
55 patients aged between 14 to 59 (mean 36.4). The results 
for the isolation of A .actinomycetemcomitans from the 98 
patients with chronic periodontitis are shown in Table 2.8. 
A . act inomycetemcomitans was isolated from 38 out of 98 
patients (39%), aged between 14 to 63 years (mean 38.5) . As 
shown in Table 2.8, the percentage carriage of A. actino­
mycetemcomitans among the different age groups, varied from 
28% to 63% excluding age groups 11-20 and 61-70 because only 
very few patients were examined. The highest percentage 
carriage of 63% was evident in the age group of 20 to 30 
years, with a figure of 45% being recorded for the 51-60 
group (Table 2.8). Of the 43 males and 55 females examined; 
3 9.5% of male and 38.2% of female patients were found to be 
positive for A .actinomycetemcomitans.
2.4.2 Isolation of A . actinomycetemcomitans from hea­
lthy control subjects
There were 55 control subjects examined in the present 
investigation (Table 2.9). The male group consisted of 27 
subjects aged from 20 to 30 years old with a mean age of 23 
years; and the female group of 28 subjects aged between 18 
and 40 years of age (mean 22 years). As shown in Table 2.9
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almost all of the subjects tested were aged from 20 to 30 
years. A . actinomycetemcomitans was isolated from only one 
(4%) male control subject and from none of the female cont­
rol subjects giving an overall mean prevalence of 2% for the 
55 control subjects.
2.4.3 Isolation frequency of A .actinomycetemcomitans 
from 302 sites sampled in 98 patients
The isolation frequency of A .actinomycetemcomitans from the 
different diseased sites in the 98 periodontitis patients 
are shown in Tables 2.10, 2.11, 2.12 and summarized in Table 
2.13. The sites were divided into 6 different segments, 
namely, (I) upper right, (II) upper left posterior, (III) 
upper anterior, (IV) lower anterior, (V) lower right 
posterior, and (VI) upper left posterior. Of the 302 subgi­
ngival plaque samples examined, 82 (27%) harboured A .actino-
mycetemcomitans; 49 (60%) of these sites were detected in
males and 31 (40%) sites from female patients . As shown in 
Tables 2.10, 2.11 and 2.12, there were approximately similar 
numbers of sites examined and sampled in both male and 
female patients.
In general the isolation of A .actinomycetemcomitans from 
these sites tended to be higher in male patients compared to 
females. The only exception to this was in the upper right 
posterior segments where the number of sites positive for 
A . act inomycetemcomitans in females was twice of that in male 
patients (32% v 16%) . When the results for males and 
females are combined (Table 2.13), the isolation frequency
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of A.actinomycetemcomitans in the six different sites exam­
ined, ranged from 19% to 34% with no large differences noted 
between any of the sites examined.
2.4.4 Viable counts of A . a.ctinomycetezncomit3.ns
In order to reduce the bulk of data, all the colony forming 
units per millilitre (cfu/ml) obtained for A.actinomycetem- 
comitans on TSBV agar plates were converted into a logari­
thmic format (log^ cfu/ml) . The log10 cfu/ml of A.actino-
mycetemcomitans for both male and female patients are shown 
in Tables 2.14 and 2.15. A.actinomycetemcomitans was 
detected in variable concentrations among different patients 
as well as in different sites in the same individual. As 
shown in Table 2.14 the concentration of A.actinomycetem­
comitans in samples from male patients ranged from log^Q
1.15 to 6.52 (mean 5.2), while a range of 1.3 to 6.34 (mean 
4.34) was recorded for samples obtained from female patients 
(Table 2.15). The overall' mean log^o cfu/ml of A.actinomy­
cetemcomitans was found to be significantly higher in males 
logiO 5.2 than in females log^o 4.34 (p < 0.03) using paired
t-Test. Although 63 and 62 samples were examined in both 
males and females respectively, more samples were positive 
for A.actinomycetemcomitans from male patients 49 (78%) com­
pared with female patients 33 (53%) (Tables 2.14 and 2.15).
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Table 2.8 Age range and prevalence of A . act Inomy- 
cetemcomitans isolated from 98 patients with chronic 
periodontitis.
Age 
distribution 
(Years)
No . 
M
tested
F
N o . 
M
+ve
F
Overall 
% +ve
0-10 0 0 0 0 0%
11-20 1 2 1 1 67%
21-30 6 13 2 10 63%
31-40 13 26 4 7 28%
41-50 15 10 6 2 32%
51-60 7 4 4 1 45%
61-70 1 0 0 0 0%
Total _ 4.3 55 17_ 21 39%
Age range: 14-63 yrs 
Mean age: 38.5 yrs 
M: Male patients 
F: Female patients
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Table 2.9 Age range and prevalence of A . a c t i n o m y ­
cetemcomitans isolated from male and female control 
subjects.
Age 
distribution 
(Years)
No. tested 
M F
No. 
M
+ve
F
Overall 
% +ve
0-10 0 0 0 0 0%
11-20 3 7 0 0 0%
21-30 24 19 1 0 2.3%
31-40 0 2 0 0 0%
Total 27 28 1 0 2%
Age range: 20-40 yrs 
Mean age: 22.5 yrs 
M: Male subjects 
F: Female subjects
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Table 2.10 Isolation frequency of A.actinomycetem­
comitans in the upper posterior segments of male and 
female patients.
Upper Right 
Posterior Segments
No.S.T No.+ve % ve
Upper Left 
Posterior Segments
No . S .T N o .+ve % ve
Males 25 4 16 24 6 25
Females 25 8 32 29 4 14
Total 50 12 24 53 10 19
No.S.T: Number of sites tested
Table 2.11 Isolation frequency of A .actinomycetem-
comitans in the lower posterior segments of male and
female patients.
Lower Right 
Posterior Segments
Lower
Posterior
Left
Segments
N o .S .T N o .+ve % ve N o .S .T N o .+ve % ve
Males 21 10 48 16 9 56
Females 22 2 9 25 5 20
Total 43 12---- 24 41 14 3.4.
No.S.T: Number of sites tested
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Table 2.12 Isolation frequency of A . actlnomycetem- 
comltans in the anterior segments of male and female 
p atie n t s .
Upper 
Anterior Segments
N o .S .T N o .+ve % ve
Lower 
Anterior Segments
N o .S .T N o .+ve % ve
Males 30 12 40 22 8 36
Females 43 9 21 20 5 25
Total 73 21 29 42 13 .31
No.S.T: Number of sites tested
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Table 2 . 13 Summary of the isolation frequency of 
A . a.ctd.nomyc6temcomitans in the different oral segme­
nts of male and female patients.
Segment No.sites tested No.+ve sites % +ve
Upper Right 
Post. Seg.
50 12 24%
Upper Left 
Post. Seg.
53 10 19%
Lower Right 
Post. Seg.
43 12 28%
Lower Left 
Post. Seg.
41 14 34%
Upper Anter. 
Segment
73 21 29%
Lower Anter. 
Segment
42 13 31%
Total 802 82 27%
Post.: Posterior 
Anter: Anterior 
Seg.: Segment
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Table 2.14 Viable counts of A. actinomycetemcomitans 
(logio cfu/ml) on TSBV from subgingival plaque samp­
les of male patients.
Patient
Number
Age
(Yrs)
No. Sit. 
tested
N o .+ve 
Sites
Range of 
logi n cfu/ml
Mean 
+ve sites
01 20 6 2 3. 0-3.9 3.65
02 23 6 3 5.08-5.11 5.08
03 30 3 3 5.62-6.52 6.30
04 33 5 5 1.15-6.11 5.76
05 34 4 4 3.0-4.83 4.36
06 35 2 2 4.08-5.36 5.08
07 38 3 3 2.78-4.95 4 .54
08 42 2 2 5.18-5.59 5.43
09 42 5 5 2.9-5.65 5.23
10 42 5 3 3.56-5.0 4.67
11 43 4 3 5.0-5.62 5.43
12 43 1 1 5.23 5.23
13 44 3 3 3.68-6.11 5.9
14 52 3 1 5.38 5.38
15 55 4 4 2.5-5.54 5.04
16 55 3 3 2.3-5.95 5.58
__ 17 58 4 2 4.34-6.0 5.7
No. Sit: Number of sites
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Table 2.15 Viable counts of A.actinomycetemcomitans 
(logio cfu/ml) on TSBV from subgingival plaque samp­
les of female patients.
Patient
Number
Age
(Yrs)
No. Sit. 
tested
N o .+ve 
Sites
Range of 
logi n cfu/ml
Mean 
+ve sites
01 20 4 1 NT NT
02 21 3 3 5.0-5.25 5.0
03 24 3 3 NT NT
04 27 2 1 2.5 2.5
05 28 1 1 4.89 4.89
06 29 5 1 4.99 4.99
07 29 4 1 5.04 5.04
08 30 3 1 5.78 5.78
09 30 6 6 1.6-5.25 4.5
10 30 1 1 5.2 5.2
11 30 3 3 1.3-3.48 3.15
12 33 5 1 2.3 2.3
13 33 1 1 4.25 4 .25
14 34 1 1 2.82 2.82
15 35 4 1 3.68 3.68
16 36 5 1 4.0 4.0
17 37 1 1 NT NT
18 38 3 1 4.99 4.99
19 41 2 1 6.34 6.34
20 48 2 1 2.48 2.48
_ 21 53 _ 3 2 1.78-5.53 5.23 _
NT: Not tested
No. Sit: Number of site
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2.4.5 Biochemical results of the freshly isolated 
strains of A .actinomycetemcomitans
The biochemical profiles of A.actinomycetemcomitans using 
the API 20 A system are summarized in Table 2.16. Results 
obtained for 38 fresh isolates, showed that all A.actino­
mycetemcomitans strains (100%) fermented glucose, maltose 
and mannose. However, 68% of isolates fermented mannitol; 
42% fermented xylose and only 8% of all isolates fermented 
glycerol or rhamanose. In addition all isolates produced 
catalase and did not require either X or V growth factors. 
Using the API 20 A system, the majority of isolates 21 (55%) 
were found to produce the profile 4110404 followed by 
4050404 (29%), 4150404 (13%), and 4010404 (3%) (see Table
2.16) .
2.4.6 The enzymatic characterization of A.actinomy­
cetemcomitans
The enzyme patterns of 26 different strains of A.actinomy­
cetemcomitans were examined using the API ZYM test. These 
A.actinomycetemcomitans strains included both Type strains 
and fresh isolates from the present investigation. Results 
summarized in Table 2.17 clearly shows that all 26 A.actino­
mycetemcomitans strains (100%) were strongly positive for 
alkaline and acid phosphatases, leucine arylamidase, but 
weakly positive for esterase and phosphohydrolase (see Table 
2.17) .
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Table 2 . 1 6  Summary of the biochemical results for 
the 3 8  freshly isolated A . actinomycetemcomitans str­
ains as determined by the A P I  2 0  A  system.
A.actinomycetemcomitans ( 3 8 strains)
Test RESULT % Positive
Indole - 0
Urea - 0
Glucose + 100
Mannitol V 68
Lactose - 0
Saccharose - 0
Maltose + 100
Salicin - 0
Xylose V 42
Arabinose - 0
Gelatin - 0
Esculin - 0
Glycerol V 8
Cellobiose - 0
Mannose + 100
Melezitose - 0
Raffinose - 0
Sorbitol - 0
Rhamnose V 8
Trehalose - 0
Catalase + 100
Sign: +, positive reaction; negative reaction; v,
variable reaction.
Number of strains which produced the profile 4110404 — 21 
(55%)
Number of strains which produced the profile 4050404 — 11 
(29%)
Number of strains which produced the profile 4150404 — 5 
(13%)
Number of strains which produced the profile 4010404 - 1 
(3%)
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Table 2.17 Summary of the enzymatic characteristics 
of A. actinomycetemcomitans (26 strains) as determi­
ned by the API-ZYM system.
A.actinomycetemcomitans (26 strains)
Enzyme tested RESULT % positive
Alkaline phoshatase + (S) 100
Esterase (butyrate) + (W) 100
Esterase-Lipase
(caprylate)
+ (W) 100
Lipase (myristate) - 0
Leucine arylamidase + (S) 100
Valine arylamidase - 0
Cystine arylamidase - 0
Trypsin - 0
Chymotrypsin - 0
Acid phoshatase + (S) 100
Naphtol-AS-BI-
phosphohydrolase + (W) 100
CX galctosidase - 0
(2 galctosidase - 0
(3 glucuronidase - 0
0! glucosidase - 0
(3 glucosidase - 0
N-acetyl-(3 glucosamindase - 0
CX mannosidase 
CX fucosidase
0
0
Sign: + (S), strong positive reaction
Sign: + (W), weak positive reaction
Sign: negative reaction
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2.4.7 The prevalence of star—shaped and non—star- 
shaped colonies in primary cultures of A.actinomy­
cetemcomitans isolated from subgingival plaque sam­
ples
The prevalence of star-shaped and non-star shaped colonies 
of A . actinomycetemcomitans was examined in the primary cult­
ures of samples from patients employed in this study. Alth­
ough, 38 patients were found to be positive for A.actino­
mycetemcomitans, full information concerning star-shaped and 
non-star-shaped colonies was only obtained for 31 of these 
patients. As shown in Table 2.18, A.actinomycetemcomitans 
isolates formed star-shaped colonies in only 16 (52%) of
patients, whereas in 20 (64%) patients, A.actinomycetemcomi­
tans produced only non-star shaped colonies on primary iso­
lation on TSBV medium. In 5 (16%) of patients, both colo­
nial types of A. actinomycetemcomitans were present on prim­
ary isolation.
While there were 31 patients examined in this study, a total 
of 157 colonies (star-shaped and non-star-shaped) were sele­
cted from the subgingival plaque samples of these patients 
for identification. As shown in Table 2.19, 120 colonies
were identified as A.actinomycetemcomitans; 50 (68%) of
which appeared star-shaped, whereas the other 70 (83%) colo­
nies were non-star shaped on primary isolation. The other 
37 colonies were identified as H .aphrophilus which also produced 
star-shaped and non-star-shaped colonies on primary isola­
tion. Furthermore, in a number of cases all of the star­
shaped colonies selected were identified as H . aphrophilus 
(eg. patients number 7 and 30) .
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Table 2.18 The prevalence of star-shaped and non­
star-shaped strains of A.actinomycetemcomitans in 
subgingival plaque samples on primary isolation on 
TSBV medium from 31 patients.
Patient
Number
A . a 
Source
A.actinomycetemcomitans 
SSC NSSC
07 GDH 310 -ve +ve
08 GDH 312 -ve +ve
18 GDH 1014 +ve -ve
19 GDH 1212 -ve +ve
20 GDH 1214 -ve +ve
27 GDH 110 -ve +ve
28 GDH 114 +ve -ve
29 GDH 127 +ve -ve
30 GDH 1114 -ve +ve
32 GDH 125 -ve +ve
33 GDH 12 9 -ve +ve
34 GDH 1116 -ve +ve
35 GDH 1123 +ve +ve
36 GDH 28/78 -ve +ve
37 GDH 33 +ve -ve
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Table 2.18 Continued.
Patient
Number
A . a 
Source
A.actinomycetemcomitans 
SSC NSSC
38 GDH 39 -ve +ve
39 GDH 1115 -ve +ve
41 GDH 1125 -ve +ve
42 GDH 227916 +ve -ve
43 GDH 117 +ve +ve
44 GDH 119 +ve -ve
45 GDH 130376 +ve -ve
46 GDH 226824 +ve +ve
47 GDH 229075 +ve -ve
48 GDH 231393 +ve -ve
50 GDH 121 +ve +ve
51 GDH 228 -ve +ve
52 GDH 213705 -ve +ve
53 GDH 225843 +ve +ve
54 GDH 229473 +ve +ve
55 GDH 239911 +ve -ve
Total 31 strains 16 20
A. a: A.actinomycetemcomitans 
SSC: Star-shaped colonies 
NSSC: Non-star-shaped colonies
Number of subjects with A.actinomycetemcomitans = 31
Number of subjects with star—shaped colonies — 16 (52 o)
Number of subjects with n o n — star—shaped colonies — 20 (64 o)
Number of subjects with both SSC and NSSC — 5 (16o)
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Table 2 . 1 9  The prevalence of star-shaped and non­
star-shaped colonies of A . actinomycetemcomitans and 
H .aphrophilus in subgingival plaque samples on prim­
ary isolation on TSBV medium from 31 patients.
Patient A . actinomycetemcomitans H .aphrophilus
Number N O .SSC No.NSSC N o .SSC N o .NSSC
07 0 4 3 0
08 0 4 0 0
18 2 0 0 0
19 0 2 0 1
20 0 3 2 0
27 0 1 1 1
28 1 .0 1 1
29 8 0 0 3
30 0 5 3 0
32 0 1 1 0
33 0 3 0 1
34 0 6 0 6
35 2 1 0 0
36 0 1 1 1
, .37..... . 2 o 0
0
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Table 2.19 Continued.
Patient A.actinomycetemcomitans H .aphrophilus
Number______ No . SSC______ No . NSSC______No.SSC No.NSSC
38 0 8 6 0
39 0 4 2 0
41 0 1 1 0
42 5 0 0 0
43 2 7 0 0
44 4 0 1 0
45 6 0 0 0
46 1 5 0 0
47 5 0 0 0
48 2 0 0 0
50 2 0 0 0
51 0 1 1 0
52 0 4 0 0
53 2 6 0 0
54 3 3 0 0
55
Tnf a 1
3
RD
0
70
0
23
0
14
Total number of colonies counted = 157
Number
120
of colonies identified as A.actinomycetemcomitans
Number
(42%)
of SSC identified as A .actinomycetemcomitans
50
Number
(52%)
of NSSC identified as A.,actinomycetemcomitans -
70
Number of colonies identified as H . aphrophilus = 37
2.4.8 The antimicrobial sensitivity of A.actinomy­
cetemcomitans
The antimicrobial sensitivity of 46 strains of A.actinomy­
cetemcomitans was investigated. The agents used were, tetr­
acycline, erythromycin, penicillin, amoxycillin and metroni­
dazole. The results obtained from duplicate readings of 
zones of inhibition showed that, all 46 A.actinomycetem­
comitans strains (100%) were sensitive to tetracycline and 
amoxycillin. Overall, 44 strains (96%) were sensitive to 
erythromycin. The sensitivity to penicillin was variable 
with only 11 strains (24%) giving sensitive results. All 
isolates (100%) were resistant to metronidazole (see Table 
2 .20) .
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Table 2 .20 The effect of five antimicrobial agents 
on A . actinomycetemcomitans (results represent dupli­
cate readings of inhibition zones using S. aureus 
NCTC 6571 as control.
Disc Sensitivity Results
Antimicr- No. Strains No. Strains No. Strains 
obial Sensitive Moderately Resistant 
agent (%) Sensitive (%) (%)
Amoxycillin 46 (100%) 0 0
Tetracycline 46 (100%) 0 0
Erythromycin 44 (96%) 2 (4%) 0
Penicillin 11 (24%) 29 (63%) 6 (13%)
Metronidazole 0 0 46 (100%)
Sensitive: Zone size equal to , greater than , or not more
than 3 mm smaller than the control zone.
Moderate: Zone size greater than 3 mm, but smaller than
the control by more than 3 mm.
Resistant: Zone size 3 mm or less and criteria as
described by StokeS ‘ and Waterworth (1972) .
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2.5 Discussion:
2.5.1 The prevalence of A .act inomyce'tGm.coniita.ns in 
healthy subjects and chronic periodontitis patients
(I) Health
There are only a few studies which have investigated the 
prevalence of A.actinomycetemcomitans in chronic periodon­
titis patients and healthy individuals using culture techni­
ques involving selective media. In the present investig­
ation A.actinomycetemcomitans was isolated from only one 
sample (2%) from 55 healthy subjects aged 18 to 40 years 
(mean 22.5). However, other researchers have reported 
higher prevalence rates of A.actinomycetemcomitans in their 
healthy control groups. For example, Slots et al.r (1980a) 
reported that 4 (36%) of 11 adults and 17% of the 66 samples 
analysed were positive for A.actinomycetemcomitans. In a 
large group of 142 healthy individuals aged 9 months to 54 
years, 24/142 (17%) of patients had A.actinomycetemcomitans
(Zambon et al., 1983b). In 1984, Okuda, et al., reported
that the prevalence of A.actinomycetemcomitans in an healthy 
adult group was higher than that in periodontitis patients. 
A.actinomycetemcomitans was recovered from 5/6 samples 
collected from healthy subjects. Furthermore, Mombelli et 
al., (1990) examined 29 periodontally healthy adults with 
partially erupted lower third molars aged 19-38 years (mean 
24) and found that 34% of subjects possessed A. actinomy­
cetemcomitans. The reason for the low prevalence figures 
obtained in the present study is uncertain but may be 
related to the fact that the majority of volunteers were
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dental students with a higher level of oral hygiene compared 
to other groups in the population.
(II) Chronic Periodontitis
The prevalence of A.actinomycetemcomitans in patients with 
chronic periodontitis have differed among researchers. Stu­
dies which have used methods similar to those employed in 
this investigation have produced a range of prevalence fig­
ures for A.actinomycetemcomitans (see Table 1.4). Slots et 
al., (1980a) reported that A.actinomycetemcomitans was isol­
ated from 6 (50%) adult patients with chronic periodontitis 
aged 30 to 65 years, and this is the highest prevalence 
level to be reported by any research group. Other workers 
have found A.actinomycetemcomitans at levels ranging between 
13% to 40% in adult chronic periodontitis patients. For 
instance, Bonta et al., (1985) reported that 30% of 10 chro­
nic periodontitis patients harboured A.actinomycetemcomi­
tans, while Dahlen et al ., (1989) detected A.actinomycetem­
comitans in 40% of 20 patients aged 30 to 65 years with the 
same condition. The results of the present investigation 
which used culture techniques similar to those described by 
Dahlen et al., (1989) produced a prevalence carriage of 39%. 
In a large group of 284 subjects with either healthy gingiva 
or with moderate chronic periodontitis, Wolff et al., (1985) 
reported an overall recovery rate of 13% for A.actinomy­
cetemcomitans. However, no details were given concerning 
the percentage carriage in the different patients examined 
by Wolff et al., (1985).
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The prevalence data for sites will be discussed next. In 
the present investigation 302 samples were collected from 
patients with periodontal pockets of ^ 6mm. A .act inomy— 
cetemcomitans was detected in 82 (27%) of samples. This is
comparable with figures reported by Slots et al., (1980a) 
and Dahlen et al., (1989) who found that 35% and 28% of
sites examined in patients with chronic periodontitis yiel­
ded A.actinomycetemcomitans. However, other researchers 
have found smaller values for positive sites which varied 
between 9 and 21% (Okuda et al., 1984; Wolff et al., 1985; 
Slots et al., 1985) . The prevalence of A.actinomycetemcomi­
tans in 6 different oral segments in the mouths of diseased 
individuals was examined in the present investigation, and 
although the prevalence in positive sites ranged from 19% to 
31% there were no large differences noted. Although there 
have been a number of studies which have investigated the 
prevalence of A.actinomycetemcomitans in chronic periodonti­
tis patients, no details have been given about the isolation 
of A.actinomycetemcomitans in the different sites examined.
In conclusion the study by Slots et al., (1980a) presented 
some evidence in which the prevalence of A.actinomycetem­
comitans in chronic periodontitis was only slightly higher 
(50% v 36%) compared to the prevalence in healthy subjects. 
Zambon et al., (1983b) reported similar observations, show­
ing that while 21% of 134 patients with chronic periodon­
titis harboured A.actinomycetemcomitans, 17% of 142 healthy 
individuals in the same study were positive. In one paper 
by Okuda et al., (1984) the opposite appeared to occur, ie.
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more healthy subjects (5/6) harboured A.actinomycetemco­
mitans compared to patients (3/8). In the present investi­
gation there was clear evidence that the number of patie­
nts with A.actinomycetemcomitans is more than that of heal­
thy adults (39% v 2%) . Although, not all studies agree, 
there is a trend which suggests that more patients with chr­
onic periodontitis harbour A.actinomycetemcomitans compared 
to healthy individuals.
(Ill) Progressive and Non-progressive Chronic Perio­
dontitis
Although there are only a few studies performed in this 
field, it has been suggested that A.actinomycetemcomitans 
could mainly be found in progressive rather than non­
progressive sites in chronic periodontitis patients (Slots 
and Genco, 1984) . Tanner et al., (1979) found that 4 out of 
16 progressive sites in patients with chronic periodontitis 
harboured A.actinomycetemcomitans, but none of the five non­
progressive sites examined yielded positive cultures. Furt­
her evidence was reported by Slots et al., (1986), who found 
that 50% of 130 sites from 71 patients with active periodon­
tal pockets (6-llmm depth) yielded A.actinomycetemcomitans, 
but only 5% of 105 non-progressive sites from 75 patients 
proved to be positive. In addition Mandell, Ebersole and 
Socransky (1987) reported that while 90% of the progressing 
sites (18/20) harboured A.actinomycetemcomitans, only 44% of 
the inactive sites were positive.
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Thus, the little information available suggests that A.anti­
nomy cetemcomi tans is moire likely be isolated from 'active* 
compared to 'inactive' sites (Slots et al., 1986; Mandell et 
al., 1987). However, further studies are needed to confirm 
these observations, and to establish the clinical importance 
of isolating A .actinomycetemcomitans from chronic periodon­
titis patients and healthy subjects. Finally, it would also 
be important to establish if the leucotoxic activity and 
other pathogenic properties of the different isolates from 
these groups are different. Only one study appears to have 
investigated this matter and suggested that there were more 
A.actinomycetemcomitans isolates from chronic periodontitis 
possessing leucotoxic activity (43%) compared to those from 
healthy subjects (11%) (Zambon et al., 1983c).
2.5.2 Percentage proportion of A . actinomycetemcomi­
tans in total microbial counts of subgingival plaque 
in healthy subjects and chronic periodontitis
The numbers of A.actinomycetemcomitans isolated on semi- 
selective media expressed as a percentage of the total micr­
obial counts on blood agar plates from healthy or infected 
areas in chronic periodontitis patients have been reported 
by a number of researchers.
(I) Health
There are only a few studies that have reported the propo­
rtion of A.actinomycetemcomitans present in the total micro­
bial counts of subgingival plaque collected from healthy 
subjects. Slots et al., (1980a) have shown that in 11 posi-
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tive sites from 12 healthy subjects, the concentration of 
A.actinomycetemcomitans ranged from 0.9% to 5% of the total 
count, with 85% of patients possessing levels of less than 
1%. Mombelli et al., (1990) have reported that A.actino­
mycetemcomitans constituted <0.01% to 0.07% (mean 0.03%) of 
the total microbial count in subgingival plaque samples from 
29 healthy individuals. Finally the proportion of A.actino­
mycetemcomitans in 5 subgingival plaque samples collected 
from 5 subjects' was reported to range from 0.05% to 1.5% 
(mean 0.72%) by Okuda et al., (1984). Although only one 
healthy individual in the present study was positive for 
A.actinomycetemcomitans, no information is available concer­
ning the concentration of A.actinomycetemcomitans in this 
subject.
(II) Chronic Periodontitis
The concentration of A. actinomycetemcomitans in samples from 
chronic periodontitis patients have varied among different 
workers. Slots et al., (1980a) have reported that the conc­
entration of A.actinomycetemcomitans in 17 positive sites 
ranged from <0.9% to 40%. However, more than 75% of these 
sites had A.actinomycetemcomitans at a concentration of 
^0.9%, while only one sample exhibited a range of 20 to 40% 
(Slots et al., 1980a). Similar observations were reported 
by Wolff et al., (1985) who found A.actinomycetemcomitans 
levels to be equal to or less than 1% of the total microbial 
flora in 87% of 47 positive sites from 37 subjects. In the 
other 13% of sites, A.actinomycetemcomitans was found at 
levels of >1% to 12% of the total flora. Okuda et al.,
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(1984) examined a small number of patients and showed that 
3/8 patients harboured A.actinomycetemcomitans at a concent­
ration ranging from 0.7% to 1.9% (mean 1.5%) of the total 
microbial count. In 1989, Dahlen et al., reported that 
A.actinomycetemcomitans accounted for 0.03% to 0.5% (mean 
(0.2%) of the total microbial flora in 11 positive sites 
from 8 patients with chronic periodontitis.
In the present study, a total microbial count as obtained 
from anaerobic blood agar culture was not available , and 
therefore a comparison with the results of other workers is 
not possible. However, the overall mean count of A.actino­
mycetemcomitans on TSBV was log]_o 4-8 (range 1.15-6.52)
cfu/ml in 82 positive sites. Using the same semi-selective 
medium used in this study incubated under anaerobic condi­
tions, Christersson et al., (1985) reported that A.actino­
mycetemcomitans was present in an overall mean log^o 5.9 in 
24 samples from two patients. In addition, a mean log]_o 5.5 
has been reported by Mandell (1984) using, the MGB semi- 
selective medium for isolation in either aerobic or anaer­
obic conditions.
(Ill) Progressive and Non-Progressive Chronic Perio­
dontitis
There are only three papers which have reported the pro­
portions of A . actinomycetemcomitans in plaque from active 
and non-progressive sites in patients with chronic perio­
dontitis. Tanner et al., (197 9) reported a mean plaque con­
centration of zero percent and 14% for A . actinomycetem-
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comitans in non progressive and sctivg sites respectively 
In comparison, Slots et al., (1986) showed that A.actinomy-
cetemcomitans accounted for 4.3% (range 0.0002-50%) of the 
total microbial count of plague collected from active perio­
dontal sites compared to 0.6% (range 0.002-2.1%) in non-pro­
gressive sites. In addition, Mandell et al., (1987) repo­
rted that 20 progressive sites in 8 patients harboured 
A . actinomycetemcomitans at a concentration ranging from 0%- 
73% (mean 20%), this compared with a range of 0%-19% (mean 
3%) in subgingival samples from non-progressive sites in the 
same patients. In contrast to the prevalence of A.actinomy- 
cetemcomitans, these results all agree that overall diseased 
sites harboured higher concentrations of A.actinomycetemco- 
mitans compared to either healthy or inactive sites. Howe­
ver, considerable variations between the diseased and non­
diseased sites also occurred.
Slots and Genco (1984) have suggested that even if the per­
centage proportion of A.actinomycetemcomitans in subgingival 
plaque is less than 2%, this low level may still cause dise­
ase due to the high virulence of A. actinomycetemcomitans. 
If this is true then the mere presence of A. actinomycetem­
comitans in any subject could lead to periodontal disease. 
Since this is not clearly supported by clinical data, it has 
been argued that the isolation of leucotoxic strains from an 
individual must be demonstrated before a significant relati­
onship between A . actinomycetemcomitans and disease can be 
considered. The question of leucotoxicity and pathogenicity 
will be discussed in Chapter 5.
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2.5.3 Biochemical charactsristics of A . a c t d. nomyce t —
emcomd.ta.ns
In the present investigation, the API 20 A system used in 
identification, gave reproducible results with all isolates 
tested. The freshly isolated A.actinomycetemcomitans stra­
ins (38) fermented glucose, maltose, mannose and produced 
catalase, results which agree with those of King and Tatum, 
1962; Pulverer and Ko, 1970; Sneath and Johnson, 1973; 
Slots, 1982a. However, 68% of isolates fermented mannitol, 
42% fermented xylose and only 8% fermented both glycerol and 
rhamnose. The variable fermentation activity of A.actinomy­
cetemcomitans strains towards mannitol and xylose have been 
previously reported by King and Tatum (1962); Pulverer and 
Ko (1970); Slots (1982a) and Tanner et al., (1982). Howe­
ver, two papers only have reported positive results for the 
two carbohydrates xylose and mannitol (Mannheim, Pohl and 
Hollander, 1980; Sneath and Johnson, 1973). In addition, 
three (8%) of the freshly isolated A.actinomycetemcomitans 
strains in the present study fermented glycerol and rham­
nose, a finding which disagrees with the results reported by 
previous researchers.
Urease has been reported to be positive by Sneath and 
Johnson, (1973) and variable by Mannheim et al., (1980) both 
of which disagree with the uniform negative results found in 
this investigation and in those of other researchers (King 
and Tatum, 1962; Pulverer and Ko, 1970; Slots, 1982a; Tanner 
et al., 1982). Differences in the composition of the basal 
media and the methods used to investigate the biochemical
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activity of A . actinomycetemcomitans may explain some of the 
conflicting results reported by different investigators. 
Thus, it would help if all researchers used one standard 
identification system such as the the API 20 A (used in this 
investigation), which although expensive is readily avail­
able and easy to use.
Slots (1982a) examined the enzyme patterns of 136 strains of 
A .actinomycetemcomitans and found that all strains (100%) 
produced strong alkaline and acid phosphatases but produced 
weak leucine aminopeptidase (86%) using the API-ZYM system. 
Results obtained using the same detection system in the 
present study with 2 6 A.actinomycetemcomitans strains, agree 
with these findings. However, only weak activity was evid­
ent with esterase (butyrate), esterase lipase (carpylate), 
and phsophohydrolase similar to those reported by Slots 
(1982a).
2.5.4 Colonial morphology of A .actinomycetemcomitans 
on primary isolation
A.actinomycetemcomitans has been described as producing 
star-shaped colonies (Slots, 1982a; Zambon, 1985), a feature 
which has been commonly used to isolate fresh strains of 
A .actinomycetemcomitans on primary isolation. Surprisingly 
no information is available about the prevalence of either 
star-shaped or non-star-shaped variants of A.actinomycetem­
comitans on primary culture. In this study the prevalence 
of non-star-shaped colonies on primary isolation was greater 
than that of star-shaped variants; of the 120 colonies
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subsequently identified as A. actinomycetemcomitans, 70 (58%) 
appeared as non-star-shaped colonies, compared to 50 (42%)
which had a star-shaped colonial morphology on TSBV plates. 
Although, only a relatively small number of isolates and 
colonies were included in this study, the results highlight 
the danger of using star-shaped morphology as a key 
criterium when isolating and identifying A.actinomycetemco­
mitans from subgingival plaque samples. For instance, if 
only catalase positive star-shaped colonies had been coun­
ted, only about half (52%) of the total number of positive 
A.actinomycetemcomitans patients would have been recorded.
H . aphrophilus was also identified in a number of samples and 
was found to produce both star-shaped and non-star-shaped 
colonies on primary isolation similar to those of A.actino­
mycetemcomitans . While a catalase test will distinguish 
between the two species, failure to perform the test for 
every isolate could well lead to false positive results in 
prevalence data.
2.5.5 Antimicrobial susceptibility of A . actinomyce- 
temcomitans
Since it has been claimed that the successful treatment of 
periodontitis associated with A. actinomycetemcomitans requi­
res the use of antibiotics (Slots and Rosling, 1983) , the in 
vitro antimicrobial activity of 5 antimicrobial agents agai­
nst 46 strains of A.actinomycetemcomitans was monitored 
using a disc sensitivity method. All strains of A.actinomy­
cetemcomitans examined in this study were sensitive to tetr-
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acycline and amoxycillin which is in agreement with ths fin- 
dings of Slots et al., (1980b) and Walker et al., (1985). 
In the present investigation almost all strains (96%) were 
found to be sensitive to erythromycin (10 }lg) which agrees 
with the results of Baker et al., (1985) where 11 strains of 
A. actinomycetemcomitans were inhibited at an MIC concentra­
tion of 25jlg/ml. However, Slots et al., (1980b) (59
strains) and Walker et al., (1985) (39 strains) reported
that only 13% and 50% respectively of their A. actinomycetem­
comitans strains were susceptible to erythromycin at MIC 
concentrations of 2flg and 4flg respectively. The low acti­
vity of erythromycin as reported by both Slots et al., 
(1980b) and Walker et al., (1985) appears to be related to 
the low concentration (2|lg and 4flg) used by these workers, 
compared to a high concentration of 10p.g used in the present 
investigation. Similarly, reports concerning the sensiti­
vity of A. actinomycetemcomitans to penicillin has been var­
ied. For instance, Slots et al., (1980b) found that only 
about 50% of isolates were susceptible to penicillin at 
4|lg/ml, but 41/42 strains examined by Walker et al., (1985) 
were inhibited at a smaller concentration of 2|lg/ml. In the 
present study penicillin was used at a concentration of 1.0 
unit per disc and only 11 strains (24%) were sensitive to 
penicillin at this concentration. Baker et al., (1985) 
reported that penicillin was only effective at high concen­
tration ie. 6.3 Jig/ml or more. Metronidazole (2.5p.g/ml) was
ineffective against the 4 6 strains examined in this study. 
However, using a higher concentration of ^ 16|lg/rnl, more
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than 80% of isolates examined by both Slots et al., (1980b) 
and Walker et al., (1985) were killed.
Some of the differences in these results may be due to a 
number of factors which include differences in the methods 
and concentrations of the antimicrobial agents used by rese­
archers, variation in the media used as well as natural var­
iation to antimicrobial agents found in the strains of 
A .actinomycetemcomitans investigated. However, there is 
overall agreement that A. actinomycetemcomitans is sensitive 
to tetracycline, which has been recommended for the treat­
ment of patients with periodontal disease associated with 
A.actinomycetemcomitans.
2.6 Conclusions:
TSBV medium was less inhibitory to pure cultures of A.actin­
omycetemcomitans compared to MGB medium.
A. actinomycetemcomitans was isolated from 8 of 31 (26%)
samples of mixed plaque on TSBV, but not on MGB medium.
A.actinomycetemcomitans was recovered from 39% of patients 
with chronic periodontitis and from 27% of the total number 
of sites examined.
Only one (2%) of 55 healthy subjects harboured A.actinomy­
cetemcomitans .
A . actinomycetemcomitans can produce both star-shaped and 
non-star-shaped colonies on primary isolation and the preva­
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lence of non-star-shaped colonies (58%) was greater than 
that of star-shaped colonies (42%).
If star-shaped colonies alone were selected for identifica­
tion, 48% of the positive A .actinomycetemcomitans patients 
would have been missed.
A . actinomycetemcomitans was found in mean concentration of
6.5 x 10^ cfu/ml in subgingival plaque samples on TSBV.
All strains of A .actinomycetemcomitans (46) were sensitive 
to both tetracycline and amoxycillin, and 44 strains were 
sensitive to erythromycin. However, only 11 strains were 
sensitive to penicillin and none was sensitive to metroni­
dazole .
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CHAPTER 3
ADHERENCE OF A . ACTINOMYCETEMCOMITANS 
TO BUCCAL EPITHELIAL CELLS
3.1 Introduction
The ability to adhere to oral surfaces is believed to be 
important for bacteria to colonize the human mouth, and 
enables bacteria to become attached on surfaces exposed to 
the mechanical washing action of saliva (Van Houte, 1983) 
Human buccal epithelial cells have been widely used as a 
test surface to which bacteria can adhere. However, as 
cited in section 1.7.5 there have been very few studies reg­
arding the adherence of A. actinomycetemcomitans to oral sur­
faces. There is information that A .actinomycetemcomitans 
can adhere to hydroxyapatite (Kagermeier and London, 1985; 
Rosan et al., 1988), and to buccal epithelial cells (Sweet, 
1986) . However, there is no satisfactory data on the effect 
of either saliva, or serum (both of which are important int­
raoral environmental factors), on the subsequent adherence 
of A.actinomycetemcomitans to the hard and soft tissue surf­
aces of the mouth.
Since there is evidence implicating A. actinomycetemcomitans 
in the aetiology of human periodontal disease (see section 
1.9), it is perhaps surprising that relatively little is 
known about the mechanisms by which this organism colonizes 
the mouth. Therefore, this study was performed to assess 
the ability of 33 strains of A. actinomycetemcomitans to adh­
ere to buccal epithelial cells using an in vitro assay.
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3.2 Materials and methods
3.2.1 Determination of bacterial concentration
Thirty three A .actinomycetemcomitans strains (Aa 01-33) were 
included in this study. The source and identification prof­
ile of these strains are listed in Table 3.1. Although many 
bacteria can be enumerated microscopically using a counting 
chamber, it was impossible to use this technique to obtain 
accurate counts of A.actinomycetemcomitans due to their 
small size. Therefore, an alternative method described by 
Sweet, MacFarlane and Samaranayake (1988) was adopted to 
determine the bacterial concentration of different strains 
of A.actinomycetemcomitans. Bacterial suspensions were pre­
pared by growing the test organism on two CBA plates for 48 
hours at 37°C, in an atmosphere of 5% CC>2 in air and harv­
ested in 6 ml of PBS (Appendix II) using sterile cotton wool
swabs. This emulsion was designated the neat suspension.
-1 -3Ten-fold dilutions were then made in PBS from 10 to 10 r
the latter being taken as•the working suspension. The opti­
cal density of this suspension was measured at 520 nm in a 
Pye Unicam SP 8-100 spectrophotometer (Pye Unicam Cambridge, 
England). From the working suspension, a series of dilut­
ions were made in PBS as shown in Table 3.2. The bacterial 
concentration of the A . actinomycetemcomitans strain under 
test was then determined by diluting the contents of tube 
number 3 to 10“3 in PBS. One millilitre of this dilution 
was then added to one ml of 0.025% acridine orange in disti­
lled water (Hopkin and Williams Ltd., Essex, England) . Pre­
viously the acridine orange was filter sterilized through a
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0.45 [lm pore Sterifil D—HA filtration unit (Nihon Millipore, 
Kogyo K.K., Yonezawa, Japan) to remove any debris which 
could be mistaken for bacteria. The mixture of bacteria and 
acridine orange was then added to a DEFT' manifold (Direct 
Epifluorescent Filter Technique) (Micromeasurements Ltd., 
Saffron Walden, Essex, U.K), as shown in (Figure 3.1) which 
contained a 0.6 flm, 25 mm diameter polycarbonate filter 
(Nucleopore, Corporation, USA) . After two minutes the 
acridine orange was removed from the filter unit by switc­
hing on the negative pressure valve attached to the DEFT 
unit. The stained bacteria were washed once with 2.5 ml of 
PBS for two minutes and the buffer was removed as before. 
The filter with attached bacteria was then removed from the 
filtration unit and mounted on a clean glass microscope 
slide with Uvinert immersion oil (BDH Chemicals Ltd., Poole, 
England). The mounted filters were then examined under 
ultra violet light at a magnification of 1000 times using a 
Nikon Optiphot microscope (Nippon Kogaku K.K., Yokyo, 
Japan). A minimum of fifty fields were randomly selected 
and the number of bacteria present in each field was coun­
ted. This procedure was repeated on three different occasi­
ons for each bacterial strain used in the adherence studies.
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Table 3.1 List of A.actinomycetemcomitans strains 
used in adherence and hydrophobicity studies.
Strain
number Source
Site of 
Isolation
API 20 A 
Profile
Aa 01 NCTC 9709 Abscess (site not given) 4110404
Aa 02 NCTC 9710 Abscess (site not given) 4110405
Aa 03 NCTC 10979 Mandibular abscess 4150404
Aa 04 NCTC 10980 Blood 4110405
Aa 05 NCTC 10981 Neck abscess 4010505
Aa 06 NCTC 10982 Chest aspirate 4050505
Aa 07 GDH 310 Juvenile periodontitis 4110404
Aa 08 GDH 312 Chronic periodontitis 4110404
Aa 09 GDH 143 4110404
Aa 10 GDH 216 ~ 4110404
Aa 11 GDH R8529 4150404
Aa 12 GDH 156 4110404
Aa 13 GDH 471 4110404
Aa 14 GDH 1954 ~ 4050404
Aa 15 GDH 107 4050404
Aa 16 GDH_ 87034..... Prepubertal ceriodontitis— 4Q5Q4Q4_
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Table 3.1 Continued.
Strain
number Source
Site of 
Isolation
API 20 A 
Profile
Aa 17 GDH 510/87 Chronic periodontitis 4050404
Aa 18 GDH 1014 Juvenile periodontitis 4110404
Aa 19 GDH 1212 ~ 4110404
Aa 20 GDH 1214 Chronic periodontitis 4110404
Aa 21 AA Y4 Juvenile periodontitis 4150404
Aa 22 ATCC 29522 Mandibular abscess 4110404
Aa 23 ATCC 29523 Blood 4050505
Aa 24 ATCC 29524 Chest aspirate 4050505
Aa 25 GDH 105 Juvenile periodontitis 4050505
Aa 26 GDH 1028 Chronic periodontitis 4050505
Aa 27 GDH 110 4050505
Aa 28 GDH 114 ~ 4110404
Aa 29 GDH 127 ~ 4110404
Aa 30 GDH 1114 ~ 4150404
Aa 31 GDH 2351 Juvenile periodontitis 4150404
Aa 32 GDH 125 Chronic periodontitis 4050404
Aa GDH 12 9 ~  ~ 4050404
NCTC: National Collection of Type Cultures 
ATCC: American Type Culture Collection 
GDH: Glasgow Dental Hospital
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Table 3.2 Dilutions made to determine the total cou­
nts of bacteria.
Tube
number
Volume 
of PBS 
(ml)
Volume of 
suspension 
(ml)
Final
volume
(ml)
Dilution
1 4.5 3.0 7.5 ml 1 in 2.5
2 6.0 3.0 9.0 ml 1 in 3.0
3 6.0 2.0 8.0 ml 1 in 4.0
4 8.0 2.0 10.0 ml 1 in 5.0
5 7.0 1.0 8.0 ml 1 in 8.0
,6 „ 9.0 1.0 10.0 ml 1 in 10.0
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Figure 3.1 DEFT-Filter unit which was used in 
determination of bacterial concentration and in 
erence studies.
the
adh-
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3.2.2 Calculation of the total number of bacteria in 
each suspension
From the known dilution factors, ie. the area of the filter 
over which the bacteria are deposited, the area of the micr­
oscopic field at a magnification of 1000 times and the mean 
number of bacteria per field, the bacterial concentration 
was calculated using the following equation:
Concent rat ion/ml=M e a n  number bacteria x filter area x dilution
Microscope field area
Once the number of bacteria present in a given tube was cal­
culated, the number of bacteria in the other tubes could be 
easily obtained. The optical density of all tubes was then 
determined at 520 nm in a Pye Unicam SP 8-100 spectrophoto­
meter (Pye Unicam Cambridge, England) , and a series of pairs 
of data of optical density versus bacterial concentration 
was obtained. A graph of these two parameters was then con­
structed (Figure 3.2) so that the optical density of the 
bacterial suspension at any given concentration could be 
determined.
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Figure 3.2 An example of a typical plot used to det­
ermine the optical density of Aa 02. A suspension 
containing 1 x 10® bacteria/ml is equivalent to an
optical density of 0.042 at 520 nm.
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3.2.3 Donor
In this study the buccal epithelial cells, saliva, blood and 
serum were all obtained from the same healthy 30 year old 
male donor, who had no previous history of periodontal dise­
ase. The donor was free from A.actinomycetemcomitans as 
determined by the sampling and microbiological techniques 
described in section 2.3.4.
3.2.4 Preparation and clarification of saliva
Whole unstimulated saliva was collected by expectoration 
into a sterile universal bottle held in ice. Saliva was 
diluted with an equal volume of Saliva Ions Buffer, pH 7.2 
(SIB) as recommended by Sweet, MacFarlane and Samaranayake 
(1987) , (Appendix II) . The diluted salivary sample was next 
clarified by centrifugation at 20,000 g for 60 minutes at 
4°C (Ericson, Pruitt and Wedel, 1975) using an MSE High Sp­
eed 18 Centrifuge (Crawley, England) . This method was used 
to prevent the significant loss of glycoprotein which can 
occur when undiluted saliva is centrifuged (Ericson, 1966). 
Finally the supernatant was collected and dispensed in 2 ml 
volumes into sterile bijou bottles and stored at -20°C until 
required.
3.2.5 Separation of serum
Ten millilitres of venous blood were collected and allowed 
to clot at room temperature in a sterile glass bottle. 
Serum was separated by centrifugation at 3000 g for 15 minu­
tes in an MSE centrifuge (MSE Scientific Instruments, Craw­
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ley, England) at iroom temperature. Serum was then removed 
and aliquoted into 2 ml volumes in sterile bijou bottles and 
stored at -20°C until required.
3.2.6 Collection of buccal epithelial cells (BECs)
Buccal epithelial cells (BECs) were collected from a single 
donor (section3^2.3) by gently scraping the inside of the 
cheeks with a sterile cotton wool swab and suspending the 
cells in 5 ml of SIB. The cells were then washed twice in 
SIB by centrifugation at 200g for 5 minutes (MSE Scientific 
Instruments, Crawley, England) and resuspended in one ml of 
the same buffer.
3.2.7 Enumeration of BECs
The BECs were counted using a haemocytometer (Hawksley and 
Sons Ltd., Lancing, England) . This was done by touching the 
edge of the coverslip with the pipette tip and allowing the 
well to fill by capillary action. After leaving the cells 
to settle for 60 seconds, the BECs were counted in the cen­
tre square and the four large corner squares of the haemo­
cytometer under 250 times magnification using an Olympus 
microscope. The final concentration of BECs was then adjus­
ted to 2 or 4 x 105 cells per ml in SIB.
3.2.8 Buccal cell adherence assay
The same 33 A.actinomycetemcomitans isolates listed in Table
3.1 were used in this investigation. The adherence assay 
was performed in 5 ml plastic disposable bijou bottles 
(Sterilin Ltd., Feltham, England). Aliquots (0.2 ml) of the
142
buccal cell suspension which contained 2.0 x 105 cells/ml 
were added to 0.2 ml of the bacterial suspension (2.0 x 10® 
bacterial cells/ml) in SIB buffer. in addition, controls 
were set up which consisted of 0.2 ml buccal cells plus 0.2 
ml of SIB to obtain background counts of indigenous bacte­
ria. Both test and control bottles were then incubated in 
an orbital shaker (A. Gallenkamp and Co. Ltd., London, Engl­
and) at a setting of 60 to 80 revolutions per minute for 60 
minutes, at 37°C.
Immediately after incubation, 5 ml of SIB was added to all 
bottles to minimize any further attachment. The buccal 
cells were then collected on 25 mm diameter polycarbonate 
filters with a pore size of 12 l^m (Nucleopore Corp., Pleas­
anton, CA., USA) mounted on a DEFT manifold unit. The reta­
ined buccal cells were washed 3 to 4 times with 2.5 ml of 
SIB to remove any unattached bacteria. While such bacteria 
can pass easily through the 12 flm pore filters the buccal 
cells with attached bacteria were retained.
3.2.9 Adherence in the presence of saliva
The affect of saliva on the adherence of A. actinomycetem- 
comitans to BECs was examined using the same method descri­
bed in section 3.2.8 with the following minor modification. 
In these experiments saliva was added to the bacterial/BECs 
mixture during the incubation period. The test consisted of 
0.2 ml saliva, 0.1 ml bacteria at a concentration of 4.0 x 
10 ® /ml in SIB and 0.1 ml buccal cells containing 4.0 x 
10®/ml. The saliva control consisted of 0.2 ml of saliva
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plus 0.1 ml SIB and. 0.1 ml BECs. These dilutions were made 
to allow comparison of the results with the standard adher­
ence assay described earlier in section 3.2.8.
3.2.10 Adherence in the presence of serum
The affect of serum on the adherence of A.actinomycetemcomi­
tans to BECs was also examined using the method described in 
section 3.2.8 with the following minor modification. The 
assay was carried out by adding 0.24 ml of bacteria at a
o
concentration of 2.0 x 10 /ml to 0.24 ml of buccal cells 
containing 2.0 x 10 cells/ml and 0.03 ml of sterile serum 
giving a final concentration of 5%. The serum control 
consisted of 0.24 ml SIB plus 0.24 ml buccal cells and 0.03 
ml serum. In addition serum was added to the control bottle 
to find out if serum had any effect on the adherence of ind­
igenous bacteria.
3.2.11 Adherence of repeated subcultured strains
Ten freshly isolated A. actinomycetemcomitans were subcult­
ured for 50 times on blood agar plates (CBA). Subculturing 
was repeated every 48 hours by sweeping a sterile loop a 
cross the plate and inoculating the material onto a fresh 
CBA plate which was then incubated at 37°C in 5% C02 in air. 
After 50 subcultures, only four of the A.actinomycetemcomi­
tans isolates (Aa 09, 16, 17 & 33) were found to produce
smooth colonies which did not adhere to the agar surface and 
produced smooth turbid growth in broth cultures. The four 
strains were subsequently tested for their ability to adhere
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to buccal epithelial cells using the same procedure descri­
bed in 3.2.8.
3.2.12 Staining procedure
While the filters still remained on the DEFT unit the buccal
cells and bacteria were stained using 2.5 ml of a 0.025%
solution of acridine orange (Hopkin and Williams Ltd.,
Essex, England) in pH 3.3, 0.1 M citrate/sodium hydroxide
buffer (BDH, Chemicals Ltd., Poole, England), (Appendix II) 
for two minutes. The filter preparation was then washed 
twice with 2.5 ml of SIB, and the excess background fluore­
scence was quenched with 2.5 ml of 0.01% potassium permang­
anate solution (BDH, Chemicals Ltd., Poole, England) for two 
minutes. Finally the cells were given two more rinses with 
SIB. Both the acridine orange and the potassium permang­
anate were filter sterilized before use through a 0.45 }im 
Sterifil D-HA filtration unit (Nihon Millipore, Kogyo K.K., 
Yonezawa, Japan) to ensure that no particulate matter was 
present which could confuse counting of attached bacteria.
3.2.13 Enumeration of attached bacteria
Air dried filters were mounted on clean glass slides (1.0-
1.2mm thick) using Uvinert immersion oil (BDH Chemicals
Ltd., Poole, England). The mounted filters were then exami­
ned under ultra-violet light at a magnification of 1000 
times using a Nikon Optiphot Microscope (Nippon Kogaku K.K., 
Tokyo, Japan) . A minimum of fifty BECs were selected at 
random and the number of adherent bacteria per BEC was coun­
ted. Buccal cells were only included for counting if they
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appeared morphologically normal, possessed a single nucleus, 
were separated from each other, appeared flat and not folded 
and were free from debris that could interfere with count­
ing. The same criteria were applied for buccal cells used 
in the control preparations and the number of indigenous 
adherent bacteria was counted. Finally after both control 
and test adherent bacteria were counted, the number of indi­
genous adherent bacteria was subtracted from the total num­
ber of adherent bacteria in the tests. The assay procedure 
was repeated on three different occasions for each strain 
tested and the mean number of bacteria attached per buccal 
cell was then calculated.
3.2.14 Statistical analysis
All assays were performed on three different occasions for 
each bacterial strain under study. Results were analysed 
using STAT-WORK software (Apple Macintosh computer), and 
significant differences were determined using the paired t- 
Test.
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3.3 Results:
3.3.1 Determination of A . s.ctinomyce’teznconii'ta.ns conc­
entration
The optical densities (O.D) of the A.actinomycetemcomitans 
strains used in the different experiments are summarized in 
Table 3.3. The O.D of the different A.actinomycetemcomitans 
isolates tested at a concentration of eg. 10^ bacteria/ml 
varied from 0.023 to 0.049 with an average of 0.034 at a 
wave length of 520 nm. These differences are probably due 
to variations in the cell size of the different strains 
used. In particular some of the Type strains (eg. NCTC 9709 
and NCTC 1097 9) appeared to be larger than the freshly 
isolated strains of A.actinomycetemcomitans when examined 
microscopically at 1000 magnification. Nonetheless, these 
variation were noted not only between Type and fresh isola­
tes, but also when the freshly isolated strains of A .actino­
mycetemcomitans were compared.
The stained bacteria were deposited evenly over the polycar­
bonate filter surface and the A.actinomycetemcomitans cells 
fluoresced bright orange when examined under ultra-violet 
light and contrasted well against the non-staining polycarb­
onate filter thus making counting of bacteria easy.
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Table 3.3 Summary of the optical densities at a con­
centration of 108 bacteria/ml obtained for A.actino­
m y c e t e m c o m i t a n s  strains used in adhesion experi­
ments .
A.actinomycetemcomitans 
strain No.
00
o
equivalent to 
bacteria/ml ± SEM
Aa 01 0.026 0.0009
Aa 02 0.042 0.001
Aa 03 0.029 0.001
Aa 04 0.037 0.004
Aa 05 0.023 0.001
Aa 06 0.025 0.002
Aa 07 0.030 0.008
Aa 08 0.024 0.002
Aa 09 0.034 0.003
Aa 10 0.033 0.002
Aa 11 0.033 0.002
Aa 12 0.039 0.003
Aa 13 0.036 0.003
Aa 14 0.034 0.003
Aa 15 0.037 0.001
Aa
i—1 0.040 0.0009
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Table 3.3 Continued.
A .actinomycetemcomitans 
strain N o .
O.D
108
equivalent to 
bacteria/ml ± SEM
Aa 17 0 .037 0.002
Aa 18 0.035 0.001
Aa 19 0.041 0.003
Aa 20 0.041 0.009
Aa 21 0.026 0.0006
Aa 22 0.028 0.001
Aa 23 0.027 0.0006
Aa 24 0.028 0.002
Aa 25 0.045 0.002
Aa 26 0.034 0.001
Aa 27 0.042 0.001
Aa 28 0.030 0.0006
Aa 29 0.035 0.006
Aa 30 0.026 0.003
Aa 31 0.032 0.001
Aa 32 0.049 0.001
Aa 33 0.037 0.001
The results represent the mean of three experiments perfor 
med on three different occasions.
±SEM: Standard error of mean
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3.3.2 Adherence of A . actinomycetemcomi tans to BECs
Ones the bacteria had been stained with acridine orange, 
they could be easily visualized and counted. The bacterial 
cells appeared bright orange and the buccal epithelial cells 
as pale green with brighter green nuclei (see Figure 3.3) 
The number of adherent bacteria on fifty test and fifty con­
trol buccal epithelial cells were counted in each assay. 
Examples of the raw data obtained for two A . actinomycetemco- 
mitans isolates (Aa 03 and Aa 18) are presented in Tables 
3.4a,b,c and 3.5a,b,c. In these examples the number of bac­
teria adhering to the individual buccal cells varied between 
one to 84 in the case of Aa 03 and between 0 and 90 for Aa 
18 (Tables 3.4 and 3.5) . The frequency distribution of the 
number of adherent bacteria per buccal epithelial cell was 
calculated for both of the two A. actinomycetemcomitans str­
ains (see Figures 3.4 and 3.5) . These histograms showed 
clearly that more than 80% of the buccal cells counted had > 
10 adhered bacteria. Although the results of only two stra­
ins were presented in Tables 3.4 and 3.5, they are represe­
ntative of the results obtained with the other A.actinomy- 
cetemcomitans isolates.
The results of all the A.actinomycetemcomitans strains which 
were tested are summarized in Table 3.6. These results show 
clearly that for the majority of the strains tested a mean 
adherence score of > 10 bacteria per buccal epithelial cell 
was recorded. However, overall adhesion values varied among 
the different strains tested. The number of adherent bact­
eria ranged from 1.7 to 27.7 bacteria/BEC with a mean of
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12.7 bacteria and a mean standard error of 1.6. The number 
of indigenous adherent bacteria per buccal cell was found to 
be low with a range of 0.2 to 2.0 bacteria/BEC. More than 
80% of the freshly isolated A .actinomycetemcomitans strains 
(GDH isolates) adhered very well to the buccal cells
with a minimum mean adherence value of 10 adherent bacteria 
per buccal cell. However, the ATCC Type strains (Aa 22, Aa 
23 & Aa 24) were found to adhere in smaller numbers/BEC, 
compared to both the fresh isolates and to the NCTC Type 
strains (Aa 01 to Aa 06) .
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Figure 3.3 A . actinomycetemcomitans adhering 
ccal epithelial cell in vitro stained by 
orange, examined at 1000 magnification.
to a bu- 
acridine
152
Table 3. 4a An example of the raw adherence data obt­
ained. for Aa 03 (data represent the number of bact- 
eria/BEC for test and control in SIB) . Experiment 
No. 1
BEC No . Test Control Control Test BEC No.
01 55 0 0 7 26
02 13 0 0 40 27
03 23 0 0 11 28
04 29 0 0 49 29
05 17 0 0 33 30
06 20 0 1 21 31
07 17 0 1 1 32
08 27 0 2 5 33
09 52 1 0 16 34
10 9 0 1 63 35
11 28 0 1 23 36
12 25 0 1 33 37
13 62 1 0 5 38
14 25 0 0 34 39
15 36 0 1 44 40
16 14 0 0 80 41
17 65 0 0 33 42
18 23 0 1 60 43
19 47 2 0 66 44
20 21 0 1 28 45
21 4 3 0 13 46
22 57 0 0 13 47
23 8 6 0 33 48
24 11 1 0 8 49
25 15... 1 2 . 18 50
Number of bacteria/BEC = 27/50 = 0.54 (Control) 
Number of bacteria/BEC = 1440/50 = 28.8 (Test) 
Mean No. of test bacteria adhering/BEC = 28.3 
Range of adhering test bacteria = 1 to 80
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Table 3. 4b An example of the raw adherence data obt­
ained for Aa 03 (data represent the number of bact­
eria/BEC for test and control in SIB) . Experiment 
N o . 2
BEC N o . Test Control Control Test BEC No.
01 64 2 9 16 26
02 58 1 0 49 27
03 16 1 0 28 28
04 23 4 1 36 29
05 65 2 1 28 30
06 52 0 2 31 31
07 41 3 0 6 2
08 34 3 0 46 33
09 76 0 0 80 34
10 6 3 0 19 35
11 12 6 0 32 36
12 47 0 1 31 37
13 22 0 0 39 38
14 15 0 0 21 39
15 25 0 28 21 40
16 55 0 1 42 41
17 20 4 0 20 42
18 34 0 0 13 43
19 18 0 0 11 44
20 48 2 0 70 45
21 51 0 10 24 46
22 50 1 0 14 47
23 23 0 5 48 48
24 32 9 2 11 49
,25 36 0 0 20.
50 ...
Number of bacteria/BEC = 100/50 = 2.0 (Control) 
Number of bacteria/BEC = 1679/50 = 33.6 (Test) 
Mean No. of test bacteria adhering/BEC — 31.6
Range of adhering test bacteria — 6 to 80
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Table 3. 4c An example of the raw adherence data obt­
ained for Aa 03 (data represent the number of bact­
eria/BEC for test and control in SIB) . Experiment 
No. 3
BEC N o . Test Control Control Test BEC No.
01 15 0 0 21 26
02 20 0 0 3 27
03 44 0 0 1 28
04 77 0 0 7 29
05 8 0 0 17 30
06 7 1 5 9 31
07 36 1 3 54 32
08 24 0 3 8 33
09 73 0 0 22 34
10 20 0 0 18 35
11 43 0 5 19 36
12 14 1 0 19 37
13 57 0 2 20 38
14 5 0 3 15 39
15 36 2 0 37 40
16 59 0 0 2 41
17 10 1 0 38 42
18 18 10 2 20 43
19 46' 0 0 17 44
20 6 0 0 84 45
21 21 0 1 18 46
22 24 6 0 16 47
23 8 0 3 25 48
24 18 0 4 14 49
_ 25 13 . 2 2 16— . 50 ...
Number of bacteria/BEC = 57/50 = 1.14 (Control) 
Number of bacteria/BEC = 1222/50 = 24.4 (Test) 
Mean No. of test bacteria adhering/BEC =23.3
Range of adhering test bacteria — 1 to 84
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Table 3. 5a An example of the raw adherence data obt­
ained for Aa 18 (data represent the number of bact­
eria/BEC for test and control in SIB) . Experiment 
No. 1
BEC N o . Test Control Control Test BEC No.
01 9 2 5 49 26
02 15 0 0 13 27
03 2 1 2 3 28
04 22 2 0 9 29
05 1 1 0 12 30
06 16 3 0 24 31
07 5 0 1 45 32
08 34 6 0 13 33
09 14 2 0 29 34
10 6 5 2 9 35
11 10 1 0 22 36
12 31 1 4 8 37
13 13 0 0 15 38
14 10 1 0 30 39
15 4 0 0 18 40
16 11 1 0 42 41
17 6 2 0 26 42
18 11 . 0 0 1 43
19 26 1 0 9 44
20 5 1 1 26 45
21 18 2 0 21 46
22 26 2 1 16 47
23 8 3 0 14 48
24 
. 25
19
19 _
1
1
0
0
5
24
49
50
Number of bacteria/BEC = 55/50 = 1.1 (Control) 
Number of bacteria/BEC = 824/50 = 16.5 (Test) 
Mean No. of test bacteria adhering/BEC = 13.4 
Range of adhering test bacteria = 1 to 49
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Table 3. 5b An example of the raw adherence data obt­
ained for Aa 18 (data represent the number of bact­
eria/BEC for test and control in SIB) . Experiment 
N o . 2
BEC N o . Test Control Control Test BEC N o .
01 7 0 0 1 26
02 22 0 0 42 27
03 90 2 0 5 28
04 20 2 0 5 29
05 23 0 10 18 30
06 0 0 0 34 31
07 7 0 20 9 32
08 36 3 0 12 33
09 33 0 0 26 34
10 10 1 2 17 35
11 8 3 0 17 36
12 4 5 0 7 37
13 10 0 0 5 38
14 22 0 27 20 39
15 35 0 0 22 40 •
16 24 1 0 6 41
17 56 1 0 10 42
18 16 0 0 23 43
19 16 2 1 27 44
20 54 0 1 2 45
21 38 0 1 15 46
22 20 0 0 13 47
23 5 14 0 2 48
24 8 2 0 6 49
25 7 1 0 2 23
50
Number of bacteria/BEC = 100/50 =2.0 (Control) 
Number of bacteria/BEC = 938/50 = 18.8 (Test) 
Mean No. of test bacteria adhering/BEC = 16.8
Range of adhering test bacteria = 0 to 90
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Table 3. 5c An example of the raw adherence data obt­
ained for Aa 18 (data represent the number of bact­
eria/BEC for test and control in SIB) . Experiment 
No . 3
BEC N o . Test Control Control Test BEC No.
01 8 0 0 3 26
02 17 0 0 14 27
03 16 2 0 7 28
04 40 0 0 14 29
05 9 0 0 19 30
06 20 0 2 18 31
07 90 0 0 8 32
08 14 0 0 8 33
09 15 0 0 13 34
10 11 0 0 13 35
11 11 0 1 13 36
12 33 0 0 5 37
13 8 0 0 15 38
14 11 0 0 0 39
15 19 0 0 7 40
16 8 0 1 13 41
17 8 0 0 7 42
18 19 0 0 28 43
19 4 0 0 2 44
20 0 0 0 18 45
21 15 0 0 2 46
22 3 0 0 20 47
23 2 0 1 9 48
24 11 0 1 40 49
_ 25 8.0,.., 0 0 12
50
Number of bacteria/BEC = 8/50 = 0.16 (Control) 
Number of bacteria/BEC = 663/50 = 13.3 (Test) 
Mean No. of test bacteria adhering/BEC = 13.0
Range of adhering test bacteria = 0 to 80
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Figure 3.4 Distribution of the number of Aa 03 (NCTC 
10979) cells adhering to 150 buccal epithelial cells 
in SIB, (the data represents the combined results 
from three different experiments).
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Figure 3.5 Distribution of the number of Aa 18 (GDH 
1014) cells adhering to 150 buccal epithelial cells 
in SIB, (the data represents the combined results 
from three different experiments).
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Table 3 . 6 Summary of the adherence results for 
A . actinomycetemcomitans strains to buccal epithelial 
cells in SIB buffer.
Mean No. of adhering bacteria/BEC 
Bacterial Experiment Number
strain No ._______1_________ 2 3________Mean (±SEM)
Aa 01 12.5 7.5 3.0 7.7 (2.7)
Aa 02 14.7 11.8 13.6 13.4 (0.8)
Aa 03 28.3 31.6 23.3 27.7 (2.4)
Aa 04 15.0 9.3 13.0 12.4 (1.7)
Aa 05 16.0 6.0 5.0 9.0 (3.5)
Aa 06 21.4 25.7 11.4 19.5 (4.2)
Aa 07 6.0 6.0 9.8 7.3 (1.3)
Aa 08 19.8 11.6 11.0 14.0 (2.8)
Aa 0 9 9.6 12.2 8.7 10.2 (1.0)
Aa 10 14.3 12 .0 14.8 13.7 (0.8)
Aa 11 19.6 18.9 14.8 17.8 (1.5)
Aa 12 22.1 16.6 18.9 19.2 (1.6)
Aa 13 17 .5 . 17.5 15.0 16.7 (0.8)
Aa 14 17.4 14.7 17.0 .16.4 (0.9)
Aa 15 25.7 20.8 18.0 21.5 (2.2)
Aa 16 12.0 12.8 . 8.2 11.0 (1.4) _
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Table 3.6 Continued.
Mean No. of adhering bacteria/BEC 
Bacterial Experiment Number
strain N o . 1 2 3 Mean (±SEM)
Aa 17 7.0 7.6 3.0 5.9 (1.4)
Aa 18 15.5 16.8 13.0 15.0 (1.1)
Aa 19 12.4 16.0 17.0 15.0 (1.4)
Aa 20 10.3 14 .5 15.0 13.3 (1.5)
Aa 21 4.0 9.0 4.0 5.7 (1.6)
Aa 22 5.4 4.7 3.4 4.5 (0.6)
Aa 23 2.2 2.2 0.6 1.7 (0.5)
Aa 24 6.5 5.0 3.3 5.0 (0.9)
Aa 25 16.0 13.7 19.0 16.3 (1.6)
Aa 2 6 6.9 11.4 18.8 12.4 (3.5)
Aa 27 11.0 10.7 8.7 10.0 (0.7)
Aa 28 12 . 6 12.4 16.0 13.7 (1.2)
Aa 2 9 9.7 15.0 8.6 11.0 (2.0)
Aa 30 4.0 8.4 7.0 6.4 (1.3)
Aa 31 15.0 17.6 10.3 14.3 (2.1)
Aa 32 12 .0 16.0 13.6 13.9 (1.1)
Aa 33 , 13.0 ___ 10.3 12.0 11 .8 (0.8)
+SEM: Standard error of mean
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3.3.3 Effect of saliva on the adherence of A. actino­
mycetemcomitans to BECs
These experiments were performed to examine the effect of 
saliva on the adherence of A. actinomycetemcomitans to BEC in 
vitro. Saliva free assays for comparison purposes were not 
performed at the same time. An example of the raw data obt­
ained with Aa 18 (GDH 1014) is shown in Table 3.7a, b & c 
and represents that obtained for the other strains tested. 
As can be seen the number of bacteria adhering to the indi­
vidual buccal cells varied between 0 to 83. The frequency 
distribution histogram (Figure 3.6) shows that more than 80% 
of buccal cells counted, had greater than 10 adherent bact­
eria. The saliva treated control buccal cells had very few 
indigenous adherent bacteria with an overall mean adherence 
value of 1.3 bacteria per buccal cell.
The results of all the A. actinomycetemcomitans strains which 
were tested are summarized in Table 3.8. These results show 
clearly that for the majority of the strains tested a mean 
adherence score of > 10 bacteria per buccal epithelial cell 
was recorded. However, overall adhesion values varied among 
the different strains tested. The number of adherent bact­
eria ranged from 1.7 to 2 6.8 bacteria/BEC with a mean of 12 
bacteria. The freshly isolated A .  actinomycetemcomitans str­
ains (GDH isolates) adhered very well to the buccal
cells with a mean adherence value of 16 adherent bacte­
ria/BEC. However, the ATCC Type strains (Aa 22, Aa 23 & Aa 
24) and NCTC Type strains (Aa 01, Aa 02 & Aa 05) were found 
to adhere in smaller numbers/BEC compared with the fresh 
isolates.
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Table 3.7 a An example of the raw adherence data
obtained for Aa 18 (data represent the number of
bacteria/BEC in the presence of saliva for test and
control assays). Experiment No. 1
BEC N o . Test Control Control Test BEC No.
01 11 0 0 32 26
02 13 4 0 38 27
03 18 0 0 33 28
04 18 0 1 15 29
05 12 0 0 16 30
06 15 0 0 13 31
07 2 5 0 9 32
08 17 0 1 6 33
09 19 0 0 31 34
10 42 0 4 57 35
11 22 0 2 28 36
12 42 3 0 32 37
13 17 2 0 15 38
14 27 4 0 10 39
15 20 2 1 13 40
16 4 0 0 9 41
17 16 0 0 27 42
18 15 0 1 3 43
19 43 0 0 42 44
20 19 0 0 18 45
21 11 0 0 52 46
22 8 0 0 30 47
23 32 0 6 4 48
24 4 0 6 4 49
__ 25 10 . 1 0 14 __ 50
Number of bacteria/BEC = 40/50 = 0.8 (Control) 
Number of bacteria/BEC = 1011/50 = 20.2 (Test) 
Mean No. of test bacteria adhering/BEC = 19.4 
Range of adhering test bacteria = 4 to 52
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Table 3. 7b An example of the raw adherence data
obtained for Aa 18 (data represent the number of
bacteria/BEC in the presence of saliva for test and
control assays). Experiment No. 2
BEC N o . Test Control Control Test BEC No.
01 0 12 2 19 26
02 0 5 0 83 27
03 6 3 5 10 28
04 49 0 16 0 29
05 1 26 0 0 30
06 0 30 7 9 31
07 6 5 0 20 32
08 0 6 0 10 33
09 4 26 2 2 34
10 0 4 0 4 35
11 3 3 0 4 36
12 2 9 0 15 37
13 1 12 0 5 38
14 0 0 1 30 39
15 0 4 1 8 40
16 6 7 8 19 41
17 2 7 0 9 42
18 11 42 1 8 43
19 0 18 0 0 44
20 0 18 0 7 45
21 0 18 4 7 46
22 0 16 1 22 47
23 0 2 0 14 48
24 0 25 0 5 49
25 0 18 0 3
50
Number of bacteria/BEC — 141/50 = 2.8 (Control) 
Number of bacteria/BEC = 629/50 = 12.6 (Test) 
Mean No. of test bacteria adhering/BEC = 9.6
Range of adhering test bacteria = 0 to 83
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Table 3.7 c An example of the raw adherence data
obtained for Aa 18 (data represent the number of
bacteria/BEC in the presence of saliva for test and
control assays). Experiment No. 3
BEC No Test Control Control Test BEC No.
01 11 0 0 6 26
02 2 0 0 3 27
03 30 0 0 9 28
04 15 0 0 21 29
05 39 0 0 33 30 .
06 23 1 3 0 31 '
07 15 0 0 3 32
08 3 0 0 13 33
09 17 0 0 11 34
10 15 0 1 4 35
11 16 0 1 1 36
12 20 1 2 25 37
13 11 0 0 27 38
14 23 0 1 10 39
15 29 0 0 7 40
16 • 26 2 0 1 41
17 6 1 0 21 42
18 42 0 0 6 43
19 7 0 1 10 44
20 1 0 0 21 45
21 17 0 0 18 46
22 17 0 0 7 47
23 9 0 0 16 48
24 9 8 2 22 49
25 1 Q i 7 29 50
Number of bacteria/BEC = 32/50 = 0.64 (Control)
Number of bacteria/BEC = 746/50 = 14.9 (Test) 
Mean No. of test bacteria adhering/BEC — 14.3 
Range of adhering test bacteria — 0 to 42
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Figure 3.6 Distribution of the number of Aa 18 (GDH 
1014) cells adhering to 150 buccal epithelial cells 
in the presence of saliva, (the data represents the 
combined results from three different experiments) .
Table 3  .  8  Summary of the adherence results for 
A . actinomycetemcomitans strains to buccal epithelial 
cells in the presence of saliva.
Bacterial 
strain N o .
Mean No. of adhering bacteria/BEC 
Experiment Number
1 2  3 Mean (±SEM)
Aa 01 6.9 6.0 5.4 6.0 (0.4)
Aa 02 11.7 9.4 8.7 10.0 (0.9)
Aa 05 8.6 5.0 5.0 6.2 (1.2)
Aa 09 11.3 13.4 10.6 11.8 (0.8)
Aa 10 14 .4 7.4 17.0 13.0 (2.9)
Aa 13 14.6 14 .0 13.0 14.0 (0.4)
Aa 14 20.3 12.6 16.2 16.4 (2.2)
Aa 15 37 .3 23.4 19.8 26.8 (5.3)
Aa 16 15.6 19.0 9.0 14.5 (2.9)
Aa 17 15.0 8.4 9.2 11.0 (2.1)
Aa 18 19.4 9.6 14.3 14.4 (2.8)
Aa 21 7.7 11.0 3.6 7.4 (2.1)
Aa 22 2.7 8.5 3.6 7.0 (2.0)
Aa 23 4.9 11.0 5.3 1.7 (0.5)
Aa 24 4.6 9.0 4.7 6.0 (1.4)
Aa 25 26.0 22.4 23.2 23.8 (1.1)
Aa 26 19.2 12.8 16.8 16.3 (1.8)
. Aa 28 15.4 . 7.2 13.3 12.0 (2.5)
±SEM: Standard error of mean
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3.3.4 Effect of serum on the adherence of A .actino-
mycetemcomitans to BECs
Fourteen freshly isolated A .actinomycetemcomitans strains 
were examined for their ability to adhere to buccal epithe—
lial cells in the presence of human serum or SIB. Two sets
of experiments (ie. adherence of A . actinomycetemcomitans 
strains in the presence of serum and SIB alone) were carried 
out simultaneously on three different occasions. An example 
of the raw data obtained' with Aa 09 (GDH 143) when serum was
present is shown in Table 3.9a, b & c and is representative
of the results obtained for the other strains tested. The 
frequency distribution histogram (Figure 3.7) shows that 
more than 85% of buccal cells had only 0 to 4 adherent bact­
eria when serum was present in the assay.
A summary of the adherence results obtained in SIB alone and 
in serum are given in Tables 3.10 and 3.11 respectively. 
The addition of serum to the bacteria/buccal cells mixture 
generally reduced the number of adherent bacteria per buccal 
epithelial cell, and in a number of experiments complete 
inhibition of bacterial adherence occurred (see Aa 20 
experiment 3 and Aa 39 experiment 2, Table 3.11). Using a 
paired t-Test the adherence of A.actinomycetemcomitans in 
the presence of serum was overall and individually highly 
significantly reduced (p <0.0005) as compared to that obta­
ined in SIB buffer alone (Table 3.12).
169
Table 3. 9a An example of the raw adherence data 
obtained for Aa 09 (data represent the number of 
bacteria/BEC in the presence of serum for test and 
control assays). Experiment No. 1
BEC N o . Test Control Control Test BEC No.
01 1 7 0 0 26
02 2 6 0 0 27
03 7 0 0 7 28
04 0 0 0 2 29
05 12 0 0 8 30
06 1 0 0 0 31
07 2 0 0 0 32
08 2 0 0 0 33
09 0 0 0 0 34
10 0 2 0 0 35
11 0 0 0 0 36
12 0 0 0 0 37
13 0 0 0 0 38
14 8 0 0 10 39
15 8 0 0 10 40
16 0 0 0 9 41
17 4 0 0 3 42
18 0 0 2 0 43
19 0 0 4 0 44
20 10 0 0 0 45
21 3 0 0 2 46
22 0 0 0 0 47
23 0 0 0 2 48
24 0 0 0 0 49
_ 25 0 _ 0 0 0
50
Number of bacteria/BEC = 21/50 = 0.42 (Control) 
Number of bacteria/BEC = 113/50 = 2.26 (Test) 
Mean No. of test bacteria adhering/BEC = 1.84
Range of adhering test bacteria — 0 to 12
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Table 3. 9b An example of the raw adherence data obt­
ained for Aa 09 (data represent the number of bact­
eria/BEC in the presence of serum for test and cont­
rol assays). Experiment No. 2
BEC N o . Test Control Control Test BEC No.
01 0 4 0 4 26
02 0 1 0 20 27
03 0 4 0 0 28
04 0 2 0 0 29
05 3 0 0 0 30
06 4 0 0 16 31
07 0 0 0 0 32
08 0 0 0 0 33
09 0 0 0 0 34
10 0 0 2 2 35
11 0 0 5 0 36
12 4 0 0 0 37
13 3 0 0 0 38
14 0 0 0 0 39
15 0 0 0 0 40
16 0 0 0 0 41
17 0 3 0 0 42
18 0 2 0 3 43
19 0 3 0 5 44
20 0 0 0 0 45
21 4 0 0 2 46
22 4 0 0 3 47
23 3 0 0 0 48
24 3 0 0 0 49
25 4 0 3 1 - 50
Number of bacteria/BEC = 29/50 = 0.6 (Control) 
Number of bacteria/BEC = 88/50 = 1.76 (Test) 
Mean No. of test bacteria adhering/BEC — 1.16 
Range of adhering test bacteria = 0 to 20
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Table 3 - 9c An example of the raw data obtained for 
Aa 09 (data represent the number of bacteria/BEC in 
the presence of serum for test and control assays) . 
Experiment N o . 3.
BEC N O . Test Control Control Test BEC No.
01 15 0 3 3 26
02 2 0 0 0 27
03 4 0 0 0 28
04 4 0 0 0 29
05 3 0 0 0 30
06 0 0 2 0 31
07 0 0 0 0 32
08 1 0 0 0 33
09 0 0 0 0 34
10 0 2 0 0 35
11 0 0 0 0 36
12 0 0 0 0 37
13 0 0 0 0 38
14 22 0 0 2 39
15 0 0 0 1 40
16 0 2 0 0 41
17 1 6 0 0 42
18 5 0 0 0 43
19 0 0 0 0 44
20 0 0 0 0 45
21 0 0 2 0 46
22 3 0 8 0
47
23 0 0 0 8
48
24 5 0 0 0
49
25 12 -3 0 . 7
50 _
Number of bacteria/BEC = 28/50 — 0.56 (Control) 
Number of bacteria/BEC = 98/50 = 1.96 (Test) 
Mean No. of test bacteria adhering/BEC =1.4
Range of adhering test bacteria = 0 to 22
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Figure 3.7 Distribution of the number of of Aa 09 
(GDH 143) cells adhering to 150 buccal epithelial 
cells in the presence of serum, (the data represents 
the combined results from three different experi­
ments) .
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Table 3.10 Adherence of A .actinomycetemcomitans to
buccal epithelial cells in SIB.
Mean No. of adhering bacteria/BEC
Bacterial 
strain number
Experiment 
1 2
number
3 Mean (±SEM)
Aa 07 4.5 6.0 5.0 5.2 (0.4)
Aa 08 6.0 6.0 8.0 6.7 (0.7)
Aa 09 12.7 9.4 15.2 12.4 (1.7)
Aa 10 12.9 7.7 10.0 10.2 (1.5)
Aa 15 11.0 7.0 7.0 8.3 (1.3)
Aa 16 10.5 10.0 11.0 10.5 (0.3)
Aa 17 12 .0 7.0 11.3 10.0 (1.6)
Aa 18 5.0 5.0 4.0 4.5 (0.3)
Aa 19 5.0 6.0 8.0 6.3 (0.9)
Aa 20 4.0 5.0 4.0 4.3 (0.3)
Aa 25 9.0 15.0 12.0 12.0 (1.7)
Aa 27 11.0 14 .0 10.0 12.0 (1.2)
Aa 32 10.0 4.0 5.0 6.3 (1.8)
Aa 39 6.0 9.0— 5.0 6.7 (1.2)
±SEM: Standard error of mean
Table 3.11 Adherence of A . actlnomycetemcomi tans to
buccal epithelial cells in the presence of serum.
Mean No. of adhering bacteria/BEC 
Bacterial Experiment number
strain number 1_______2________ 3______ Mean (±SEM)
Aa 07 0.4 0.5 0.3 0.4 (0.06)
Aa 08 1.0 0.7 0.2 0.6 (0.2)
Aa 09 1.8 1.2 1.4 1.5 (0.2)
Aa 10 2.0 1.5 1.6 1.7 (0.1)
Aa 15 1.4 1.2 0.3 1.0 (0.3)
Aa 16 3.6 4.0 2.6 3.4 (0.4)
Aa 17 3.5 1.4 0.6 1.8 (0.9)
Aa 18 1.5 2.0 0.1 1.2 (0.6)
Aa 19 0.3 0.1 1.8 0.7 (0.5)
Aa 20 1.7 0.7 0.0 0.8 (0.5)
Aa 25 0.2 0.7 0.4 0.4 (0.1)
Aa 2 7 4.0 1.4 2.0 2.5 (0.8)
Aa 32 4.5 0.5 0.4 1.8 (1.3)
Aa 3 9 0.7 0.0 1.4 0.7 (1.4)
±SEM: Standard error of mean
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Table 3.12 Comparison of adherence of A. actinomy- 
cetemcomitans to buccal epithelial cells in SIB and 
in the presence of serum.
Bacterial 
strain number
Mean N o . 
SIB
of adhering 
SERUM
bacteria/BEC
P
Aa 07 5.2 0.4 0.005
Aa 08 6.7 0.6 0.01
Aa 09 12.4 1.5 0.01
Aa 10 10.2 1.7 0.02
Aa 15 8.3 1.0 0.02
Aa 16 10.5 3.4 0.005
Aa 17 10.0 1.8 0.02
Aa 18 4.5 1.2 0.005
Aa 19 6.3 0.7 0.005
Aa 20 4.3 0.8 0.02
Aa 25 12.0 0.4 0.01
Aa 27 11.0 2.5 0.02
Aa 32 12.0 1.8 0.01
Aa 39 .. 6.7 0.7 0.05 -
p: Probability as determined by paired t-Test.
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3.3.5 Effect of repeated subculturing on adherence
Although there were ten freshly isolated A .actinomycetem- 
comitans subcultured on 50 occasions, only four strains cha­
nged in morphology and produced colonies that did not adhere 
to the agar surface and when grown in broth culture did not 
aggregate. The adherence results for the four strains of 
A.actinomycetemcomitans (Aa 9, 10, 16 & 17) as freshly
isolated (rough form) and after subculture (smooth form) are 
shown in Tables 3.13 and 3.14 respectively. The combined 
results are presented in Table 3.15. No significance diff­
erence in adherence values between the smooth and rough 
forms of the same isolate were noted.
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Table 3.13 Adherence of rough (fresh) strains of 
A. actinomycetemcomitans to buccal cells in SIB.
Bacterial 
strain N o .
Mean No. of
Experiment 
1 2
adhering
number
3
bacteria/BEC 
Mean (±SEM)
Aa 09 12.7 9.4 15.2 12.4 (1.7)
Aa 10 12.9 7.7 10.0 10.2 (1.5)
Aa 16 10.5 10.0 11.0 10.5 (0.3)
Aa 17
oCM 
«—1 7.0 . ; 11.3 10.1 (1.6)
±SEM: Standard error of mean
Table 3.14 Adherence of smooth (subcultured) vari-
ants of A .actinomycetemcomitans to buccal cells in
SIB .
Mean N o . of adhering bacteria/BEC
Bacterial 
strain N o .
Experiment 
1 2
number
3 Mean (±SEM)
Aa 09 13.0 11.0 10.8 11.6 (0.7)
Aa 10 10.0 10.0 10.2 10.0 (0.07)
Aa 16 19.0 11.3 11.7 14.0 (2.5)
Aa 1 7 10.7 13.0 11.6 11.8 (0.7)
iSEM: Standard error of mean
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Table 3.15 Comparison of adherence between rough and 
smooth variants of A. actinomycetemcomitans.
Bacterial 
strain N o .
Mean N o . 
Rough
of adhering 
Smooth
bacteria/BEC
P
Aa 09 12 . 4 11. 6 NS
Aa 10 10.2 10 .1 NS
Aa 16 10.5 14.0 NS
Aa 17 10.1 11.8 NS
Overall NS
P : probability as determined by paired t-Test 
NS: Not significant
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3.4 Discussion:
3.4.1 Experimental methods
The methods commonly used to standardize bacterial concentr­
ations, are microscopical enumeration using a counting cham­
ber or viable counts by culture techniques. Other methods 
which have been used for counting bacteria include, spectro- 
photometric, coulter counters, filtration and dry-weight met­
hods. Preliminary studies suggested that the use of count­
ing chambers to obtain accurate results with A .actinomycet- 
emcomitans was not possible due to the difficulty of accur­
ately visualizing the small A .actinomycetemcomitans cells. 
Staining of these cells with simple stains such as carbolfu- 
chsin or crystal violet did not markedly improve the results 
using a counting chamber. The viable plate counting method 
is only appropriate to determine viable counts but not total 
counts which were preferred in this study. Moreover, it is 
a retrospective method which could not be used to standard­
ize bacterial suspensions before performing either the adhe­
rence or hydrophobicity assays. The present method used to 
determine the total counts of A. actinomycetemcomitans in the 
bacterial suspension for the adherence assay employed acri- 
dine orange staining, and was based on a technique developed 
to count bacteria in milk (Pettipher et al., 1980) . The
method was subsequently modified by Sweet (1986) to dete­
rmine counts of a variety of Gram-negative rods including 
A.actinomycetemcomitans prior to adherence assays. Once the 
optical density of a particular strain has been determined, 
bacterial suspensions of a wide range of concentrations can
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then be prepared and adjusted accurately. The main disad­
vantage of this technique is that it is time consuming.
Fresh isolates of A.actinomycetemcomitans were found to agg­
regate in broth cultures which presented some difficulties 
in performing adherence assays. However, suspensions of 
fresh strains grown on CBA did not readily aggregate and 
were therefore used to prepare the bacterial suspensions in 
this study. Although the problem of aggregation by A.actin­
omycetemcomitans has been previously reported (Slots, 
1982b), no information has been given about how previous 
workers have solved this problem in relation to adherence 
assays (Gibbons and Etherden, 1983; Kagermeier and London, 
1985; Rosan et al., 1988). Almost all papers give the impr­
ession that fresh isolates of A. actinomycetemcomitans can be 
easily grown in broth cultures and enumerated using counting 
chambers both of which have been found to be unsatisfactory 
in the present study.
The adherence method used here was developed by Sweet et 
a.1., (1988) to investigate the adherence of oral bacteria
(especially small Gram-negative rods) to buccal epithelial 
cells. Since the technique overcomes some of the problems 
encountered when using other adherence techniques, such as 
inadequate visualization of attached bacteria and poor stan­
dardization of bacterial suspensions it was the method of 
choice. This epifluorescence technique overcomes the prob­
lems mentioned above since staining with acridine orange 
permits clear visualization of attached bacteria to buccal 
cells. In addition, the saliva ions buffer (SIB) used thr­
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oughout this study is believed to contain the main ionic 
constituents of saliva (Sweet et al. , 1988) . A similar buf— 
fer has been used by a number of other researchers (Clark, 
Bammann and Gibbons, 1978; Applebaum et ad., 197 9) to study 
the adherence of bacteria to oral surfaces. In general the 
adherence of bacteria to buccal cells in vitro may be affe­
cted by different factors such as, the type of buffer used 
(Yamazaki, Ebisu and Okada, 1981) and the source of epithe­
lial cells. It has been shown that the same bacterial str­
ains may vary in their ability to adhere to buccal cells 
obtained from different donors (Gibbons and Dankers, 1983). 
Moreover, it has been suggested that buccal cells that har­
bour small numbers of indigenous bacteria may have low affi­
nity for bacterial adherence and vice versa (Sweet et al., 
1988) . Therefore, in order to minimize the effect of these 
different parameters in the present adherence assay, both 
saliva and buccal cells were collected from the same donor.
3.4.2 Adherence of A . acti.nomycetemcomi.tans to BECs
This study was performed to examine the ability of a wide 
range of A. actinomycetemcomitans strains to adhere to human 
buccal epithelial cells since little is known about the eco­
logy of this organism. As stated previously in section 3.1 
there is little literature concerning the adherence of 
A.actinomycetemcomitans to buccal cells. In fact there is 
only one report which has investigated the adherence of a 
single Type strain of A. actinomycetemcomitans (NCTC 9710) to 
buccal epithelial cells in the presence of SIB (Sweet et 
al>, 1988). Since this strain of A .actinomycetemcomitans
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was also investigated in the present study using SIB, a dir­
ect comparison of results is possible. Sweet et al., (1988)
reported a mean adherence value of 7.5 bacteria/buccal epit­
helial cell, while the value obtained in this study was 13.4 
bacteria per buccal cell; an increase of almost 50 percent. 
This difference may be due to a number of factors such as 
the source of epithelial cells or growth conditions used in 
the two studies. Sweet et al., (1988) used Anaerobic Blood 
Broth supplemented medium for growing A . actinomycetemco­
mitans, whereas Columbia Blood Agar medium was used in the 
present investigation. However, results from both studies 
clearly demonstrate the ability of A.actinomycetemcomitans 
to adhere to buccal epithelial cells in vitro.
There was a wide variation of adherence levels obtained with 
the different strain of A.actinomycetemcomitans examined in 
the present study. A mean range of 1.7 to 27.7 bacte­
ria/buccal epithelial cell was obtained with the 33 A.acti­
nomycetemcomitans isolates giving an overall mean of 12.7 
bacteria/BEC. These results highlight the importance of 
testing a large number of bacterial strains to investigate 
the adherence of a particular species to buccal epithelial 
cells. In addition, it would be interesting to carry out 
similar adherence experiments using pooled buccal epithelial 
cells from different donors, since the present study only 
used buccal cells from the same donor.
183
3.4.3 Effect of saliva on the adherence of A.actino­
mycetemcomitans to BECs
The effect of clarified whole saliva on the adherence of 
A .actinomycetemcomitans to buccal cells in vitro was inves­
tigated using 18 strains of A .actinomycetemcomitans. The 
same adherence assay described in Section 3.2.8 was empol- 
yed, but with the addition of saliva. Although the in vitro 
adherence system used in this study is not the same as the 
in vivo situation, the results of these experiments may help 
to identify some of the factors which are involved in the 
colonization of human oral surfaces by A.actinomy- 
cetemcomitans.
Since the adherence experiments in SIB alone and in the pre­
sence of saliva alone were performed at different times, any 
direct comparison of the results must take into account the 
possible effect of variations in bacterial suspensions and 
buccal cells. However, A.actinomycetemcomitans adhered to 
buccal epithelial cells in the presence of saliva in similar 
numbers to those found when the same isolates were tested in 
SIB buffer alone. In general the presence of saliva had 
little or no effect on the number of adherent bacteria per 
buccal cell, although noticeable differences were recorded 
for a few strains eg. Aa 02, 09, 13 and 25. Saliva was
found to increase the number of adherent bacteria of strains
Aa 09, and Aa 25 compared with assays using SIB. On the 
other hand it reduced the number of adherent bacteria of 
strains Aa 02 and Aa 13 when compared with SIB assays. The
reason for these differences is not known.
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Unfortunately there are no reported studies on the effect of 
saliva on the adherence of A.actinomycetemcomitans to buccal 
cells, with which to compare the findings of this study. 
Sweet (1986) has reported that the number of A.actinomy­
cetemcomitans NCTC 9710 which adhered to saliva treated Hela 
cells was 93 bacteria/0.018 mm2 . a value of 85 adherent 
bacteria/0.018 mm2 to buccal cells was obtained in this 
study using the conversion formula described by Sweet
(1986) . However, it is difficult to compare these results 
since Hela cells are of non-oral origin and may possess dif­
ferent receptors for adherence compared with oral tissues. 
Saliva from only one healthy individual was studied here, 
and it would be interesting to carry out further work to 
find out if saliva from patients with A.actinomycetem- 
comitans and healthy subjects have the same or different 
effects on the adherence of this organism to buccal epith­
elial cells.
3.4.4 Effect of serum on the adherence of A. actino­
mycetemcomitans to BECs
Serum was added to the adherence system used in this study 
to mimic the in vivo environment where crevicular epithelial 
cells are exposed to crevicular fluid, which has a similar 
composition to serum (Cimasoni, 1983). Results obtained in 
this study showed that human serum almost completely 
inhibited A . actinomycetemcomitans from adhering to buccal 
epithelial cells. An average mean number of 0.4 to 3.4 
bacteria per buccal epithelial cell was obtained for the 14 
freshly isolated A.actinomycetemcomitans strains. These
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results are compared with an average mean of 4.3 to 12.5 
bacteria/BEC obtained with the same A .actinomycetemcomitans 
strains tested in SIB buffer alone (Table 3.15). This sign­
ificant difference (P <0.0005) can not be attributed to-exp­
erimental error, as both sets of experiments were carried 
out simultaneously using the same preparation of buccal 
cells and bacteria. Moreover, the same pattern of results 
was found with all tested strains. There appears to be no 
previous publication concerning the adherence of A .actino­
mycetemcomitans to buccal cells in the presence of serum.
3.4.5 Effect of repeated subculturing on adherence
In a number of recent studies some freshly isolated strains 
of A.actinomycetemcomitans have been shown to possess fimb­
riae (Scannapieco et al., 1987; Rosan et al., 1988), which 
appeared to be irreversibly lost after 30 to 40 subcultures 
onto TSBV agar plates (Rosan et al., 1988). The fimbriated 
strains were found to produce star-shaped colonies and 
tended to aggregate readily in fluid media, whereas the non­
fimbriated cells formed uniform suspensions and did not pro­
duce star-shaped colonies. Two of the fimbriated strains of 
A.actinomycetemcomitans tested by (Rosan et al., 1988) 
adhered 3 to 4-times better than non-fimbriated variants to 
both hydroxyapatite and saliva treated hydroxyapatite. 
However, one strain showed no difference in adherence to the 
tested surfaces when the fimbriated and non-f imbriated vari­
ant were compared. The presence of fimbriae on A.actinomy­
cetemcomitans was detected using electron microscopy which 
showed that in any positive culture many of the cells had
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only a. single fimbria, whereas others possessed several fim­
briae (Rosan et al., 1988) . These authors suggested that
the presence of fimbriae is an important mediator for adhes­
ion to hydroxyapatite by A.actinomycetemcomitans. However, 
it must be remembered that one of the 3 strains tested by 
(Rosan et al., 1988) failed to exhibit any difference in
adherence whether fimbriated or not. Moreover, it is not 
known if the number of fimbria present on each bacterial 
cell plays any role in adherence. Kagermeier and London 
(1985) reported that A. actinomycetemcomitans Y4 lost some of 
its capacity to adhere to hydroxyapatite after it had been 
subcultured over a period of one year. In the present study 
four freshly isolated A .actinomycetemcomitans strains (Aa 
09, 10, 16 & 17) were subcultured 50 times on blood agar
plates and examined for their ability to adhere to buccal 
epithelial cells in vitro. Interestingly the four strains 
tested gave almost the same numbers of adhered bacteria per 
buccal cell after repeated subculture when compared to 
results obtained with fresh strains subcultured on only 5 or 
6 occasions. These results suggest that repeated subcultu- 
ring has no effect on the adherence of A . actinomycetemco­
mitans to buccal cells. It was not possible to confirm the 
presence or absence of fimbriae in the A.actinomycetemcomi­
tans strains used in the present investigation. In conclu­
sion, further investigations are necessary before the role 
of fimbriae in the adherence of A . actinomycetemcomitans to 
oral surfaces can be clearly defined.
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3.4.6 Adherence of fresh isolates compared to Type 
strains
There is no published information with which to compare the 
adherence of fresh and Type strains of A.actinomycetemcomi­
tans to buccal epithelial cells. In the present study more 
than 80% of the fresh isolates of A .actinomycetemcomitans 
adhered well to buccal cells at levels of > 10 bacteria/BEC 
with an overall mean of 13.3 bacteria. Results obtained 
with the Type strains also demonstrated similar findings to 
that obtained with the fresh isolates giving an overall mean 
of 10.7 bacteria/BEC and no significant difference was 
found. However, there was a wide variation between the abi­
lity of different strains to adhere to buccal cells. These 
results emphasize the inaccuracies which may occur if only 
one or two strains of a bacterial species are examined and 
conclusions are then drawn on the adherence of that micro­
organism. For example, if by chance Aa 23 (adherence value 
of 1.7 bacteria/BEC) had been the only strain tested in this 
investigation, then the conclusion would have been that 
A.actinomycetemcomitans adheres poorly to buccal epithelial 
cells. However, the opposite would have been the case if 
another strain which adhered in higher numbers was chosen 
eg. Aa G3 with a value of 27.7/BEC. It is interesting to 
note that although strains NCTC 1097 9 and ATCC 29522 are 
said to be same isolate (American Type Culture Catalogue, 
1985), different adherence values to BECs were obtained. 
While A .actinomycetemcomitans NCTC 1097 9 showed the highest 
adherence value of 27.7 bacteria/BEC; ATCC 295222 only
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adhered at a level of 4.5 bacteria/BEC. The reason for this 
5-fold difference in adherence between what is believed to 
be the same Type culture is unknown. Therefore as a general 
rule it is important to study a wide selection of isolates 
including fresh and Type strains when investigating the 
adherence of a bacterial species.
3.4.7 Adherence of A.actinomycetemcomitans to other 
surfaces
There are a few papers which deal with the adherence of 
A . actinomycetemcomitans to hydroxyapat ite and other oral 
surfaces, and although this is not directly related to the 
present investigation, it is interesting to consider the 
results. Two strains of A.actinomycetemcomitans (ATCC 29523 
and Y4) were reported to adhere poorly to hydroxyapatite 
beads (Gibbons and Etherden, 1983) . Surprisingly due to the 
differences in the surfaces tested and the nature of adhere­
nce assay used, the results obtained for both strains in the 
present study were also low. For instance, A.actinomycetem­
comitans ATCC 29523 showed the lowest level of all strains 
tested at 1.7/BEC, while Y4 adhered at 5.7 bacteria per buc­
cal cell.
The effect of saliva on the adherence of A .actinomycetem­
comitans to hydroxyapatite has also been reported by 
Kagermeier and London (1985) . They found that the adherence 
of A.actinomycetemcomitans strains Y4 and N27 to hydroxy­
apatite was reduced after coating with saliva. This reduc­
tion was said to be around 50% for the N27 strain and was
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only slightly reduced for Y4. However, Rosan et al.f (1988) 
showed that three strains of A .actinomycetemcomitans adhered 
to both hydroxyapatite and saliva treated hydroxyapatite to 
a similar extent. In addition, one Type strain (NCTC 9710) 
was found to adhere in high numbers (324/0.018 mm2) to sal­
iva treated tooth enamel (Sweet, MacFarlane and Samaranay- 
ake, 1990).
There is little information about the affect of serum on the 
adherence of A .actinomycetemcomitans to oral surfaces. How­
ever, it has been shown that serum reduced the adherence of 
two A.actinomycetemcomitans strains (N27 and Y4) to hydro­
xyapatite by 20 and 66% respectively (Kagermeier and London, 
1985) . Although the test surfaces and adherence assays used 
in the Kagermeier and London (1985) study and the present 
investigation are very different, they do both report a mar­
ked inhibitory effect of serum on the adherence of A .actino­
mycetemcomitans . Finally it should be emphasized that until 
more investigations are carried out using serum, saliva and 
buccal epithelial cells from different individuals as well 
as more strains of A.actinomycetemcomitans, the factors 
which affect the adherence of A.actinomycetemcomitans will 
remain uncertain. However, the assay method described here 
and the results obtained, should provide a start for subse­
quent studies in this field.
3.5 Conclusions:
The results of this study showed clearly that all 33 strains 
of A . actinomycetemcomitans had the ability to adhere to hu­
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man buccal epithelial cells in vitro with an overall mean of
12.5 bacteria/BEC.
In general the freshly isolated A.actinomycetemcomitans iso­
lates adhered better than the Type strains, but the diffe­
rence was not statistically different.
Adherence of A. actinomycetemcomitans in the presence of sal­
iva was similar to that observed in SIB buffer alone.
Human serum significantly reduced the number of adhered bac­
teria per buccal epithelial cells compared to that obtained
in either SIB or in the presence of saliva.
Continuously subcultured strains of A.actinomycetemcomitans 
were found to adhere to buccal epithelial cells to a similar
extent compared with the fresh isolates.
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CHAPTER 4
HYDROPHOBICITY OF A . ACTINOMYCETEMCOMITANS
4.1 Introduction
Hydrophobic interactions have been considered primarily res­
ponsible for mediating bacterial adherence to most oral 
surfaces (Rosenberg et al., 1983a). Thus if the adherence
of microorganisms to oral surfaces is mediated by hydropho­
bicity, there should be a clear association between hydro- 
phobicity and adherence. There is little information conc­
erning the hydrophobic activity of A .actinomycetemcomitans 
and what has been reported is conflicting (see section 
1.7.6). For example, Gibbons and Etherden (1983) reported 
that two strains of A.actinomycetemcomitans were hydrophilic 
as assessed by their inability to adsorb to hexadecane, and 
adhered in only low numbers to hydroxyapatite. However, 
Kozlovsky et al., (1987) found that one A .actinomycetem­
comitans strain possessed hydrophobic activity, which was 
found to vary depending on the medium used for growth, the 
age of culture and the suspending medium employed.
Therefore, the aim of this study was (I) , to evaluate the 
hydrophobic activity of the same 33 isolates of A. actinomy­
cetemcomitans which had been used in Chapter 3 to study 
adherence to BECs and (II) , to determine if there is any 
correlation between hydrophobicity and the adherence of 
A.actinomycetemcomitans to BECs.
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4.2 Materials and methods
4.2.1 Preparation of A .actinomycetemcomitans suspen­
sions
Thirty three A.actinomycetemcomitans isolates were tested 
for their hydrophobic activities. The isolates included 10 
reference strains and 23 GDH fresh isolates (see Table 3.1). 
Suspensions of all A.actinomycetemcomitans strains were pre­
pared by growing the test bacteria on two CBA plates for 48 
hours at 37°C in an atmosphere of 5% CC>2 in air. Growth was 
harvested using a sterile cotton swab and then added to 5 ml 
SIB. After centrifugation at 8000 g for five minutes using 
an MSE centrifuge (MSE Scientific Instruments, Crawley, Eng­
land) , the resultant pellet was resuspended in 10 ml SIB, 
and diluted to give an optical density of 1.0 at 520 nm (SP
8-100 Spectrophotometer, Pye Unicam, England) representing a 
concentration of approximately 3 x 10^/ml.
4.2.2 Hydrophobicity assay
The assay procedure used was that described by Sweet et al.-,
(1987) with the minor modification that aeration of the 
A.actinomycetemcomitans suspensions was extended from 1 to 4 
minutes since the recommended time of one minute failed to 
remove all xylene from the bacterial test suspensions. For 
each A.actinomycetemcomitans strain tested, 5 ml of the 
bacterial suspension (3 x 10^/ml) was added to each of two 
test tubes (15mm diameter and 150mm long), one tube label­
led as test and the other as control. A second set of test 
and control tubes containing the same suspending medium were
193
included in each assay to provide a background reading (see 
Figure 4.1). To all tubes labelled ’test1, one millilitre 
of xylene (Raymed, Leeds, England) was carefully added to 
ensure that the xylene formed a layer on top of the suspens­
ion medium, without mixing occurring. All tubes (both test 
and control) were then incubated in a water bath (HETO, Den­
mark) at 37°C for 10 minutes. Following incubation, all the 
tubes were then vortex mixed for 30 seconds and immediately 
returned to the water bath for a further 30 minutes. During 
this period, xylene formed a separate layer at the top. The 
aqueous lower layer was next carefully removed using a clean 
glass pasteur pipette to a new test tube, the first few 
drops being discarded. Since it is impossible to carry this 
out without transferring some xylene, the latter was removed 
by bubbling compressed air through the fluid for 4 minutes 
using a clean pasteur pipette.
The tubes were once more vortex mixed and the optical densi­
ties were measured at 520 nm using a Pye Unicam SP 8-100 
Spectrophotometer. The tube containing the suspending med­
ium without xylene was used to adjust the spectrophotometer 
to a zero reading for measuring the optical densities of the 
xylene-free control bacterial suspensions. The suspending 
medium containing xylene was used to zero the spectrophotom­
eter before measuring the optical densities of the bacterial 
suspensions to which xylene was added.
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4.2.3 Hydrophobicity of A .3Lctj.nomycetemcomd.tans aft­
er repeated subculturing
Four freshly isolated A.actinomycetemcomitans strains (Aa 9, 
16, 17 & 33) were subcultured on 50 occasions on blood agar 
plates (CBA). Subculturing was repeated every 48 hours by 
sweeping some of the growth using a sterile loop and inoc­
ulating it onto a fresh CBA plate which was then incubated 
under 5% C02 in air at 37°C. These isolates were found to 
produce smooth colonies and grew in broth culture without 
aggregation occurring. The four strains were subsequently 
tested for their hydrophobic properties as opposed to the 
rough variants (only subcultured for 5 to 6 times) using the 
same method described earlier in section 4.2.2. The results 
obtained with the rough and smooth subcultured variants were 
then compared.
4.2.4 Effect of suspending media on hydrophobicity
The effect of suspending media (ie. SIB and PBS) on the hyd­
rophobicity of A. actinomycetemcomitans (Aa 09, 10 and 16)
was examined using the same procedure described in section
4.2.2. The bacteria were prepared as described in section
4.2.1 and then suspended in either SIB or PBS.
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Figure 4.1 Diagrammatic representation of the hydro- 
phobicity assay used in this study.
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4.2.5 Effect of growth, conditions on the hydxophobi— 
city of the subcultured strains
Five of the freshly isolated A.actinomycetemcomitans strains 
(Aa 9, 10, 16, 17 & 18) were grown on CBA for 24 and 48
hours in 5% C02 in air. Bacterial suspensions of these iso­
lates were then prepared in SIB as described in section
4.2.1. The hydrophobic activities of these strains was then 
determined using the same procedure described in section
4.2.2.
4.2.6 Calculation of hydrophobicity values
To determine the hydrophobicity of the test strains, the pe­
rcentage reduction in optical density of the test suspension 
which contained xylene as compared with the control suspe­
nsion which was xylene free, were calculated. These perce­
ntage values are proportional to the hydrophobicity of the 
test bacteria in any given suspending medium (Rosenberg et 
al. r 1980). The assay was repeated ohce on three different 
occasions for each A.actinomycetemcomitans strain tested.
4.2.7 Statistical analysis
All assays were performed on three different occasions for 
each bacterial strain under study. Results were tested to 
discover if they were normally distributed or not using STAT 
WORK software (APPLE Macintosh computer). Significant diff­
erences were determined using the non-parametric Mann-whit- 
ney U test. In addition, correlation coefficients were det­
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ermined for comparisons of the hydrophobicity results with 
the adherence results reported in Chapter 3.
4 . 3 Results:
4.3.1 Hydrophobicity of A . actinomycetemcomitans in 
SIB
The hydrophobicity results for the same 33 strains of 
A.actinomycetemcomitans (Aa 01 to Aa 33) used in the adher­
ence assay are shown in Table 4.1. In general all A.actino­
mycetemcomitans isolates were shown to be hydrophobic as 
assessed by their ability to adsorb to xylene. The perce­
ntage reduction in absorbance at a wave length of 520 nm for 
these isolates ranged from 3 9 to 82% with an overall mean of 
67%. All the fresh GDH strains of A.actinomycetemcomitans 
exhibited over a 50% reduction in absorbance with an overall 
mean of 70% reduction in SIB. The Type strains showed an 
overall mean reduction of 58%. Moreover, the ATCC strain 
(Aa 22) gave the lowest hydrophobic value (39%), and the 
highest recorded value of 82% was obtained with the fresh 
GDH strain (Aa 18) . The Mann-Whitney U test was used to 
compare these results which showed no significant difference 
between fresh and Type strains (p >0.05).
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Table 4.1 Hydrophobicity results of 33 strains of
A. actinomycetemcomitans in SIB buffer.
Bacterial 
strain number
% Drop in
Experiment 
1 2
Absorbance
number
3
at 520 nm 
Mean (±SEM)
Aa 01 61 58 62 60 (1.2)
Aa 02 75 79 83 79 (2.3)
Aa 03 61 63 60 61 (0.9)
Aa 04 83 75 82 80 (2.5)
Aa 05 65 76 48 63 (8.1)
Aa 06 48 53 46 49 (2.0)
Aa 07 82 74 64 73 (5.2)
Aa 08 86 62 73 74 (6.9)
Aa 09 74 77 76 76 (0.9)
Aa 10 73 73 72 73 (0.3)
Aa 11 62 59 71 64 (3.6)
Aa 12 81 73 76 77 (2.3)
Aa 13 71 80 77 76 (4.6)
Aa 14 81 76 80 79 (2.6)
Aa 15 66 62 62 63 (1.3)
Aa 16 54 59 70 61 (4.7)
.. Aa 17 68 76 62 69 (4.0)
±SEM: Standard error of mean
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Table 4.1 Continued.
Bacterial 
strain number
% Drop in
Experiment 
1 2
Absorbance
number
3
at 520 nm 
Mean (±SEM)
Aa 18 72 84 90 82 (5.3)
Aa 19 81 85 67 78 (5.4)
Aa 20 88 70 78 79 (5.2)
Aa 21 44 47 46 46 (0.9)
Aa 22 35 40 42 39 (2.1)
Aa 23 51 66 51 56 (5.0)
Aa 24 52 54 45 50 (2.7)
Aa 25 77 79 73 76 (1.8)
Aa 2 6 64 73 63 67 (3.2)
Aa 27 51 63 50 55 (4.2)
Aa 28 68 78 70 72 (3.0)
Aa 29 82 77 69 76 (3.8)
Aa 30 66 61 73 67 (3.5)
Aa 31 58 67 76 67 (5.2)
Aa 32 58 61 58 59 (1.0)
. Aa_, 33 66 57 62 62 (2.6)
iSEM: Standard error of mean
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4.3.2 Effect of repeated subculturing on hydrophob- 
i city
Repeated subculturing on 50 occasions on CBA plates, resul­
ted in the loss of homotypic aggregation in broth cultures 
and in adherence to agar surfaces by the strains of A.actin- 
omycetemcomitans tested. However, as shown in Tables 4.2 
and 4.3, repeated subculturing did not affect the hydrophob- 
icity of these strains. Although only four strains were 
tested, results showed clearly that both variants were hyd­
rophobic. A .actinomycetemcomitans (Aa 31) lost some of its 
hydrophobic activity after it had been subcultured for 50 
times (Table 4.4) . However, there was no significant diff­
erence between any of the results presented in Table 4.4 as 
determined by the Mann Whitney-U test.
4.3.3 Effect of suspending medium on hydrophobicity
Three strains (Aa 9, 10 & 16) were tested for their hydro-
phobic activity in different suspending media (ie. SIB, 
Table 4.5, and PBS, Table 4.6). None of the strains showed 
a significant difference in hydrophobicity when suspended in 
either of the two buffers used, and the mean % drop in adso­
rption was 70.3 for SIB and 71% for PBS (see Table 4.7) .
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Table 4.2 Hydrophobicity of the 4 rough (fresh) iso­
lates of A . a.ctinoia.ycB't&m.coxD.i.t.s.ns strains before sub­
culture .
% Drop in Absorbance at 520 nm
Bacterial 
strain number
Experiment 
1 2
number
3 Mean (jhSEM)
Aa 0 9 74 77 76 76 (0.9)
Aa 16 54 59 70 61 (4.7)
Aa 17 68 76 62 69 (4.0)
Aa 31 58 67 76 67 (5.2)
±SEM: Standard error of mean
Table 4.3 Hydrophobicity of 4 A.actlnomycetemcomi- 
tans strains after 50 repeated subcultures over a 
period of 16 weeks (smooth forms).
Bacterial 
strain number
% Drop in
Experiment 
1 2
Absorbance
number
3
at 520 nm 
Mean (±SEM)
Aa 09 77 80 73 77 (2.0)
Aa 16 68 55 61 61 (3.7)
Aa 17 71 71 78 73 (2.3)
Aa 31 45 53 51 50 (2.4)
±SEM: Standard error of mean
Table 4.4 A comparison of the hydrophobicity of rou­
gh and smooth colonial forms of A .actlnomycetemcomi- 
t a n s .
Bacterial 
strain number
% Drop in 
Rough
Absorbance at 
Smooth
520 nm 
P
Aa 09 ‘ 76 78 NS
Aa 16 61 61 NS
Aa 17 69 73 NS
Aa 31 67 50 NS
p: Probability determined by Mann-Whitney U-test 
NS: Not significant
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Table 4.5 Hydrophobicity of three strains of A.acti-
nomycetemcomltans in SIB buffer.
% Drop in Absorbance at 520 nm
Bacterial 
strain number
Experiment 
1 2
number
3 Mean (±SEM)
Aa 09 77 80 73 77 (2.0)
Aa 10 73 73 72 73 (0.3)
Aa 16 68 55 61 61 (3.7)
±SEM: Standard error of mean
Table 4.6 Hydrophobicity 
nomycetemcomitans in PBS
of three strains of A.acti- 
buffer.
% Drop in Absorbance at 520 nm
Bacterial Experiment number
strain number 1 2 3 Mean (±SEM)
Aa 09 75 78 79 77 (1.2)
Aa 10 73 65 70 69 (2.3)
Aa 16 65 66 69 67 (1.2)
±SEM: Standard error of mean
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Table 4.7 Comparison of hydrophobicity of three 
strains of A. actlnomycetemcomitans in SIB and PBS.
Bacterial 
strain number
% Drop 
SIB
in Absorbance at 
PBS
520 nm 
P
Aa 09 77 77 NS
Aa 10 73 69 NS
Aa 16 61 67 NS
Mean 70.3 71 NS
p : Probability determined by Mann-Whitney U-test 
NS: Not significant
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4.3.4 Effect of incubation time on hydrophobicity
These results were obtained from five different strains (Aa
9-10 and 16-18) after they had been incubated on CBA plates 
for 24 and 48 hours. As shown in Tables 4.8 and 4.9 there 
were variations between the percentage reduction in absor­
bance under these conditions. A range of 57 to 93% reduc­
tion in absorbance was obtained for the test strains after 
incubation for 24 hours on CBA compared with a range of 50 
to 80% reduction, after 48 hours incubation. As expected 
these slight variations shown in Table 4.10 were not signi­
ficant .
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Table 4.8 Hydrophobicity of A.actinomycetemcomitans 
after incubation for 24 hours on CBA.
Bacterial 
strain number
% Drop in Absorbance
Experiment number 
1 2  3
at 520 nm 
Mean (±SEM)
Aa 09 96 92 90 93 (1.8)
Aa 10 80 86 78 81 (1.4)
Aa 16 47 49 44 47 (2.4)
Aa 17 58 56 58 57 (0.7)
Aa 18 88 90 88 89 (0.7)
± SEM: ,Standard error of mean
Table
after
4.9 Hydrophobicity of 
incubation for 48 hours
A.actinomycetemcomitans 
on CBA.
Bacterial 
strain number
% Drop in
Experiment 
1 2
Absorbance
number
3
at
Mean
520 nm 
(±SEM)
Aa 09 82 80 77 80 (1.4)
Aa 10 70 74 84 76 (4.2)
Aa 16 46 46 57 50 (3.7)
Aa 17 57 63 76 65 (5.6)
—  Aa 18 77 74 7 9 77 (1.4)
± SEM: Standard error of mean
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Table 4.10 Comparison of hydrophobicity of A.actino­
mycetemcomitans after incubation for 24 and 48 hours 
on CBA.
Bacterial 
strain number
% Drop in 
24 hour
Absorbance at 
48 hour
52 0 nm 
P..
Aa 09 93 80 NS
Aa 10 81 76 NS
Aa 16 47 50 NS
Aa 17 57 65 NS
Aa 18 89 77 NS
p: Probability determined by Mann-Whitney U-test 
NS: Not significant
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4.4 Discussion:
4.4.1 Experimental methods
The original method for determining bacterial hydrophobicity 
was described by Rosenberg et al., (1980) in which three 
different hydrocarbons (hexadecane, octane and xylene) were 
used. Results obtained from testing different bacteria sho­
wed different affinities towards the three hydrocarbons used 
(Rosenberg et al., 1980). This suggested that the affinity 
for hydrocarbons may vary among different bacteria. The 
methods used to study the hydrophobicity of A.actinomycetem- 
comitans include the adherence to hexadecane (Gibbons and 
Etherden, 1983); octane (Kozlovsky et al., 1987) and xylene 
(Sweet, 1986) . In the present study hydrophobicity of 
A.actinomycetemcomitans was determined using the method des­
cribed by Sweet et al., (1987) . This technique was perfor­
med on all isolates and showed reproducible results with 
xylene as the test hydrocarbon. A standard error range of 
0.3 to 8.1 was recorded for the 33 tested A.actinomycetem­
comitans strains with an overall mean of 3.3. The main 
problem encountered in the present study in using this 
technique was the removal of xylene from the aqueous bacter­
ial suspensions. Although Sweet et al., (1987) found that 
aeration of bacterial suspensions for one minute resulted in 
the removal of xylene, this time proved to be inadequate in 
this study as xylene droplets were still noted in the bacte­
rial suspensions containing A.actinomycetemcomitans. There­
fore, suspensions were aerated for four minutes which resul­
ted in the removal of visible xylene. It has been sugges-
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ted that although hexadecane is widely used by researchers 
to study bacterial hydrophobicity, failure to aerate hexade­
cane may account for the poor reproducibility of experiments 
using this hydrocarbon (Rosenberg et al., 1980; Olsson and
Westergren, 1982; Sweet et al., 1987). However, at present 
there is insufficient evidence to confirm or refute the fin­
ding that a period of aeration is important in hydrophobic­
ity assays and more studies are needed in this field.
4.4.2 Hydrophobicity results
This is the first report when a large number of A.actinomy- 
cetemcomitans isolates (33 strains) were examined for their
hydrophobic activity. In general all the strains tested
were hydrophobic as assessed by their ability to adsorb to 
xylene. These isolates exhibited an overall range of 39% to 
82% reduction in the bacterial suspensions with an overall 
mean of 67%. Previous studies have only tested one or two 
Type strains (Gibbons and Etherden, 1983; Sweet et al., 
1986; Kozlovsky et al., 1987). The first report was that of 
Gibbons and Etherden (1983) who studied A .actinomycetem- 
comitans ATCC 29523 and Y4. They found both of these stra­
ins to be hydrophilic as assessed by their inability to ads­
orb to hexadecane. Later Kozlovsky et al., (1987) tested Y4 
and concluded that it was hydrophobic as determined by its 
ability to adsorb to octane. The adherence of Y4 to octane 
varied between 60 and 90% depending on the medium used for 
cultivation, age of culture and the suspending medium (these
factors are discussed in sections 4.4.3-4.4.5). In this
study using xylene however, A .actinomycetemcomitans Y4 and
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ATCC 29523 both exhibited moderately hydrophobic activities 
with a 46% and 56% reduction in optical density respecti­
vely. Sweet (1986) examined a single strain of A.actinomy- 
cetemcomitans (NCTC 9710) and found it to be highly hydro- 
phobic (89% reduction in absorbance). This is in agreement 
with the findings of the present study where a level of 7 9% 
reduction was obtained for the same strain. Since both inv­
estigations used almost the same methodology, there is thus 
a good evidence that the method chosen to evaluated hydro­
phobicity was reproducible. In conclusion the findings of 
this study strongly confirm the earlier suggestions that 
A.actinomycetemcomitans is hydrophobic.
4.4.3 Effect of repeated subculturing on hydrophobi- 
city
Continuous repeated subculturing for 50 times was found not 
to affect the hydrophobicity of A.actinomycetemcomitans (Ta­
ble 4.4) . Although only four strains were studied, there 
was little difference between the hydrophobicity of the two 
different colonial forms of A.actinomycetemcomitans. Never­
theless, one strain (Aa 31) was found to lose some of its 
hydrophobic activities after it had been repeatedly subcult­
ured. A decrease of 17% in the absorbance of the bacterial 
suspension was obtained with the smooth variant compared 
with the value obtained with the rough colonial form. How­
ever, this change was not significant when compared to that 
obtained with the rough variant of the same isolate (Table 
4.4) .
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Surprisingly there is no information in the literature conc­
erning the effect of repeated subculture on hydrophobicity 
although there are some reports dealing with other oral 
microorganisms. Sweet et al., (1986) failed to show any 
difference in hydrophobicity when 8 fresh and 8 Type oral 
bacterial species were compared. However, A.actinomycetem­
comitans was not included in Sweet's comparison. In another 
study Streptococcus mutans was found to be less hydrophobic 
after repeated subculturing (Olsson and Westergren, 1982). 
However, this was subsequently shown to occur with serotype 
c strains only (Westergren and Olsson, 1983) . In conclusion 
the hydrophobicity of A .actinomycetemcomitans appears to be 
generally unaffected by laboratory maintenance.
4.4.4 Suspending medium
In a previous report the hydrophobicity of A.actinomycetem­
comitans was said to be affected by the type of buffer in 
which the bacteria was suspended (Kozlovsky et al., 1987). 
In their investigation potassium/urea/magnesium (PUM) buffer 
gave the highest hydrophobicity results for A.actinomycetem­
comitans Y4 compared with phosphate and PBS buffers. Kozlo­
vsky et al., (1987) did not statistically analyse their 
results, but using the published results, this was carried 
out as part of the present investigation. Analysis showed 
that their results were not significantly different as dete­
rmined by t-Test. The three A.actinomycetemcomitans isola­
tes examined in the present study appeared to be unaffected 
by the type of buffer used, ie. SIB and PBS (see Table 4.7). 
However, other researchers have demonstrated that suspending
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medium may affect hydrophobicity of oral bacteria other than 
A.actinomycetemcomitans (Rogers, Pilowsky and Zilm, 1984; 
Sweet, 1986). Rogers et al., (1984) found oral Streptococci 
to be more hydrophobic in PUM buffer compared to hydropho­
bicity in phosphate or Hepes buffer. Sweet (1986) on the 
other hand, showed that oral bacteria gave higher hydropho­
bic values when suspended in SIB than in PBS buffer. Rogers 
et al., (1984) suggested that the main factor affecting
hydrophobicity may be related to the ionic concentration of 
the buffers used, which can enhance the partitioning of the 
bacteria between phases. Increased salt concentration is 
known to cause the precipitation of proteins or bacteria 
according to their degree of hydrophobicity (Lindhal et al., 
1981) . This would suggest that buffers with a higher ionic 
strength may yield higher bacterial hydrophobicity values. 
According to this assumption it would be expected that PBS 
with a higher ionic strength (0.284) than SIB (0.055) would 
produce higher bacterial hydrophobicity values (Sweet, 
1986) . However, this was not demonstrated in the case of 
A.actinomycetemcomitans when tested in the two buffers (PBS 
and SIB) . Nevertheless, it may be of interest to examine 
the hydrophobicity of A.actinomycetemcomitans in other types 
of buffers.
4.4.5 Age of culture
The overall hydrophobicity results of A.actinomycetemcomi­
tans after cultivation for 24 or 48 hours on CBA were not 
significantly different as compared by either Mann-Whitney U 
test or t-Test. Nonetheless, it has been'suggested that the
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age of bacteria may affect hydrophobicity. Kozlovsky et 
al., (1987) found that A. actinomycetemcomitans Y4 grown for
24 hours in fluid thioglycollate broth or brain heart infu­
sion agar gave the highest hydrophobic activities compared 
to the results obtained from cells cultured for 48 hours on 
the same media. These authors did not present any evidence 
that these differences were statistically significant. How­
ever, when Kozlovsky's data were analysed by the present 
author using a t-Test, the differences were found not to be 
significant. Thus on statistical grounds the results of 
this study with five fresh isolates of A.actinomycetemcomi­
tans agree with the findings of Kozlovsky et al., (1987).
4.4.6 Correlation between hydrophobicity and adhe­
rence
Recent studies have tended to directly relate bacterial 
adherence with hydrophobicity (Rosenberg et al., 1981; Ros­
enberg et al., 1983a). However, not all findings agree with 
the previous statement (Rosan, Eifert and Golub, 1985) and 
therefore, the relationship between the two phenomena is not 
entirely clear. Gibbons and Etherden (1983) have suggested 
that A.actinomycetemcomitans was hydrophilic since it failed 
to adsorb to hexadecane and only adhered in low numbers to 
hydroxyapatite. The adherence of other oral bacteria such 
as Actinomyces viscosus, S.sanguis and Bacteroides gingi- 
valis to hydroxyapatite and the adherence of Acinetobacter 
calcoaceticus to buccal epithelial cells, correlated with 
their hydrophobic activities (Gibbons and Etherden, 1983; 
Rosenberg et al., 1983a) . However, there was no statistical
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analysis carried out in these papers to confirm these obser­
vations .
The combined adherence results (Table 3.6) and hydropho­
bicity values (Table 4.1) obtained for the same 33 A.actino­
mycetemcomitans isolates investigated in this study are 
shown in Table 4.11. There was a clear significant overall 
correlation (p <0.05) between adherence to BECs and hydro­
phobicity in xylene of A .actinomycetemcomitans (Spearman 
correlation coefficient 0.371). These results are similar 
with the findings of Sweet (1986) where a significant level 
of 0.536 (p <0.05) was obtained for 18 pairs of different 
oral bacteria which did not include A.actinomycetemcomitans. 
As two distinct groups, the freshly isolated A. actinomy­
cetemcomitans strains were found to adhere in higher numbers 
to buccal epithelial cells and showed higher hydrophobic 
activities compared to the Type cultures. However, these 
differences were found to be not significant.
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Table 4.11 Comparison between A . a ctinomycetemcomi­
tans adherence to buccal epithelial cells and hydro­
phobicity .
Bacterial 
strain number
Hydrophobicity 
% drop in abs. 
at 520 nm
(±SEM)
Adherence 
No. bacteria/BEC 
(±SEM)
Aa 01 60 (1.2) 7.7 (2.7)
Aa 02 79 (2.3) 13.4 (0.8)
Aa 03 61 (0.9) 27 .7 (2.4)
Aa 04 80 (2.5) 12 .4 (1.7)
Aa 05 63 (8.1) 9.0 (3.5)
Aa 06 49 (2.0) 19.5 (4.2)
Aa 07 73 (5.2) 7.3 (1.3)
Aa 08 74 (6.9) 14.0 (2.8)
Aa 09 76 (0.9) 10.2 (1.0)
Aa 10 73 (0.3) 13.7 (0.8)
Aa 11 64 (3.6) 17.8 (1.5)
Aa 12 77 (2.3) 19.2 (1.6)
Aa 13 76 (4.6) 16.7 (0.8)
Aa 14 79 (2.6) 16.4 (0.9)
Aa 15 63 (1.3) 21.5 (2.2)
M 16 61 (4 .,71 ll.iQ_ (1,4) .
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Table 4.11 Continued.
Hydrophobicity
% drop in abs. Adherence
Bacterial at 520 nm No. bacteria/BEC
strain number__________(±SEM)__________________ (±SEM)______
Aa 17 69 (4.0) 5.9 (1.4)
Aa 18 82 (5.3) 15.0 (1.1)
Aa 19 78 (5.4) 15.0 (1.4)
Aa 20 79 (5.2) 13.3 (1.5)
Aa 21 46 (0.9) 5.7 (1.6)
Aa 22 39 (2.1) 4.5 (o.6)
Aa 23 56 (5.0) 1.7 (0.5)
Aa 24 50 (2.7) 5.0 (0.9)
Aa 25 76 (1.8) 16.3 (1.6)
Aa 26 67 (3.2) 12.4 (3.5)
Aa 27 55 (4.2) 10.0 (0.7)
Aa 28 72 (3.0) 13.7 (1.2)
Aa 29 76 (3.8) 11.0 (2.0)
Aa 30 67 (3.5) 6.4 (1.3)
Aa 31 67 (5.2) 14.3 (2.1)
Aa 32 59 (1.0) 13.9 (1.1)
Aa 33 62 (2.6) 11.8 m.8)
Comparison of hydrophobicity v adherence, p — 0.03
abs: absorbance
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4.5 Conclusions:
The method used to determine the hydrophobicity of A.actino— 
mycetemcomitans was simple, reproducible and rapid to per­
form. In addition, the use of xylene was of advantage
since it was easily removed by aeration for four minutes.
All of the freshly isolated A.actinomycetemcomitans strains 
were hydrophobic when tested in SIB buffer. However, some 
of the Type strains appeared to be only moderately hydro- 
phobic (especially the ATCC strains).
There were no overall significant differences between the 
hydrophobicity of fresh and Type strains of A. actinomycetem­
comitans .
Factors such as repeated subculturing (50 times) , type of 
buffer used and incubation time were found not to affect the 
hydrophobicity of A .actinomycetemcomitans.
A significant overall correlation was found between hydro­
phobicity and adherence to buccal epithelial cells by 
A. actinomycetemcomitans which may suggest that the adherence 
of this organism to oral surfaces in vivo can be influenced 
by hydrophobic forces.
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CHAPTER 5
LEUCOTOXIC ACTIVITY OF A . ACTINOMYCETEMCOMITANS
5.1 Introduction
A . actinomycetemcomitans is a suspected pathogen in Localized 
Juvenile Periodontitis (LJP) (Reviewed by Zambon, 1985). 
This organism has been shown to produce several biologically 
active factors including a leucotoxin which kills human 
polymorphonuclear leucocytes (PMNLs), monocytes (Taichman et 
al., 1984) and promyelocytic HL-60 cell line, in vitro. It 
has been suggested that PMNLs may play a defensive role in 
the normal and diseased gingival crevice (Miyasaki et
al., 1987) . The mechanisms by which A.actinomycetemcomitans 
leucotoxin causes destruction of target cells is not 
completely understood, but recently the leucotoxin has been 
cloned (Kolodrubetz et al., 1989; Lally et al., 1989). Both 
leucotoxic and non-leucotoxic A.actinomycetemcomitans stra­
ins have been isolated from LJP or patients with other types 
of periodontal disease, eg. adult periodontitis, generalized 
juvenile periodontitis as well as healthy individuals 
(Zambon et al., 1983c) . This variation in toxicity has not 
been fully explained at the molecular gene level, nor is 
there any information to suggest that bacteriophages acts as 
mediators for leucotoxicity (Ohta et al., 1987). Tsai and 
Taichman (1986) found that leucotoxic A.actinomycetemcomi­
tans strains were isolated from younger patients (6-12 years 
of age) but not from older patients (13-25 years old) .
This investigation was designed to examine the leucotoxicity 
of a number of freshly isolated and Type strains of A.acti-
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nomycetemcomitans for human PMNLs obtained from a single 
donor with no history of periodontal disease and for a prom­
yelocyte tissue cell line (HL-60) in vitro.
5.2 Materials and methods
5.2.1 Bacterial strains
Test strains of A.actinomycetemcomitans included 6 Type str­
ains (NCTC 97 0 9, 9710, 10979, 10980, and 10981), A.actino­
mycetemcomitans Y4 and twelve fresh isolates from patients 
attending Glasgow Dental Hospital and School (see Table
5.1) . The bacterial suspension for the leucotoxic assay was 
prepared by growing the test bacteria in 20 ml NIH-Thiogly- 
collate Broth (Difco, Detroit, Michigan, USA), (Appendix I) 
in an anaerobic chamber (Don Whitley, Scientific Ltd., West 
Yorkshire, England) with an atmosphere of 85% N2, 10% H2 and 
5% CC>2 at 37°C for 48 hours. This medium and growth condi­
tions were used so that results could be compared with prev­
ious reports (Zambon et al., 1983c) . Bacteria were harve­
sted by centrifugation in a MSE High Speed 18 Centrifuge 
(MSE Ltd., Crawley, England) at 16000 g for 10 minutes and 
washed twice in PBS at 8000 g for 5 minutes. The collected 
pellet was then resuspended in Hanks Balanced Salt Solutions 
(HBSS) (Gibco-Europe, Paisley, Scotland), (Appendix II) and 
the optical densities were adjusted to 0.6-0.7 at 520 nm 
using a Pye Unicam SP 8-100 Spectrophotometer. The resul­
tant suspension contained 2.0 x 10^ bacteria/ml (see section
3.2.1) .
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Table 5.1 A . actinomycetemcomitans strains used in 
the leucotoxicity studies.
Strain
number Source
Site of 
Isolation
API 20 A 
Profile
Aa 01 NCTC 9709 Abscess (site not given) 4110404
Aa 02 NCTC 9710 Abscess (site not given) 4110405
Aa 03 NCTC 10979 Mandibular abscess 4150404
Aa 04 NCTC 10980 Blood 4110405
Aa 05 NCTC 10981 Neck abscess 4010505
Aa 07 GDH 310 Juvenile periodontitis 4110404
Aa 08 GDH 312 Chronic periodontitis 4110404
Aa 09 GDH 143 ~ 4110404
Aa 10 GDH 216 ~ 4110404
Aa 15 GDH 107 ~ 4050404
Aa 16 GDH 87034 Prepubertal periodontitis 4050404
Aa 17 GDH 510/87 Chronic periodontitis 4050404
Aa 18 GDH 1014 Juvenile periodontitis 4110404
Aa 19 GDH 1212 ~ 4110404
Aa 20 GDH 1214 Chronic periodontitis 4110404
Aa 21 GDH 1115 Juvenile periodontitis 4150404
Aa 39 GDH 1115 Chronic periodontitis 4110404
Aa 40 GDH 1224 Juvenile periodontitis 4110404 ...
NCTC: National Collection of Type Cultures 
ATCC: American Type Culture Collection 
GDH: Glasgow Dental Hospital
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5.2.2 Isolation of Polymorphonuclear leucocytes 
(PMNLs)
Human peripheral blood PMNLs were isolated from a healthy 30 
year old male donor by collecting 10 ml venous blood in a 
sterile universal bottle containing one millilitre heparin 
at 100 units/ml (Leo Laboratories Ltd., Bucks., UK). This 
sample was then added to 30 ml of Hank's Balanced Salt 
Solution (HBSS) giving a dilution of one in 4. Twenty 
millilitres of this diluted blood sample was then carefully 
layered onto 4 ml of histopaque solution (Histopaque-1077, 
Sigma, St., Louis, USA) in a universal bottle and centri­
fuged at 600 g for 30 minutes at room temperature (MSE Cent­
aur Centrifuge, Crawley, England). The supernatant was dis­
carded and the pelleted cells were collected and suspended 
in 20 ml lysis buffer (Boyum, 1968, see Appendix II for 
constituents) and left at room temperature to lyse any blood 
cells other than PMNLs. Treatment with lysis buffer was 
repeated once more to make sure that very few contaminant 
cells remained in the PMNL suspension. The PMNLs in the 
lysis buffer were centrifuged at 180 g for 10 minutes, susp­
ended and washed three times in PBS. Finally the cells were 
collected and resuspended in 2 ml HBSS after which they were 
counted using a haemocytometer and adjusted to give a conce­
ntration of 107 cells/ml. Before use, cells were stained 
with trypan blue to determine the percentage of viable and 
dead cells (see Section 5.2.5 for details) . The PMNLs were 
used in the assay experiments when > 90% of the cells were
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designated viable as monitored by the trypan blue exclusion 
test.
5.2.3 Promyelocytic Leukaemia Cell Line (HL-60)
The HL-60 cell line was originally established from the per­
ipheral blood of a patient with acute promyelocytic leukae­
mia (Collins, Gallo and Gallagher, 1977) . These cells deve­
lop along the myelocytic lineage and in culture maintain 
many enzymatic and cell surface characteristics of mature 
granulocytes (Gallagher et al., 1979). The HL-60 cell line 
was obtained from the European Collection of Animal Cell Cu­
ltures (PHLS Centre, Salisbury, England). These cells were 
cultured in 50 ml Nunc tissue culture cell flasks (Inter 
Med, Denmark) using RPMI 164 0 medium with glutamine (Gibco- 
Europe, Paisley, Scotland), (Appendix I) supplemented with 
200 |lg/ml gentamicin, 2.5 flg/ml fungizone (both supplied by 
Gibco, Europe, Paisley, Scotland) and 10% sterile foetal 
calf serum (Globepharm Ltd., Surrey, UK). Cultures were 
maintained at 37°C in a humified C02 incubator (LEEC, Ltd., 
Nottingham, England) containing an atmosphere of 5% CO2 and 
95% air. The cells do not attach to surfaces and so grow in 
the fluid phase of the medium. Subcultures were performed 
twice weekly as described below. Since most of the HL-60 
cells remained at the bottom of the tissue culture flask, it 
was possible to discard the old medium by tilting the flask 
and leaving 2 to 3 ml of cells. Thirty to forty millilitres 
of the freshly prepared RPMI 1640 medium was then added to 
the cells and incubated as before. In preparation for the 
leucotoxic assay, the cells were collected in universal bot-
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ties and centrifuged at 180 g for 10 minutes. The super­
natant was discarded and the pelleted cells were collected 
and suspended in 5 ml PBS and washed twice by centrifugation 
at 180 g (MSE Centaur 2, Crawley England) for 5 minutes. 
Finally the cells were resuspended in 2 ml HBSS and cell 
viability was determined by trypan blue staining (see method 
below). The concentration of the HL-60 cells was adjusted 
to give 10 cells/ml using HBSS. The HL-60 cells were only 
used when more than 75% of cells were viable.
5.2.4 Leucotoxicity assay procedure
The assay was performed by adding 0.5 ml of the test bact-
q
eria containing 2.0 x 10 /ml to 0.5 ml of human PMNLs or HL-
7
60 (both at a concentration of 10 /ml) in bijou bottles, 
thus producing a ratio of approximately 200 bacteria per 
target cell. A number of controls were included in each 
leucotoxicity assay as described in Table 5.2. All tubes 
were incubated in a shaking water bath (HETO, Denmark) at 
37°C for 1, 2 or 7 hours depending on the experiment being 
performed. Target cells (ie. PMNLs or HL-60 cells) were 
incubated with bacteria for up to 7 hours because a number 
of A.actinomycetemcomitans strains failed to kill the target 
cells when incubated for one hour in preliminary experime­
nts. Death of target cells was measured using two different 
methods namely the trypan blue exclusion and lactate dehy­
drogenase release (LDH) methods.
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Table 5.2 The constituents of the test and control 
tubes in the leucotoxic assays.
Test: 0 5 ml PMNLs or HL-60 cells + 0.5 ml test bacteria
Control (a) : 0.5 ml PMNLs or HL-60 cells + 0.5 ml HBSS
Control (b) : 0.5
0.2%
ml PMNLs or HL-60 
solution of Triton
cells + 0.5 ml of a 
-X 100 (TX-100)
Control (c) : 0.5 ml bacteria + 0.5 ml HBSS
Control (d) : 0.5
0.5
ml of a 0.2% solution of Triton-X 100 + 
ml HBSS
HBSS = Hanks Balanced Salt Solutions (see appendix II) 
(TX-100): Triton-X 100
Controls (a, b, c and d) were employed in the lactate 
dehydrogenase release assays.
Control (a) only was employed in the trypan blue exclusion 
method.
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5.2.5 Measurement of cell death by the trypan blue 
exclusion method
The viability of both PMNLs and HL—60 cells was assessed by 
the trypan blue (BDH, Laboratory Chemicals, Poole, England) 
exclusion test (Baehni et al., 1979). At the end of the
incubation period the tubes containing the assay mixture 
were removed from the water bath and placed in a vessel 
containing ice to limit any further leucotoxic activity of 
A.actinomycetemcomitans. Filter sterilized trypan blue (0.1 
ml of a 0.4% solution) in HBSS was added to 0.1 ml of the 
test or control mixtures in bijou bottles and stained for 5 
minutes at room temperature. The number of cells which were 
stained by trypan blue (dead cells) or remained dye free 
(viable cells) (Figures 5.1a, 5.1b) were counted in a
haemocytometer using microscopical examination at 250 times 
magnification (Olympus Optical CO LTD., Japan) . A minimum 
total of 100 target cells were counted and the percentages 
of dead cells was calculated using the formula below.
Any bacterial strain causing greater than 25% kill of target 
cells within 60 minutes exposure was regarded as leucotoxic.
% Dead Cells = Total No. of cells counted - No. of cells staine.d_x 100
Total No. of cells counted
5.2.6 Measurement of cell death by the Lactate dehy­
drogenase method (LDH)
Lactate dehydrogenase (LDH) release was also used to measure 
the damage which occurred to both PMNLs and HL-60 cells 
after they have been exposed to A.actinomycetemcomitans. 
The technique described by Zambon et al., (1983c) was used
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in this investigation. The release of LDH is used to 
monitor cytotoxicity, and is considered to be directly prop­
ortional to the percentage of total cellular LDH released 
(Zambon et al., 1983c) . After the end of the incubation
period the test and control bottles were removed from the 
water bath and placed on ice for 5 minutes to inhibit furt­
her toxic activity. All test and control samples were cent­
rifuged at 4°C using an MSE High Speed 18 centrifuge at 
1200g for 10 minutes. Supernatants from the test and cont­
rol were removed and a series of two-fold dilution was made 
in HBSS from neat to 1/128. Aliquots (50 Jll) were removed 
from each dilution and added to a fresh bijou bottle. The 
LDH detection system was prepared by adding 1 ml of pyruvate 
substrate (Sigma Kit No. 500 L-l) (Sigma, Diagnostics, St., 
Louis, USA) to a vial containing 1 mg ft-Nicotinamide adenine 
dinucleotide (Sigma) and preheated in a water bath at 37°C 
for 5 minutes. Aliquots (0.1 ml) of this solution were 
added to each bottle containing the supernatant of both test 
and control samples which were then incubated in a shaking 
water bath at 37°C for 15 minutes. Bottles were then 
removed and 100 JXl of a Sigma colour reagent containing 2,4- 
dinitrophenyl-hydrazine in 1 N-hydrochloric acid were added 
and the bottles held at room temperature for 20 minutes. A 
reference blank was included with every set of experiments 
by adding 0.1 ml of the buffer substrate to 0.1 ml of the 
coloured reagent and treated as other samples. Finally a 
one ml volume of 0.4 M NaOH was added to all bottles and 
after rapid mixing the optical densities were read against a
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water blank at 450 nm using a Pye Unicam SP 8-100 spectro­
photometer (Pye Unicam Cambridge, England).
5.2.7 Quantitation of LDH release
The optical density readings were plotted against dilutions 
(for example see Figure 5.2) and the percentage LDH release 
was determined using the data obtained from the plotted 
graphs. The optical density reading of the 'reference 
blank1 containing pyruvate and the Sigma colour reagent 
given above, was taken as the maximum amount of substrate 
present in each assay. Leucotoxic assays were employed to 
determine the amount necessary to reduce about 50% of the 
pyruvate used in the standard assay (ie. reference blank). 
In this region, activity is proportional to dilution (Zambon 
et al., 1983c) . Lysis of cells by Triton-XlOO (Sigma, 
Diagnostics, St., Louis, USA) is used to indicate the total 
cellular release of LDH from target cells. The dilution of 
Triton-XlOO required to produce a 50% reduction of the 
pyruvate used in the standard assay was then compared to the 
dilution of the test bacteria at the 50% point on the graph. 
Experiments were repeated on three different occasion and 
the mean values were calculated. A minimum level of 15% LDH 
release after one hour was considered as a positive leuco­
toxic effect by A.actinomycetemcomitans.
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Figure 5.1a, HL-60 cells stained by trypan
after 60 minutes exposure to whole cells of A. 
nomycetemcomitans (Aa 40).
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Figure 5.1b, HL-60 cells stained by trypan
after 60 minutes incubation in Hanks Balanced 
Solutions buffer.
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Figure 5.2 An example of a graph used for measuring 
lactate dehydrogenase release from PMNLs using whole 
cells of Aa 40 (GDH 1224). The optical density 
reading of the pyruvate substrate (reference blank 
not shown) was 0.6 at 450 nm.
In Figure 5.2 shown above, the dilutions required to reduce 
50% of the pyruvate used in the leucotoxicity assay were as 
follows:
100% LDH release is equivalent to a dilution of 1:16 (ie 50% 
reduction of pyruvate) in the presence of Triton-XlOO
Aa 40 + PMNLs (Test) at dilution of 1:6 = 37.5% LDH release
PMNLs + HBSS (Control) at dilution of 1:2 = 12.5% LDH
release
Therefore, 37.5 - 12.5 = 25% LDH release for Aa 40
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5 . 3 Results:
5.3.1 Leucotoxic activity as measured by trypan blue 
exclusion of five Type strains of A. a ctinomycetemco- 
mitans for HL-60 cells after 7 hours exposure
The leucotoxic activity of five Type strains of A.actinomy- 
cetemcomitans for HL-60 cells was determined using the 
trypan blue exclusion test (Tables 5.3 and 5.4). In these 
experiments the HL-60 cells were exposed to 200 bacteria per 
target cell in HBSS for up to 7 hours. The percentage kill 
of target cells was calculated as described in section 5.2.5 
and the percentage killed in the presence of HBSS alone 
(negative control) was then subtracted from all experiments 
were the test bacteria were used. None of the A.actinomy­
cetemcomitans strains showed any detectable toxic activity 
against the HL-60 cells after 2 and 3 hours incubation.
However, as the incubation time was extended up to 5 then 7
hours, a modest increase in cell death compared to controls 
occurred with all five A.actinomycetemcomitans strains. The 
highest percentage kill of 22% of HL-60 cells was obtained 
with Aa 05, while the other tested strains gave similar 
results and produced percentage kill levels of 13% to 19%
(Figure 5.3) . Thus, despite the long incubation time of HL-
60 cells with A.actinomycetemcomitans, only a small number 
of tissue culture cells were killed and according to the 
criteria used in this study all of the tested strains are 
designated non-leucotoxic.
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Table 5.3 Leucotoxic activity of five Type strains 
of A .actinomycetemcomitans for HL-60 cells at zero 
time (the data represent the mean of three different 
experiments).
Strain
number
Number 
Source No.D.
and %
(±SEM)
of Dead/Live
No.L. (±SEM)
HL-60
% Dead
cells
% Live
Bacteria 13 (4.4) 109 (9.8) 11 % 89 %
free control
Aa 01 NCTC 9709 14 (4.4) 122 (6.7) 10 % 90 %
Aa 02 NCTC 9710 16 (2.0) 105 (12.3) 13 % 87 %
Aa 03 NCTC 10979 11 (2.3) 114 (11.0) 9 % 91 %
Aa 04 NCTC 10980 11 (4.3) 108 (6.1) 9 % 91 %
Aa 05 NCTC .10981 10 (3.4) 108 (12.0) 9. % 91 %
Bacteria free control: HL-60 cells incubated in HBSS buffer 
alone
±SEM: Standard error of mean
Table 5.4 Leucotoxic activity of five Type strains 
of A . actinomycetemcomitans for HL-60 cells after 7 
hours exposure (the data represent the mean of three 
different experiments).
Strain
number
Number 
Source No.D.
and %
(±SEM)
of 1
No .L
Dead/Live
. (±SEM)
HL-60
% Dead
cells
% Live
Bacteria free 
control
41 (7.9) 95 (7.5) 30 % 70 %
Aa 01 NCTC 9709 49 (4.6) 59 (3.5) 45 % 55 %
Aa 0 2 NCTC 9710 57 (8.4) 60 (9.9) 49 % 51 %
Aa 03 NCTC 10979 61 (8.5) 63 (12.0) 49 % 51 %
Aa 04 NCTC 10980 52 (4.5) 68 (3.7) 43 % 57 %
Aa 05 NCTC 10 981_ 66 (5.2) 61. (1.0) 52 % 48 %
Bacteria free control: HL-60 cells incubated in HBSS buffer 
alone
±SEM: Standard error of mean
No.L: Number of Live; No.D: Number of dead
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Figure 5.3 Leucotoxic activity of five Type strains 
of A . a c t i n o m y c etemcomitans for HL-60 cells over a 
period of 7 hours using the trypan blue exclusion 
method (figures represent the mean of three diffe­
rent experiments after subtracting the % dead cells 
in control assays) .
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5.3.2 Leucotoxic activity as measured by trypan blue 
exclusion of five Type strains of A . actinomycetemco­
mitans for PMNLs after 7 hours exposure
The results of these experiments are shown in Tables 5.5 and 
5.6. When the A.actinomycetemcomitans strains were examined 
for their leucotoxic activity using PMNLs over a period of 
seven hours, A.actinomycetemcomitans killed fewer PMNLs com­
pared to the percentage kill of HL-60 cells. As shown in 
Tables 5.6 and 5.7 the highest percentage kill recorded was 
only 8% after 7 hours incubation and the lowest being 3%. 
In conclusion, as shown in Table 5.7, none of the five Type 
strains of A.actinomycetemcomitans was toxic for either HL- 
60 cells or PMNLs in vitro.
5.3.3 Leucotoxic activity as measured by trypan blue 
exclusion of 12 GDH-fresh isolates of A . a c t i n o m y ­
cetemcomitans against HL-60 cells
In this investigation 12 freshly isolated A.actinomycetem­
comitans strains were examined for their leucotoxic activity 
against HL-60 cells in vitro. All experiments were repeated 
on three different occasions for a maximum of two hours 
using a bacterial/HL-60 cell ratio of 200:1. Leucotoxicity 
was assessed by trypan blue exclusion method as described in 
Section 5.2.5. Despite the two hour incubation period 
employed only one (Aa 4 0) of the 12 A.actinomycetemcomitans 
strains tested showed any toxic activity (Tables 5.8-5.11) 
as compared to control HL-60 cells incubated in HBSS alone. 
The leucotoxic effect of Aa 40 increased only slightly with 
the time of incubation; 33% of cells were killed at 60 min­
utes and 42% at 120 minutes.
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Table 5.5 Leucotoxic activity of five Type strains 
of A . actinomycetemcomitans for PMNLs at zero time 
(the data represent the mean of three different 
experiments) .
Strain
number Source No
Number and %
.D. (±SEM) No.L.
of Dead/Live PMNLs
(±SEM) % Dead % Live
Bacteria free control 7 (0.7) 121 (2.3) 6 % 94 %
Aa 01 NCTC 9709 7 (1.3) 118 (3.7) 6 % 94 %
Aa 02 NCTC 9710 8 (1.8) 108 (4.3) 7 % 93 %
Aa 03 NCTC 10979 8 (2.3) 106 (5.2) 7 % 93 %
Aa 04 NCTC 10980 10 (1.2) 100 (2.9) 9 % 91 %
Aa 05 NCTC 10981 7 (2.2) 101 (4.0) 7 % 93 %
Bacteria
alone
free control: HL-60 cells incubated in HBSS buffer
±SEM: Standard error of mean
Table 5.6 Leucotoxic activity of five Type strains 
of A . actinomycetemcomitans for PMNLs after 7 hours
exposure (the data 
erent experiments).
represent the mean of three diff-
Strain Number and % of Dead/Live PMNLs
number Source No,.D . (±SEM) No.L. (±SEM) % Dead % Live
Bacteria free control 5 (2.6) 100 (4.0) 5 % 95 %
Aa 01 NCTC 9709 13 (4.3) 105 (8.1) 11 % 89 %
Aa 02 NCTC 9710 13 (4.9) 118 (7.7) 10 % 90 %
Aa 03 NCTC 10979 9 (1.8) 105 (3.7) 8 % 92 %
Aa 04 NCTC 10980 17 (2.5) 112 (7.9) 13 % 87 %
Aa 05 NCTC 10981 14 (4.4) 102 (8.2) 12 % 88 %
Bacteria free control: HL-60 cells incubated in HBSS buffer 
alone
±SEM: Standard error of mean
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Table 5.7 Summary of the leucotoxic activity on both 
HL-60 cells and PMNLs after 7 hours exposure to five 
Type strains of A. actinomycetemcomitans.
Strain
number
Source
PERCENTAGE of
HL-60 cells 
0 time 7 hours
DEAD CELLS*
PMNLs 
0 time 7 hours
Aa 01 NCTC 9709 0 % 15 % 0 % 6 %
Aa 02 NCTC 9710 2 % 19 % 1 % 5 %
Aa 03 NCTC 10979 0 % 19 % 1 % 3 %
Aa 04 NCTC 10980 0 % 13 % 3 % 8 %
Aa 05 NCTC 10981 0 % 22 % 1 % 7 %
* : All figures were obtained after subtracting the % death 
of control HL-60 cells incubated in HBSS alone.
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Table 5.8 Leucotoxic activity of 12 GDH strains of 
A . actinomycetemcomitans for HL-60 cells at Zero time 
(figures represent the mean of three different expe­
riments) .
Strain Number and % of Dead/Live HL-60 cells
number Source No.D. (±SEM) No.L. (±SEM) % Dead % Live
Bacteria
control
free 26 (4.4) 96 (4.3) 21 79
Aa 07 GDH 310 33 (5.3) 93 (6.7) 26 74
Aa 08 GDH 312 28 (4.9) 101 (4.5) 22 78
Aa 09 GDH 143 28 (0.3) 100 (4.8) 21 79
Aa 10 GDH 216 28 (5.3) 98 (3.2) 22 78
Aa 15 GDH 107 28 (1.5) 106 (8.5) 21 79
Aa 16 GDH 87034 30 (2.0) 97 (6.6) 24 76
Aa 17 GDH 510/87 28 (5.2) 97 (3.3) 22 78
Aa 18 GDH 1014 27 (1.3) 97 (3.0) 22 78
Aa 19 GDH 1212 25 (0.9) 94 (3.8) 21 79
Aa 20 GDH 1214 34 (3.2) 105 (2.3) 24 76
Aa 39 GDH 1115 28 (3.5) 90 (9.0) 24 76
Aa 40 GDH 1224 25 (1.7) 97 (4.7) 21 79
Bacteria free control: HL-60 cells incubated in HBSS buffer 
alone
±SEM: Standard error of mean 
No.D: Number of dead 
No.L: Number of Live
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Table 5 .9 Leucotoxic activity of 12 GDH strains of 
A . a c t i n o m y c e t e m c o m i t a n s  for HL-60 cells after 60 
minutes exposure (figures represent the mean of 
three different experiments) .
Strain
number
Number 
Source No.D.
and %
(±SEM)
of Dead/Live
No.L. (±SEM)
HL-60
% Dead
cells
% Live
Bacteria
control
free 26 4.0) 103 (4.5) 20 80
Aa 07 GDH 310 34 6.4) 96 (5.8) 26 74
Aa 08 GDH 312 34 5.8) 95 (3.2) 26 74
Aa 09 GDH 143 27 1.5) 100 (9.0) 21 79
Aa 10 GDH 216 29 2.3) 100 (11.0) 22 78
Aa 15 GDH 107 24 5.0) 105 (2.0) 19 81
Aa 16 GDH 87034 30 8.2) 99 (12.0) 23 77
Aa 17 GDH 510/87 33 6.5) 95 (9.9) 26 74
Aa 18 GDH 1014 30 5.6) 98 (5.7) 23 77
Aa 19 GDH 1212 26 2.2) 97 (7.6) 21 79
Aa 20 GDH 1214 31 5.9) 97 (1.2) 24 76
Aa 39 GDH 1115 23 5.0) 94 (13.0) 20 80
40 GPH 1224 69 (4.91- 6I_ (9.7) 53 4.1
Bacteria free control: HL-60 cells incubated in HBSS buffer 
alone
±SEM: Standard error of mean 
No. D : Number of dead 
No.L: Number of Live
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Table 5.10 Leucotoxic activity of 12 GDH strains of 
A .actinomycetemcomitans for HL-60 cells after 120 
minutes exposure (figures represent the mean of 
three different experiments).
Strain
number
Number 
Source No.D.
and %
(±SEM)
of Dead/Live
No.L. (±SEM)
HL-60
% Dead
cells
% Live
Bacteria
control
free 23 2.3) 102 (3.8) 20 80
Aa 07 GDH 310 27 1.0) 99 (2.7) 21 79
Aa 08 GDH 312 26 2.5) 95 (7.4) 22 78
Aa 09 GDH 143 30 1.7) 95 (7.0) 24 76
Aa 10 GDH 216 27 2.3) 103 (5.3) 21 79
Aa 15 GDH 107 27 4.0) 107 (4.5) 20 80
Aa 16 GDH 87034 23 5.5) 106 (12.0) 18 82
Aa 17 GDH 510/87 26 4.8) 98 (4.9) 21 79
Aa 18 GDH 1014 20 3.6) 101 (8.5) 17 83
Aa 19 GDH 1212 28 7.6) 101 (3.8) 22 78
Aa 20 GDH 1214 29 4.9) 97 (5.1) 23 77
Aa 39 GDH 1115 26 8.5) 98 (13.0) 21 79
, Aa 40 GDH 1224 .16 (5,9). 47 (2.6) 62 38 ..
Bacteria free control: HL-60 cells incubated in HBSS buffer 
alone
±SEM: Standard error of mean 
No.D: Number of dead 
No.L: Number of Live
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Table 5.11 Summary of the leucotoxic activity of 12
GDH A . actinomycetemcomitans strains for HL-60 cells.
Strain
number
Source Mean 
Zero
Percentage 
time 60
Death of 
minutes
HL-60 cells* 
120 minutes
Aa 07 GDH 310 5 6 1
Aa 08 GDH 312 1 6 2
Aa 09 GDH 143 0 1 4
Aa 10 GDH 216 1 2 1
Aa 15 GDH 107 0 0 0
Aa 16 GDH 87034 3 3 0
Aa 17 GDH 510/87 1 6 1
Aa 18 GDH 1014 1 3 0
Aa 19 GDH 1212 0 1 2
Aa 20 GDH 1214 3 4 3
Aa 39 GDH 1115 3 0 1
Aa 40 GDH 1224 o 33 42
* : All figures were obtained after subtracting the % death 
of control HL-60 cells incubated in HBSS alone.
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5.3.4 Leucotoxic activity of five strains of A . a c t i ­
nomycetemcomitans for HL-60 cells as determined by 
both trypan blue and LDH release
In this investigation five A.actinomycetemcomitans strains 
(Aa 03, 09, 16, 21 and Aa 40) were tested in vitro for their
leucotoxic activity for HL-60 cells. Target cells were exp­
osed to 200 A.actinomycetemcomitans per cell for 60 minutes 
and leucotoxicity was assessed by trypan blue and LDH rele­
ase. As shown in Table 5.12 an average mean of 0.5 to 3.2% 
kill was obtained with A.actinomycetemcomitans strains 3, 9, 
16 and 21, and all were designated as non-leucotoxic. How­
ever, Aa 40 killed 73% of HL-60 cells after 60 minutes expo­
sure and was accepted as leucotoxic (Table 5.12).
The percentage of LDH released from HL-60 in the presence of 
the test bacteria is shown in Table 5.13. An average mean 
of 2.2% to 4.6% LDH release were obtained for Aa 03, 9, 16
and 21, while Aa 40 produced a 50% LDH release, compared to 
that obtained with Triton X-100 (total LDH release). Thus 
using the criteria used in this study for designating leuco­
toxicity, only Aa 40 possess leucotoxic activity using eit­
her trypan blue or LDH release methods.
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Table 5.12 Leucotoxic activity of five strains of 
A . a c t i n o m y c e t e m c o m i t a n s  for HL-60 cells after 60 
minutes exposure as determined by trypan blue exclu­
sion method.
Bacterial
Strain Source
Mean % Death of HL-
Experiment Number 
1 2  3
60*
Mean (±SEM1
Aa 03 NCTC 10979 6 0 3.5 3.2 (1.7)
Aa 09 GDH 143 2 2 0.0 1.3 (0.7)
Aa 16 GDH 87034 0 1.5 0.0 0.5 (0.5)
Aa 21 AA Y4 2.5 2.0 0.0 1.5 (0.8)
Aa 40 GDH 1224. .. 78 69 71 73 (2.7)
±SEM: Standard error of mean
* : All figures were obtained after subtracting the % death 
of control HL-60 cells incubated in HBSS alone.
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Table 5.13 Leucotoxic activity of five strains of 
A . a c t i n o m y c e t e m c o m i t a n s  for HL-60 cells after 60 
minutes exposure as determined by lactate dehydroge­
nase release method.
Bacterial
Strain
Mean
Source
% LDH Release from
Experiment Number 
1 2  3
HL-60
Mean
cells*
(±SEM)
Aa 03 NCTC 10979 2.5 2 2 2.2 (0.2)
Aa 0 9 GDH 143 5 3 6 4.6 (0.9)
Aa 16 GDH 87034 5 6 2.8 4.6 (0.9)
Aa 21 AA Y4 5 4.7 2.8 4.2 (0.7)
. Aa 40 GDH 1224 51 49 50 50 f0.6)
±SEM: Standard error of mean
* : All figures were obtained after subtracting the % death 
of control HL-60 cells incubated in HBSS alone.
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5.3.5 Leucotoxic activity of five strains of A . a c t i ­
n o m y c e t e m c o m i t a n s  for PMNLs as determined by both 
trypan blue and LDH release
The experiments which were carried out using HL-60 as the 
target cells were repeated using PMNLs and leucotoxicity was 
determined using both the trypan blue exclusion method and 
LDH release. Four of the A.actinomycetemcomitans strains 
(Aa 03, 9, 16 and 21) failed to kill target cells (PMNLs),
as shown in Table 5.14. An average mean of 0.3% to .5.3% 
kill was recorded for the four A.actinomycetemcomitans 
strains tested. However, Aa 40 killed 29.3% of PMNLs used 
in the assay, being the only fresh isolate showing leuco­
toxic activity.
Further confirmation of these early negative results were 
obtained from the LDH release experiments where only a small 
percentage LDH release was obtained with the four strains 
(Aa 03, 09, 16, and Aa 21). An average mean of 0% to 4.2%
LDH release was obtained for these strains (Table 5.15). 
However, Aa 4 0 caused 25% LDH release from PMNLs in vitro.
In conclusion, Aa 40 was the only A.actinomycetemcomitans 
strain which possessed leucotoxic activity against both HL- 
60 cells and human PMNLs as determined by both the trypan 
blue exclusion method and LDH release (Table 5.16). There 
was no LDH release from any of the bacteria incubated in 
HBSS or in the Triton X-100 incubated in HBSS alone.
244
Table 5.14 Leucotoxic activity of five strains of 
A . a.ctd.nomycetemcomita.ns for PMNLs after 60 minutes 
exposure as determined by trypan blue exclusion 
m e t h o d .
Mean % Death of PMNLs*
Bacterial Experiment Number
Strain Source 1 2  3 Mean (+SEM)
Aa 03 NCTC 10979 0 0 2 0.7 (0.7)
Aa 09 GDH 143 0 0 1 0.3 (0.3)
Aa 16 GDH 87034 5 4 7 5.3 (0.9)
Aa 21 AA Y4 0 0 4 1.3 (1.3)
Aa 40 GDH 1224 31 .. 2 9., 2 8 29. 3 (0 .
±SEM: Standard error of mean
* : All figures were obtained after subtracting the % death
of control PMNLs incubated in HBSS alone.
Table 5.15 Leucotoxic activity of five strains of 
A. a ctinomycetemcomitans for PMNLs after 60 minutes 
exposure as determined by lactate dehydrogenase rel­
ease .
Mean % LDH Release from PMNLs*
Bacterial
Strain Source
Experiment 
1 2
Number
3 Mean (±SEM)
Aa 03 NCTC 10979 3.2 1 7.7 4.0 (2.0)
Aa 09 GDH 143 7.6 3 2 4.2 (1.7)
Aa 16 GDH 87034 0 0 0 0 (0)
Aa 21 AA Y4 7 2 2.5 3.8 (1.6)
— Aa 40 GDH 1224 24 20 25 25 (0.6)
±SEM: Standard error of mean
* : All figures were obtained after subtracting the % death 
of control PMNLs incubated in HBSS alone.
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Table 5.16 Summary of leucotoxic activity of five 
strains of A . actinomycetemcomitans for PMNLs and HL- 
60 cells after 60 minutes exposure as determined by 
both lactate dehydrogenase release and trypan blue 
exclusion.
Bacterial
Strain
Trypan Blue 
Sour c e . HL- 6 0
(% Death) 
PMNLs
% LDH 
HL-60
Release
PMNLs
Aa 03 NCTC 10979 3.2 0.7 2.2 4.0
Aa 09 GDH 143 1.3 0.3 4.6 4.2
Aa 16 GDH 87034 0.5 5.3 4.6 0
Aa 21 AA Y4 1.5 1.3 4.2 3.8
-Aa 40 GD.H.122.4__ 73 29 50 25
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5.4 Discussion:
5.4.1 Experimental methods
The common methods which have been used to determine the 
leucotoxicity of A.actinomycetemcomitans are the exclusion 
of trypan blue from viable cells, lactate dehydrogenase rel­
ease and 53-Cr release from prelabelled cells (Tsai et al.r 
1979; Taichman and Wilton, 1981; Taichman et al., 1987a; 
Simpson et al., 1988). Other techniques less widely used 
include measurement of lysosomal constituents release, and 
electron microscopic examination of target cells (Baehni et 
al., 1979; Taichman et al., 1980).
The trypan blue method is simple and rapid to perform, and 
thus can be used to monitor leucotoxicity of a wide range of 
bacterial strains at any given time. The sensitivity of the 
method under the conditions used in this thesis is unknown 
and although the technique has been used by other workers no 
information about the sensitivity of PMNLs or HL-60 cells to 
trypan blue after exposure to A.actinomycetemcomitans has 
been reported. It has been suggested that if host cells are 
suspended in a protein rich medium with high affinity for 
trypan blue, this may give rise to false positive results, 
because of protein-dye complexes attached to the surface of 
viable cells. In particular serum at a concentration of 5% 
may cause errors with trypan blue (Paul, 1975). Although 
HL-60 cells were cultured in a medium containing 10% serum, 
the cells were washed twice in PBS, before use. Further­
more, all experiments used in this investigation were serum
247
free, and therefore errors due to serum rich conditions are 
very unlikely.
The lactate dehydrogenase method used in this investigation 
to determine the leucotoxicity of A.actinomycetemcomitans 
for HL-60 cells and human PMNLs was first described by 
Zambon et al., (1983c) . The method depends on the LDH 
released from injured target cells to catalyse the reduction 
of pyruvate to lactate, and results are expressed as "perce­
ntage release" of LDH. As in the case of trypan blue there 
is no information about the sensitivity of this technique 
and its suitability in determining the toxicity of bacteria 
such as A.actinomycetemcomitans. Nonetheless, the technique 
proved to be reproducible and was in agreement with the 
trypan blue exclusion method. However, it was more diffi­
cult to perform and more time consuming compared to the dye 
exclusion method.
5.4.2 Factors affecting the leucotoxicity of A . a c t i ­
nomycetemcomitans
Although there were 18 strains of A.actinomycetemcomitans (6 
Type strains plus 12 fresh isolates) included in this study, 
only one of the freshly isolated A.actinomycetemcomitans was 
found to be leucotoxic : according to the criteria used in 
this thesis. These results were not expected because a num­
ber of the Type strains tested (ie. Y4 & ATCC 29522) have 
been shown to posses leucotoxic activity by previous resear­
chers (Baehni et al., 1981; Zambon et al., 1983c). The fac­
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tors which may be responsible for the negative results obta­
ined, will be discussed separately.
Effect of media
The effect of media on the leucotoxic activity of A.actino­
mycetemcomitans has not been previously investigated. 
However, thioglycollate broth medium (Difco) under anaerobic 
conditions has been the most widely used medium for cultu­
ring A.actinomycetemcomitans for leucotoxic studies (see 
Table 5.17 for details). Since the same medium and culture 
conditions as described by previous workers, were used in 
the present investigation, it was hard to argue that failure 
to demonstrate leucotoxicity in certain Type strains of 
A.actinomycetemcomitans was due to the use of different gro­
wth conditions. However, it has been suggested that media 
may affect the leucotoxic activity of A.actinomycetemcomi­
tans. Baehni et al., (1979) reported that A.actinomycetem­
comitans Y4 was non-leucotoxic when grown on trypticase soy 
agar, but was later found to be toxic when grown in thiogly­
collate broth medium (TGB) . However, there was no strong 
scientific evidence to support this observation and it sho­
uld be regarded as a personal view. Other media such as 
Peptone Yeast Extract broth (Taichman et al., 1987a) or Lom- 
bard-Dowell broth (Kalmar, Arnold and Van Dyke, 1987) have 
been used to culture Y4 prior to leucotoxin assays which 
proved to be positive.
In preliminary experiments carried out in the present inves­
tigation, A.actinomycetemcomitans Y4 and NCTC 1097 9 which
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have been reported previously as leucotoxin positive, were 
grown in this study on Columbia blood agar, Anaerobic Blood 
Broth (ABB) and thioglycollate broth (TGB-Difco) in 5% CO2
in air. Bacterial suspensions made from these different 
media failed to show any strong evidence of leucotoxic acti­
vity for HL-60 cells after 2 hours exposure. These experi­
ments were only carried out once, and therefore, it is impo­
ssible to reach any definite conclusions. Since there is 
little or no scientific data on the effect of media on leu­
cotoxin production by A .actinomycetemcomitans, specific stu­
dies are required to clarify this area.
Effect of bacterial concentration
A.actinomycetemcomitans has been used in leucotoxic assays 
as either whole cells (Baehni et al., 1979; Baehni et al.,
1981; Zambon et al., 1983c; Miyasaki et al., 1986a; Tsai and 
Taichman, 1986; Chung et al., 1989), sonic extracts of whole 
cells (Tsai et al., 197 9; Taichman and Wilton, 1981; Ohta et 
al., 1987) or as purified toxin (Simpson et al., 1988) .
Whole cells
Although, HL-60 cells have been used as target cells in 
leucotoxicity studies, there is no information on the effect 
of different concentrations of whole cells of A. actinomy­
cetemcomitans on the viability of these cells using the try­
pan blue exclusion method. However, using LDH release, Zam­
bon et al., (1983c) have reported that increasing the conc­
entration of whole cells of Y4 using optical density at 540 
nm from 0.3, 0.6 to 1.0, resulted in an increase in the rel­
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ease of LDH from approximately 12% to 17% and 26% respect­
ively .
In the case of human PMNLs, the lowest number of A.actinomy­
cetemcomitans cells used by researchers was 5 bacteria, the 
maximum number being 200 bacteria per target cell (see Table 
5.17) . Baehni et al., (1979) showed that more PMNLs were 
killed as the number of bacteria was increased from 50 to 
200. The percentage kill of PMNLs increased from 85% to 95% 
and 96% in the presence of 50, 100 and 200 bacteria respec­
tively, using trypan blue staining. However, it is ques­
tionable if the results reported by Baehni et al., (1979) 
were significant. In a study in 1981 Baehni et al., repo­
rted results using both the trypan blue exclusion and LDH 
release methods, only the LDH results were published. An 
investigation of the killing of A. actinomycetemcomitans by 
human neutrophils (PMNLs) at a ratio of <10 bacteria per 
cell using six strains of A .actinomycetemcomitans was carr­
ied out by Miyasaki et al., (1986a). They reported that two
of the strains (Y4 and 650) which have previously been repo­
rted to be leucotoxic for PMNLs by Baehni et al., (1981) and 
another four isolates, were non-leucotoxic, and their assays 
in fact the bacteria were killed by the PMNLs. In addition, 
Miyasaki et al., (1986a) reported that 88% and 99% of the 
A.actinomycetemcomitans cells were killed -within 30 minutes 
of exposure to the PMNLs under anaerobic and aerobic condit­
ions respectively. Furthermore, the viability of PMNLs rem­
ained above 90% as assessed by trypan blue exclusion over 
the 30 minute incubation period. Although the previously
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characterized leucotoxic and non-leucotoxic strains were 
killed rapidly by the PMNLs, Miyasaki et al., (1986a) sugg­
ested that their results did not contradict an earlier rep­
ort by Baehni et al., (1981) which recorded positive results
for leucotoxin activity. It is difficult to understand how 
Miyasaki et al., (1986a) reached this conclusion especially
in the case of Y4 and 650 both of which had been leucotoxic 
at a level of 5 bacteria per PMNL (Baehni et al., 1981) with 
no evidence of A.actinomycetemcomitans cells being killed by 
PMNLs.
In one of the preliminary experiments carried out in the 
present investigation, the concentration of bacteria used 
was 1400 per target cell. However, none of the six strains 
examined at this high concentration caused any detectable 
killing of target cells over a two hours period. Thus it 
seems unlikely that the failure to demonstrate leucotoxic 
activity in these strains could be related to insufficient 
bacteria in assay experiments. Similarly Baehni et al., 
(1981) reported that A .actinomycetemcomitans strains which 
had been designated, non-leucotoxic failed to kill target 
cells even when the concentration of bacterial cells was 
increased to 200 per PMNL.
The effect of different concentrations of whole cells of 
A.actinomycetemcomitans on the release of LDH from PMNLs was 
investigated by a number of workers. Baehni et al., (1979) 
have shown that the LDH release was increased from 12% to 
approximately 20% in the presence of 50 and 100 Y4 bacterial 
cell respectively. Similarly, McArthur et al., (1982) have
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reported that as the concentration of A .actinomycetemcomi­
tans whole cells was increased from 25 to 100 per PMNL, 
there was a direct relationship with PMNL damage as measu­
red by the release of lactate dehydrogenase (LDH). For ex­
ample, LDH release in the presence of Y4 increased from 55%
to 62% at a concentration of 25 to 100 bacterial cells per
PMNL respectively. However, with two other strains of 
A . actinomycetemcomitans (ATCC 29522 & ATCC 29524) only a 
small increase in LDH release was obtained as the concentr­
ation of bacterial cells was increased from 25 to 50 per 
target cell (McArthur et al., 1982). Similar observations 
were reported by Taichman et al., (1982) who used a number 
of fresh and Type strains of A.actinomycetemcomitans. Alth­
ough the concentration of whole cells was increased from 25 
to 100, the increase of LDH did not exceed more than 20% 
with six of the strains tested by Taichman et al., (1982) .
No statistics were performed in these investigations, and it 
seems unlikely that the difference in LDH release would be 
highly significant.
Sonic extracts
Sonic extracts of A. actinomycetemcomitans have also been 
used at different concentrations ranging from 0.001 to 3.6mg 
protein/ml. However, there is no information on the acti­
vity of different concentrations of sonic extracts of A.act­
inomycetemcomitans on the viability of HL-60 cells using 
either the trypan blue exclusion method or LDH release. In 
contrast, the effect of sonic extracts of A.actinomycetem­
comitans on the viability of PMNLs in vitro has been inves-
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tigated. Taichman and Wilton (1981) reported that increa­
sing Y4 sonic extracts concentration from zero to 1.0 |lg/ml 
resulted in more PMNLs being killed by Y4 as monitored by 
trypan blue exclusion method. The percentages of dead PMNLs 
were increased from 22% to 50% in the presence of 0.001 and 
1. 0flg/ml sonic extract respectively.
There appear to be no other reports to either confirm or 
dispute these findings. Most of the published data has ten­
ded to highlight the effect of A.actinomycetemcomitans soni­
cates in respect to LDH release from PMNLs. Tsai et al., 
(1979) reported that LDH release was increased from 28% to 
63% in the presence of 0.25 fig and 1.5 |ig sonic extract from 
A .actinomycetemcomitans Y4 respectively. Baehni et al., 
(1981) have examined the effect of sonic extracts prepared 
from 13 strains of A.actinomycetemcomitans on PMNLs. While 
nine of these strains were found to be leucotoxic, there was 
clear evidence that increasing the sonic extract concentrat­
ion from 0.1 to 0.8mg protein/10^ PMNLs resulted in an incr­
ease of LDH release reaching a maximum at the highest conc­
entration of extracts used. Other studies which have shown 
a direct relationship between extract concentration or the 
amount of purified leucotoxin and LDH release, have been 
reported by Zambon et al., (1983c) and Simpson et al., 
(1988).
A .actinomycetemcomitans ATCC 10979 and five of the freshly 
isolated strains in this thesis (Aa 07, 16, 17, 19 and Aa
40) have been examined using whole cells and their sonic 
extracts (Solanki, 1989). The results showed that whole
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cells of strains ATCC 29522 and Aa 16 were non-leucotoxic 
when tested with both HL-60 cells and PMNLs. However, sonic 
extracts from both strains were found to be toxic as asses­
sed by LDH release or by the trypan blue exclusion method. 
A.actinomycetemcomitans strains 17 and 19 were found to be 
non-leucotoxic whether used as whole cells or sonic extra­
cts, and finally Aa 40 produced detectable levels of LDH 
when used as a sonic extract or as whole cells, but activity 
was higher with sonic extracts. All six strains were exami­
ned in the present investigation as whole cells at a concen­
tration of 200 bacteria per target cells but sonicates were 
not used. All strains with the exception of Aa 40 were 
found to be non-leucotoxic which agrees with the results 
reported by Solanki (1989).
In conclusion, surprisingly, there are no reported direct 
comparisons of leucotoxic activity as produced by whole 
cells and sonic extracts of A .actinomycetemcomitans. How­
ever, the information available suggests that while sonic 
extracts have a dose dependent action, whole cells only 
poorly exhibit this relationship. Furthermore, some reports 
give the impression that more positive results could be ach­
ieved if sonic extracts are used instead of whole cells. 
However, more specific scientific studies are needed before 
definite conclusions can be made.
Effect of exposure time
The contact time for A.actinomycetemcomitans and target 
cells (PMNLs or HL-60 cells) has varied among research gro-
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ups with the time ranging from 30 to 120 minutes (Miyasaki 
et al., 1986a; Zambon et al., 1983c). Tsai et al,, (1979)
reported that as the exposure time was increased from 10 to 
60 minutes, more PMNLs were killed by A .actinomycatam- 
comitans which resulted in an increase in LDH release from 
15 to >40% respectively. Similarly, Zambon et al,, (1983c) 
have shown that more target cells (both PMNLs and HL-60) 
were killed by the same concentration of whole cells of leu- 
cotoxic strains of A.actinomycetemcomitans in a time depen­
dent fashion. The maximum kill of target cells as indicated 
by LDH release was obtained within 4 5 minutes of incubation. 
However, when sonic extracts of A.actinomycetemcomitans were 
used, the maximum kill of PMNLs (% LDH release) was achieved 
after 60 minutes (Tsai et al., 1979) or 120 minutes when 
human monocytes were used as target cells (Taichman et al,, 
1980) . The time used in this investigation was usually 80 
minutes but was increased in some experiments to 2 and 7 
hours. Since the majority of investigators used 60 to 120 
minutes, the time employed in the present investigation was 
within the limits used by other researchers. In the experi­
ments when incubation of A. actinomycetemcomitans with target 
cells was increased to 7 hours, both HL-60 cells and JP'MNls 
appeared to be modestly killed by the Type strains of 
A. actinomycetemcomitans (NCTC 9709, 9710, 10979, 10980 and 
10981), However, it is not possible to relate this level of 
toxic activity over such a long period of time directly to 
leucotoxin production due to the real possibility of mild 
injury to host cells with time, which may predispose them to 
more severe damage from A.actinomycetemcomitans cells. The
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viability of HL-60 cells was reduced by approximately 20% 
after 7 hours incubation in the HBSS control, whereas the 
viability of the negative PMNLs control showed little change 
over the same period.
Effect of temperature
Temperature appears to have a definite effect on the leuc­
otoxic activity of of A.actinomycetemcomitans. In the early 
studies by Tsai et al., (1979), it was shown that A.actino­
mycetemcomitans leucotoxin was inactive at temperatures of 
4°C but killed target cells at 37°C. In the same study the 
activity of the toxin was found also to be temperature dep­
endent, with increasing numbers of PMNLs being killed as the 
temperature was raised from 15 to 30 then 37°C.(Tsai et al., 
1979). The release of LDH, as a measure of cell death, was 
increased from 5% to 25% then 32% respectively. Similarly, 
Zambon et al., (1983c) reported that there was no measurable 
LDH release at 4°C, but as the temperature was raised to 21 
and 37°C, LDH release was increased to 11% and 22% respe­
ctively. In the present study all experiments were carried 
out at 37°C and the temperature was monitored throughout the 
incubation period.
Type of target cells
Almost all researchers who have studied the leucotoxic acti­
vity of A . actinomycetemcomitans have used human PMNLs (see 
Table 5.17) or human leukaemic cell lines such as, HL-60, 
U937 or KG-1 (Zambon et al., 1983c; Taichman et al., 1987b; 
Simpson et al., 1988; Iwase et al., 1989). Other types of
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human cells have also been used, including monocytes, lymph­
ocytes, fibroblasts, platelets or erythrocytes (Taichman et 
al., 1980; Tsai et al., 1979). However, only human PMNLs, 
monocytes and HL-60, U937 or KG-1 cell lines are killed by 
A .actinomycetemcomitans leucotoxin (Baehni et al., 1981; 
Zambon et al., 1983c; Simpson et al., 1988) . Similarly
PMNLs and monocytes from the great apes and Old World mon­
keys are susceptible to the leucotoxin of A .actinomycetemco­
mitans (Taichman et al., 1984; Taichman et al., 1987a). In 
the present investigation two types of cells were used; 
human PMNLs and HL-60 cells, and A.actinomycetemcomitans 
strains designated non-leucotoxic in this study showed lit­
tle if any activity towards either of the target cells used. 
However, the single strain of A.actinomycetemcomitans which 
was leucotoxin positive (Aa 40) killed both types of cells 
which agrees with previous published findings (Zambon et 
al., 1983c; Simpson et al., 1988).
There seems to be some disagreement in the literature about 
which cells are most sensitive to A.actinomycetemcomitans 
leucotoxin. Zambon et al., (1983c) found the HL-60 cells 
are slightly more sensitive than the PMNLs to leucotoxic 
strains, eg. 1.5 to 2 times more LDH was released from HL-60 
m  the presence/whole cells of Y4 than from PMNLs. However, 
Simpson et al., (1988) using purified leucotoxin, found 
PMNLs were the most susceptible cells to toxin activity 
compared to both HL-60 and U937 cell lines. The results 
obtained in the present investigation with a single positive 
A.actinomycetemcomitans strain are in agreement with those
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reported by Zambon et al., (1983c), ie. HL-60 cells (73%
kill) were more susceptible than PMNLs (29% kill). Finally, 
in view of the little information available and the disagre­
ement about the susceptibility .of target cells to A.actino- 
mycetemcomitans, it is clear that more scientific studies 
are needed to establish the sensitivity and the suitability 
of both HL-60 cells and PMNLs in leucotoxic studies.
Criteria used to determine leucotoxicity 
Trypan Blue Exclusion
Despite the information available concerning the leucotoxi­
city of A.actinomycetemcomitans, there are no clear criteria 
to assist with categorizing a particular strain of A.actino­
mycetemcomitans as either leucotoxic or non-leucotoxic using 
either LDH release or the trypan blue exclusion method. 
Although a number of investigators have used trypan blue, 
they failed to present their results in full (Baehni et al., 
1981; Zambon et al., 1983c; Taichman et al., 1987a). There 
is no detailed information regarding the toxic activity of 
A.actinomycetemcomitans for HL-60 cells using trypan blue 
exclusion test. In the case of human PMNLs, the lowest 
level of dead PMNLs stained by trypan blue in the literature 
appears to be 30% (Ohta et al., 1987), while the highest
levels of dead cells range from 85% to 95% (Tsai et al., 
1979) . However, generally figures of 50% to 60% have been 
most commonly reported (Taichman and Wilton, 1981; Zambon et 
al., 1983c). In the present investigation a minimum level 
of 25% dead cells was taken as the cut off point to disting­
uish leucotoxic from non-leucotoxic strains. However, the
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appropriatenes of this level of activity could be questio­
ned, since it is less than the lowest figure previously rep­
orted for PMNLs. Since both HL-60 cells and PMNLs appear to 
possess different sensitivity to leucotoxin (see section 
5.4.2), it would seem reasonable that different killing val­
ues should be employed to designate positive and negative 
strains when using these different cells. The position of 
borderline strains eg. those giving leucotoxic values of 20- 
24% needs to be clarified. Until more studies using large 
number of isolates and possibly an animal model are perfor­
med, this issue remains unsolved.
LDH release
The problem is rather more complicated with the LDH release 
method. As shown in Table 5.17 different values of LDH rel­
ease have been accepted for reporting A .actinomycetemcomi­
tans isolates as leucotoxin positive. Chung et al., (1989) 
presented the lowest levels of LDH with a range of 2.5% to 
10.7% for 12 A.actinomycetemcomitans isolates. A mean level 
of 7.5% was used by Ohta et al., (1987) for designating
positive strains. On the contrary, Zambon et al., (1983c)
reported a figure of 5.6% LDH release for one A.actinomycet­
emcomitans strain, which they categorized as non-leucotoxic. 
Nonetheless, higher LDH levels have been reported for leuco­
toxic strains using different methods. For instance, Baehni 
et al., (1981) reported a range of 17% to 89% LDH with part 
of the variation being related to the concentration of bact­
erial cells used, as well as to the different strain used.
Other researchers who have reported high levels of LDH rele-
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ase (46% to 63%) include Tsai et al., (1979) and McArthur et
al., (1981) (see Table 5.17) . There is also evidence of 
marked differences in the percentage LDH release by the same 
A.actinomycetemcomitans Type strain as reported by different 
workers. For example, Baehni et al., (1979) reported a 
level of 23% LDH release from PMNLs in the presence of Y4 
(200/PMNL) compared with a figure of 62% obtained by Baehni 
et al., (1981) using the same bacterial strain but at half 
the concentration of bacterial cells used in the earlier 
investigation.
Taking these different results into account a minimum level 
of 15% LDH release within 60 minutes of exposure to A.actin­
omycetemcomitans (200 bacteria per target cell) was taken to 
designate a particular strain as leucotoxic in the present 
study. A.actinomycetemcomitans strains which have produced 
only small LDH release values (2.5% to 7.5%) have been acce­
pted as leucotoxic by a number of workers (Ohta et al. , 
1987; Chung et al., 1989). If this range of LDH values is
applied to the strains examined in the present investiga­
tion, three strains Aa 03, 09 and Aa 21 which produced LDH
release ranging from 3.8% to 4.2% would be recorded as 
positive for leucotoxicity. It is possibly necessary to set 
different values for both HL-60 cells and PMNLs since the 
susceptibility of these cells to A.actinomycetemcomitans may 
vary even when the same bacterial strain is used. Further­
more, other confirmatory tests are needed to be developed to 
clarify the position of borderline strains (eg. those betw­
een 10-14%).
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In conclusion it is surprising that no clear, agreed cut-off 
values for leucotoxicity have been proposed for any of the 
tests used to assess this property of A.actinomycetem­
comitans and that such a wide range of values has been acce­
pted. It is possible that the results from two different
tests (eg. trypan blue and LDH release) are needed to be
certain about the presence or absence of leucotoxicity. In 
addition, there is a need for standard tests with clear-cut 
criteria to ensure comparability of results obtained from 
different laboratories.
5.4.3 Leucotoxic activity of fresh isolates of 
A.actinomycetemcomitans
There are only a few papers that have studied the leuco­
toxic activity of fresh isolates of A.actinomycetemcomitans 
using either PMNLs or HL-60 cells in vitro (Baehni et al.,
1981; Zambon et al., 1983c; Tsai and Taichman, 1986; Ohta et
al., 1987; Chung et al., 1989) . Furthermore, little details 
were given by these research groups concerning the activity 
of the strains which they studied. Baehni et al., (1981) 
examined 10 A.actinomycetemcomitans plaque isolates and rep­
orted that 7 (70%) of these strains produced leucotoxic act­
ivity as determined by LDH release. A range of 17% to 89% 
LDH release was obtained for the 7 isolates depending on the 
concentration of bacterial cells used (Baehni et al., 1981). 
A large number of fresh isolates were studied by Zambon et 
al., (1983c), but since 100 were isolated from 55 subjects,
a number of strains were clearly isolated from the same sub­
ject. Zambon et al., (1983c) reported that 16% from 11 hea-
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lthy subjects; 43% from 13 adult periodontitis patients; 75% 
from 4 insulin dependent diabetics; 66% from 2 generalized 
juvenile periodontitis patients and 55% from Localized Juve­
nile Periodontitis, produced leucotoxin. These result high­
light the fact that leucotoxic strains are present in heal­
thy as well as diseased subjects, though diseased subjects 
harboured higher percentages of leucotoxic strains. More­
over, some individuals harboured both leucotoxic and non- 
leucotoxic strains, eg. 5 out of 10 isolates from both a LJP 
and a rapidly progressive periodontitis patient were leuco­
toxic positive (Zambon et al., 1983c; Ohta et al., 1987). A 
total number of 32 strains isolated from 3 patients were 
examined by Ohta et al., (1987) and only 8 (25%) of these
isolates were found to produce toxic activity as assessed by 
LDH release (mean 7.5%) . Chung et al., (1989) investigated
the leucotoxic activity of 46 fresh isolates of A.actino- 
mycetemcomitans from LJP patients, and reported that 10 of 
the strains (22%) from 13 diseased sites in 8 patients 
possessed leucotoxic activity as measured by LDH release. 
These strains released LDH from target cells within the 
range of 2.5 to 10.7 percent. Despite the low activity of 
these strains, they were considered leucotoxic.
In the present investigation 12 fresh isolates of A.actino- 
mycetemcomitans were examined for their leucotoxic activity 
for HL-60 cells using trypan blue staining. As shown in the 
results section only Aa 40 was found to be leucotoxic for 
HL-60 cells and PMNLs. The other isolates failed to show 
any toxic activity towards the HL-60 cells despite a two
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hour incubation period. Two of these strains (Aa 09 and Aa 
16) were also found to be non-leucotoxic for PMNLs.
The reason for failure to produce leucotoxin by some strains 
of A.actinomycetemcomitans is not clear. Tsai and Taichman 
(1986) have reported that leucotoxic strains are found 
mainly in younger patients (6-12 years of age) with fewer 
isolated from older patients (13-25 years old) . In addi­
tion, leucotoxic activity was detected in 100% of the isola­
tes from 15 patients aged 6-12 years (no information was 
given about the number of isolates tested), whereas only 23% 
of isolates from 23 older subjects were found to be 
leucotoxic (Tsai and Taichman, 1986). However, these findi­
ngs disagree with the results of Taichman et al. , (1987b)
who reported that leucotoxic strains were isolated from 
adult periodontitis patients aged 30 to 65 years (no full 
details were given). Furthermore, Chung et al., (1989) 
isolated leucotoxic strains from 8 (50%) LJP patients aged
18 to 33 years who are older than those described by Tsai 
and Taichman (1986). All of the A.actinomycetemcomitans 
strains examined in the present study were isolated from 
different individuals, but it would have been interesting if 
multiple strains from the same site or subject were examined 
for their leucotoxic activity since there is some evidence 
that different isolates can give different results. In 
fact, a number of multiple strains were isolated in the 
clinical investigation described in Chapter 2, but because 
of shortage of time none have been tested. It is possible
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that if more isolates had been tested in this study the low 
leucotoxic activity found would have been much higher.
In conclusion detailed scientific studies especially on the 
molecular basis of toxin production are needed to explain 
this variation in leucotoxicity among A.actinomycetemcomi­
tans strains.
5.4.4 Leucotoxic activity of Type strains of A . a c t i ­
nomycetemcomitans
In the present investigation six Type strains of A.actinomy­
cetemcomitans were examined for their leucotoxic activity, 
these include Y4, NCTC 9709, 9710, 10980, 10981, and 10979, 
the latter being the same strain as ATCC 29522. There is no 
information in the literature about the leucotoxicity of 
most NCTC Type strains of A.actinomycetemcomitans, although 
ATCC 29522 (NCTC 10979) has been reported as leucotoxic 
positive by Baehni et al., (1981); McArthur et al., (1982); 
Zambon et al., (1983c) and Ohta et al., (1987) . However,
results obtained in the present study for NCTC 1097 9 (ATCC 
29522) failed to show any activity under similar conditions 
used by these researchers. Similarly Ohta et al., (1985) 
reported ATCC 2 9522 as leucotoxic negative which agrees with 
the findings of this study. The only evidence of very low 
levels of leucotoxic activity produced by the NCTC Type str­
ains examined here appeared after an excessively prolonged 
incubation period of 7 hours with both target cell types 
(PMNLs or HL-60 cells).
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The reason why NCTC strains of A.actinomycetemcomitans fai­
led to produce leucotoxin in the experiments reported in 
this thesis is not clear. Moreover, in preliminary experim­
ents using Type strains of A.actinomycetemcomitans (ATCC 
29522, 29523 & 29524) and NCTC 10979, where the culture
medium was Columbia Blood Agar (CBA) , no evidence of leuco­
toxin activity for HL-60 or PMNLs over a period of 2 hours 
period was observed, despite the fact that, the suspensions 
of these strains contained 200 to 1000 bacteria per target 
cell. However, since these experiments were only carried 
out once, it is not possible to draw any firm conclusion or 
to compare the results with other leucotoxic studies.
A.actinomycetemcomitans strain Y4 have been extensively stu­
died by researchers and found to be leucotoxic by many of 
them (Tsai et al., 1979; McArthur et al., 1981; Baehni et
a l . , 1981; Taichman et al., 1982; Zambon et al., 1983c;
Chung et al., 1989) . Nevertheless, the activity of this 
Type strain, has been found to vary among the different res­
earchers. For example, Baehni et al., (1979) reported a 23%
LDH release from PMNLs in the presence of 200 Y4 bacterial 
cells, which is similar to the 25% level reported by Zambon 
et al., (1983c) in the presence of the same bacterial str­
ain. In comparison, 62% release was achieved by Baehni et 
al., (1981) using Y4 and employing the same method but in
the presence of only 100 bacterial cell. However, results 
obtained in the present study failed to demonstrate any 
leucotoxic activity for the Y4 strain using either PMNLs or 
HL-60 cells. There are two reports one by Tsai et al.,
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(1.977 '• O'-"1 the other by Miyasaki et al . , (198 6a) where
A .actinomycetemcomitans Y4 failed to kill human PMNLs. The 
--- lack of leucotoxicity was not understood, but later the same 
-organism from a different stock culture was found to be leu- 
-“-cotoxic ■ (Baehni et al., 197 9) . Miyasaki et al., (1986a)
-— reported that the reason for Y4 failing to kill PMNLs was 
— s- due to the low concentration of_bacteria < 10:1 used In the 
— ^assay.
—  Ifk-o-on-c-lusion it appears that there is some disagreement 
mr-about the "leuoQtoxioi activity of Type strains of A . actinomy- 
'rrr^^p&mcomitans amon_gr:ditf-erent workers. This clearly highli- 
. m  ghts the .importance o-f not. .depending solely on Type strains 
aaa when "studying the -leucotoxic activity of A.actinomycetemco- 
ZLzcjndtaiLS-/ and it yLs -important to include fresh isolates in 
assras-ssy: experiments .
L. .5 . 4-v-5 Action of ..leucotoxin
■ss^-Recen-tly the .leucotoxin . produced by A.actinomycetemcomitans 
zs hap been identified and cloned (Lally et al., 1989i Kolodru-
betz et al., 1989) and appears to be closely related to the
-.— -l-eucotoxin of Pasteurella haemolytica (Kolodrubetz et al., 
yy 1989) and Escherichia coli haemolysin (Lally et al., 1989). 
—^Jiowever, the mechanism by which leucotoxin destroys specific 
3^-.-.target cells (eg. PMNLs, HL-60 cells or U937) remains unkn- 
sr own (Lally et al., 1989). Nonetheless, it has been sugge­
sted that for the toxin to be active it must first bind to
the cell membranes of target cells (Taichman et al., 1980) 
thus causing plasma membrane damage (Simpson et al., 1988) .
(1978) and the other by Miyasaki et al., (1986a) where 
A.actinomycetemcomitans Y4 failed to kill human PMNLs. The 
lack of leucotoxicity was not understood, but later the same 
organism from a different stock culture was found to be leu­
cotoxic (Baehni et al., 1979). Miyasaki et a l., (1986a) 
reported that the reason for Y4 failing to kill PMNLs was 
due to the low concentration of bacteria < 10:1 used in the 
assay.
In conclusion it appears that there is some disagreement 
about the leucotoxic activity of Type strains of A.actinomy­
cetemcomitans among different workers. This clearly highli­
ghts the importance of not depending solely on Type strains 
when studying the leucotoxic activity of A.actinomycetemco­
mitans, and it is important to include fresh isolates in 
assay experiments.
5.4.5 Action of leucotoxin
Recently the leucotoxin produced by A.actinomycetemcomitans 
has been identified and cloned (Lally et al., 1989; Kolodru­
betz et al., 1989) and appears to be closely related to the 
leucotoxin of Pasteurella haemolytica (Kolodrubetz et al., 
1989) and Escherichia coli haemolysin (Lally et al., 1989). 
However, the mechanism by which leucotoxin destroys specific 
target cells (eg. PMNLs, HL-60 cells or U937) remains unkn­
own (Lally et al., 1989). Nonetheless, it has been sugge­
sted that for the toxin to be active it must first bind to 
the cell membranes of target cells (Taichman et al., 1980) 
thus causing plasma membrane damage (Simpson et al., 1988).
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Killing oL target cells by A.actinomycetemcomitans leucoto­
xin is inhibited in a dose-dependent manner by polyclonal 
and monoclonal antibodies against the leucotoxin (Lally et 
a l . , 1989). Furthermore, incubation of target cells or
toxin with certain saccharides such as mannose or galactose 
(Simpson and Taichman, 1987a), lectins such as wheat germ 
agglutinin and Phaseolus vulgaris lectin (Simpson and Taich­
man, 1987b), can prevent cell destruction by A.actinomycet­
emcomitans leucotoxin. Similarly, trypsin was found to sig­
nificantly inhibit leucotoxic activity. In addition, extra­
cellular calcium (Ca++) appears to modulate cell killing, 
since leucotoxicity was greater in Ca++ free medium and was 
inhibited by the addition of > 2mM Ca++ in the medium. 
These data suggested that the toxin reacts with the plasma 
membrane components of the target cells where it initially 
affects cell surface determinants before becoming interna­
lized within the target cells and thus expressing its cyto­
toxicity (Iwase et al., 1989). Finally Simpson et al.,
(1988) have suggested that cells which are not killed by the 
toxin may lack or have very few leucotoxin receptors on 
their cell membranes. Alternatively, resistance to the 
leucotoxin may be a consequence of an impairment of cytopa- 
thic events that occur subsequent to toxin binding and memb­
rane perturbation (Simpson et al., (1988).
5.5 Conclusions:
Only one (Aa 4Q) of the 12 A.actinomycetemcomitans isolates 
from juvenile periodontitis and chronic periodontitis patie­
nts killed both PMNLs and HL-60 cells in vitro.
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The Type strains of A.actinomycetemcomitans failed to show 
any leucotoxic activity for both HL-60 cells and PMNLs.
The trypan blue exclusion method and lactate dehydrogenase 
release produced similar results with regard to leucotoxi­
city.
For the one positive strain human PMNLs appeared to be slig­
htly more resistant than HL-60 cells to A.actinomycetemco­
mitans leucotoxin.
It is important to develop a standard method with a clear 
criteria which can be used to determine leucotoxic activity 
of A.actinomycetemcomitans, so comparisons of results betw­
een different laboratories can be possible.
Further studies are required to answer many of the unsolved 
questions about the leucotoxin of A.actinomycetemcomitans, 
especially the mechanism by which toxin production is activ­
ated, how it destroys target cells and why it is specific 
for certain cells.
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CHAPTER 6
GENERAL DISCUSSION 
6.1 Introduction
The aim of this final chapter is to investigate the results 
obtained in the previous 4 Chapters and to suggest lines of 
future investigation.
6.2 Adherence and hydrophobicity
6.2.1 Adherence
As discussed in Chapters 3 and 4 that there is little infor­
mation in the literature concerning the hydrophobic activity 
and adherence of A.actinomycetemcomitans to human buccal 
epithelial cells in vitro. Although it has been reported 
that the main habitat for A.actinomycetemcomitans is dental 
plaque, it can also be found in low numbers in saliva, on 
the buccal mucosa and on the dorsum of the tongue (Slots et 
al., 1980a) . Using in vitro studies, Sweet et al., (1988)
reported that one Type strain of A.actinomycetemcomitans 
(NCTC 9710) adhered at a mean adherence value of 7.5 bacte- 
ria/BEC in SIB buffer. In the present investigation a wide 
range of adherence levels in SIB were obtained for 33 
isolates (1.7 to 27.7 bacteria/BEC) which consisted of both 
fresh and Type strains of A.actinomycetemcomitans. Although 
an overall mean adherence values of 13.3 and 10.7 bacteria 
were obtained for both the fresh and Type strains of A.acti­
nomycetemcomitans respectively, the difference was not stat­
istically significant. These results highlighted the impo­
rtance of examining large number of bacterial strains inclu­
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ding fresh and Type isolates when investigating the adhere­
nce of a particular species. They also emphasize the inacc­
uracies which may occur if only one or two strains of a bac­
terial species are examined and conclusions are then drawn 
from such experiments.
Some studies have reported the isolation of A.actinomycetem­
comitans from mixed saliva of both healthy and adult perio­
dontitis patients (Slots et al., 1980a), however, the intra­
oral reservoir of the organism especially in the'healthy 
carriers is unknown. The results of this study certainly 
suggest that A.actinomycetemcomitans can attach to buccal 
cells in the presence of saliva. However, even if the same 
adherence mechanisms function in vivo it is not certain if 
A.actinomycetemcomitans would be able to colonize and profi- 
lerate at that site.
The results obtained in this study clearly showed that the 
presence of human serum almost completely inhibited the adh­
erence of A.actinomycetemcomitans to buccal cells in vitro. 
An overall mean range adherence value of 0.4 to 3.4 bacte- 
ria/BEC was obtained for 14 freshly strains of A.actinomy­
cetemcomitans, compared with an average mean of 4.3 to 12.5 
adhered bacteria obtained for the same strains tested in SIB 
(Table 3.15). These results showed a significant deference 
(p <0.0005) which was very unlikely due to experimental 
error since both experiments were carried out at the same 
time using the same buccal epithelial cells, bacterial inoc­
ulum, and controls.
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The addition of serum to the adherence assay was to mimic 
the in vivo environment at the gingival crevice where the 
highest concentrations of A .actinomycetemcomitans are usua­
lly to be found (Slots et al. , 1980a). Thus it would seem
reasonable to theorize that serum would increase the adhere­
nce of A .actinomycetemcomitans to intraoral sites coated 
with serum eg. gingival epithelial cells. However, in the 
present experimental studies the opposite was found which 
requires some explanation. If the serum used in this study 
contained antibodies against A.actinomycetemcomitans, which 
could aggregate the bacteria during the assay, it might res­
ult in clumps of A.actinomycetemcomitans which would then 
fail to adhere to buccal cells. Such clumps would probably 
not be washed through the filter, and would be arranged in a 
haphazard way on the filter surface. However, no evidence 
of this was noted microscopically, even although the count­
ing of adherence preparations was performed anonymously. As 
discussed in Chapter 3, microbiological studies of plaque 
have shown the donor of both BECs and serum to be negative 
for A.actinomycetemcomitans. However, no immunological exa­
mination was carried out to establish if antibodies were 
present. It is possible that serum blocked the bacterial 
receptors on buccal cells in either specific or non-specific 
fashion, and thus prevented A.actinomycetemcomitans from 
adhering. Kagermeier and London (1985) used pooled human 
serum to coat hydroxyapatite and found a reduction in the 
number of adherent cells of two strains of A.actinomycetem­
comitans to this surface. Although the surfaces used in 
these two studies were different, it is interesting that
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both found serum depressed the adherence of A.actinomycetem­
comitans. However, in spite of these in vitro results the 
fact remains that A.actinomycetemcomitans is mainly found in 
subgingival plaque where it regularly comes into contact 
with low levels of serum, in the form of gingival exudate, 
which is a transudate of plasma. It is also possible that 
in vivo A.actinomycetemcomitans interacts with serum in a 
way not possible to reproduce in vitro experiments. In view 
of these results, the effect of serum on the adherence of 
A.actinomycetemcomitans to buccal cells requires more in 
vitro experiments.
In conclusion, it is difficult to correlate in vitro results 
with the in vivo situations, but it can be postulated that 
A.actinomycetemcomitans has the ability to adhere to buccal 
mucosa before finally colonizing the gingival area and poss­
ibly leading to the development of periodontal disease. It 
would be interesting to find out if saliva and serum colle­
cted from different donors, would have a similar effect, on 
the adherence of A.actinomycetemcomitans to buccal epithel­
ial cells as discussed in this thesis. Ideally, BEC pooled 
from a number of donors should be used.
6.2.2 Hydrophobicity
Recent studies have suggested that hydrophobic interactions 
can promote bacterial adhesion to buccal epithelial cells 
and to the tooth surface itself (Westergren and Olsson, 
1983). The hydrophobic activity of A.actinomycetemcomitans 
has been investigated previously (Gibbons and Etherden,
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1983; Sweet et al., 1986; Kozlovsky et al., 1987), but only 
one or two Type strains of A.actinomycetemcomitans have been 
examined. The results of the present investigation using 33 
strains (10 Type strains and 23 fresh isolates) and those by 
Sweet et al., (1986) and Kozlovsky et al., (1987) all agree
in describing A.actinomycetemcomitans as hydrophobic altho­
ugh one report presents the opposite view (Gibbons and Ethe­
rden, 1983) . A clear and significant correlation (p <0.05) 
between the adherence of A.actinomycetemcomitans to buccal 
epithelial cells and hydrophobicity using xylene, confirms 
the view that hydrophobic interactions are implicated in ad­
hesion phenomena as suggested previously for other bacteria.
Since both hydrophobicity and adherence to buccal cells 
appear to be related, it seems likely that both saliva and 
serum may in return affect the hydrophobic activity of 
A.actinomycetemcomitans in vivo. There is no information to 
confirm or to dispute this suggestion and it would be of 
interest to perform adherence and hydrophobicity studies in 
the presence of both saliva and serum. However, it seems 
likely that the use of serum in hydrophobicity experiments, 
would pose certain technical difficulties, and new methods 
need to be developed.
6.3 Morphological and Biochemical Characteristics of 
A.actinomycetemcomitans
Although the formation of star-shaped colonies by A.actino­
mycetemcomitans and catalase production on primary isolation 
on semi-selective media has been used widely by researchers
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for identification, no information has been published about 
the prevalence of either star-shaped or non-star-shaped var­
iants of A.actinomycetemcomitans in previous studies (Slots, 
1982b; Christersson et al., 1985; Slots et al., 1986). Thus 
the results of this study which showed that the prevalence 
of non-star-shaped colonies was greater than those of star­
shaped variants on primary isolation on TSBV medium has 
important implications. If catalase positive star-shaped 
colonies had been selected for identification in the present 
investigation, only about half (52%) of the total number of 
positive A.actinomycetemcomitans patients would have been 
recorded. Since the presence of non-star-shaped colonies 
appears not to have been considered by previous workers, the 
accuracy of much of the published prevalence data must be 
regarded as doubtful, and new epidemiological studies perfo­
rmed.
There is also a need for a reproducible and widely available 
commercial, method for identifying A.actinomycetemcomitans. 
In this thesis the API 20 A system was used for identifica­
tion, and gave reproducible results with all Type and fresh 
isolates of A.actinomycetemcomitans. The 38 freshly isola­
tes of A.actinomycetemcomitans fermented glucose, maltose, 
mannose and produced catalase, and produced variable reacti­
ons with mannitol and xylose which is in agreement with the 
majority of other workers (Sneath and Johnson, 1973; Slots 
1982a). Therefore, while different basal media have been 
used by researchers, it would be sensible to use one stand­
ard medium such as the API 20 A system for identification to
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allow satisfactory comparison of results between different 
laboratories .
6.4 Detection and Distribution of A . a c t i n o m y c e t e m ­
comitans in healthy and chronic periodontitis pati­
ents
6.4.1 Prevalence of A.actinomycetemcomitans
Although there were 55 healthy subjects examined in the cli­
nical study of this thesis, A.actinomycetemcomitans was iso­
lated from only one (2%) of these subjects. However, other 
workers have reported higher prevalence rates of A.actino­
mycetemcomitans in their healthy control subjects ranging 
from 17% to 36% (Slots et al., 1980a; Zambon et al., 1983b; 
Mombelli et al., 1990). In the case of chronic periodon­
titis patients, A.actinomycetemcomitans has been isolated 
from 30% to 50% of patient (Slots et al., 1980a; Bonta et 
al., 1985; Dahlen et al., 1989), although other workers have 
reported lower prevalence rates ranging from 13% to 21% 
(Zambon et al., 1983b; Okuda et al., 1984; Wolff et al.,
1985) . These results show clearly that the prevalence of 
A.actinomycetemcomitans in both health and disease appears 
to be similar in some studies, which certainly questions the 
significance of isolating A.actinomycetemcomitans from subg­
ingival plaque collected from chronic periodontitis pati­
ents .
It can be argued that the number of A.actinomycetemcomitans 
at a given site is an important factor in pathogenicity, and 
that the mere presence of A.actinomycetemcomitans is of less
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ignificance. Although the numbers of A .actinomycetemcomi- 
ans in subgingival plaque samples was not carried out in 
his study, it has been reported in a number of other 
tudies. Such levels in diseased patients have ranged from 
11.0% to 40% of the total microbial flora, with the majority 
»f patients having A.actinomycetemcomitans levels of less 
,han or equal to 1.0% (Slots et al., 1980a; Okuda et al.,
.984; Wolff et al., 1985) . While these figures appear to 
>e higher than those reported for healthy sites which ranged 
:rom 0.01% to 5% (Slots et al., 1980a; Okuda et al., 1984;
lombelli et al., 1990), the prevalence of A.actinomycetem-
:omitans in both health and disease is not substantially 
Lifferent. Slots and Genco (1984) have suggested that a low 
soncentration of A . actinomycetemcomitans (<2%) in subgin­
gival plaque could cause disease due to the high virulence 
>f A.actinomycetemcomitans. The available data show that 
>oth healthy and periodontitis patients harbour A.actinomy- 
:etemcomitans at low numbers. However, it must emphasized 
:hat most of these data were based mainly on figures repre­
senting star-shaped colonies which were only counted by 
ihese researchers and the presence of non-star-shaped colo- 
lies have been largely ignored. If the results of this the­
sis are taken into account it seems likely that higher cou- 
lts of A.actinomycetemcomitans might have been reported, if 
lon-star-shaped colonies had been investigated thoroughly.
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significance. Although the numbers of A .actinomycetemcomi­
tans in subgingival plaque samples was not carried out in 
this study, it has been reported in a number of other 
studies. Such levels in diseased patients have ranged from 
<1.0% to 40% of the total microbial flora, with the majority 
of patients having A.actinomycetemcomitans levels of less 
than or equal to 1.0% (Slots et al., 1980a; Okuda et al., 
1984; Wolff et al., 1985). While these figures appear to 
be higher than those reported for healthy sites which ranged 
from 0.01% to 5% (Slots et al., 1980a; Okuda et al., 1984;
Mombelli et al., 1990), the prevalence of A.actinomycetem­
comitans in both health and disease is not substantially 
different. Slots and Genco (1984) have suggested that a low 
concentration of A.actinomycetemcomitans (<2%) in subgin­
gival plaque could cause disease due to the high virulence 
of A.actinomycetemcomitans. The available data show that 
both healthy and periodontitis patients harbour A.actinomy­
cetemcomitans at low numbers. However, it must emphasized 
that most of these data were based mainly on figures repre­
senting star-shaped colonies which were only counted by 
these researchers and the presence of non-star-shaped colo­
nies have been largely ignored. If the results of this the­
sis are taken into account it seems likely that higher cou­
nts of A.actinomycetemcomitans might have been reported, if 
non-star-shaped colonies had been investigated thoroughly.
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6.4.2 Leucotoxicity
The pathogenic activity of A.actinomycetemcomitans has been 
related to a number of factors (see section 1.7). However, 
much importance has been attached to its ability to produce 
a leucotoxin which is toxic for human PMNLs and monocytes in 
vitro (Tsai et al., 197 9; Taichman et al.r 1980) . Since the 
number of A.actinomycetemcomitans in subgingival plaque in 
health plus disease is similar (see section 6.4.1), it has 
been suggested that the ability of A.actinomycetemcomitans 
to produce leucotoxin is more important than the level of 
cells present. There were six Type and twelve fresh strains 
of A.actinomycetemcomitans examined in this study, but only 
one fresh isolate (Aa 40) was found to be leucotoxic for 
both HL-60 cells and PMNLs in vitro. These results were 
unexpected, especially in the case of certain Type strains 
which have previously been reported as leucotoxin positive 
by other workers. However, negative results for recognized 
leucotoxic strains of A.actinomycetemcomitans have been men­
tioned in a few papers. For instance, Ohta et al., (1986-
1987) reported that two Type strains of A.actinomycetemcomi­
tans (ATCC 29522 & 29524) which had been previously reported 
leucotoxin positive were negative in their hands, but made 
no attempt to discuss reasons for these negative results. 
These two strains were also examined in preliminary experi­
ments in the present study and were found to be negative for 
toxicity which agree with the findings of Ohta's group.
The largely negative results obtained in this study require 
some discussion and the factors which could affect leuco­
toxin activity have been covered in detail in Chapter 5.
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These factors include the effect of media, bacterial concen­
tration, exposure time, temperature, type of target cell 
used and the criteria employed for a positive or negative 
test. While some of these factors have been investigated in 
detail by previous workers, others have been all but igno­
red. As discussed in Section 5.4.2 the effect of growth 
media on toxin production has not been specifically investi­
gated, although it has been suggested that media may affect 
the leucotoxic activity of A.actinomycetemcomitans (Baehni 
et al., 1979). More recently Mukherjee, Murphy and Wawsz-
kiewcz (1988) reported that the addition of ferric ammonium 
citrate enhanced the virulence of one Type strain of A.acti­
nomycetemcomitans (NCTC 2 9522) using a guinea-pig model. In 
view of this findings it is possible that leucotoxin produ­
ction may be triggered by the presence or absence of speci­
fic nutrients. There are examples of such mechanisms in 
other toxic bacterial infections, eg. Corynebacterium diph- 
theriae (Collier, 1975), which shows little or no toxin 
production in vitro until the later stages of growth when 
nutrients become exhausted and the intracellular iron cont­
ent begins to decrease. The role of growth or other factors 
in switching on toxin production in vivo and and in vitro is 
important, and studies are required to investigate the 
effect of a range of substances on the toxin production by 
A.actinomycetemcomitans.
The leucotoxic activity of A.actinomycetemcomitans has alw­
ays been described as a dose dependent phenomena (McArthur 
et al., 1982; Taichman et al., 1982). However, the avail­
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able data suggest that while sonic extracts exhibit a dose 
dependent action, whole cells of A.actinomycetemcomitans do 
not generally show this relationship. Although these resu­
lts suggest that more positive results for leucotoxin could 
be obtained if sonic extracts rather than whole cells were 
used, no detailed comparisons have been performed using a 
range of fresh and Type isolates.
Recent studies have reported the identification and cloning 
of A.actinomycetemcomitans leucotoxin. However, there is no 
information to suggest that specific toxin has ever been 
isolated from diseased sites in patients harbouring A.acti­
nomycetemcomitans. However, the release of microvesicles 
which may contain leucotoxin by A.actinomycetemcomitans into 
growth media and into the crevicular environment has been 
suggested (Nowotny et al., 1982). Since serum from juvenile 
periodontitis has been found to contain antibodies which 
neutralized A.actinomycetemcomitans leucotoxin, this may 
rapidly neutralize leucotoxin in the crevicular environment, 
which would make toxin detection difficult from in vivo sam­
ples. It is also interesting to speculate on the possibi­
lity eg. that star-shaped and non-star-shaped variants of 
A. actinomycetemcomitans may possess different toxic activ­
ity. Obviously only large scale investigation can answer 
many of these unsolved problems. In the present study it 
was intended to investigate the activity of a large number 
of A.actinomycetemcomitans strains; (fresh and Type, star­
shaped and non-star-shaped) would be tested, but shortage of 
time limited the work to that presented earlier.
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The effect of time and temperature on leucotoxin detection 
is agreed by all workers, with a maximum incubation period 
of two hours being accepted sufficient for all strains to 
show toxic activity (Zambon et al. , 1983c) . The maximum
activity of leucotoxic strains appears to take place at a 
temperature of 37°C (Tsai et al. , 1979; Zambon et al. ,
1983c), but there is little information to suggest that the 
usually used target cells (ie. PMNLs or HL-60) are necess­
arily the most suitable for leucotoxic studies. Certainly 
the collection of human PMNLs is a time consuming procedure 
compared to the collection of HL-60 cells from laboratory 
cultures. However, the suitability of both types of cells 
must be established by carrying out specific studies using a 
large number of fresh and Type strains of A.actinomycetem­
comitans .
It was surprising to find that no clear criteria for cut-off 
points exist to categorize a particular strain of A.actino­
mycetemcomitans as leucotoxic or non-leucotoxic using either 
the trypan blue exclusion or the LDH release methods. Tak­
ing into account previously published data it was suggested 
in the present study that a minimum level of 25% cell death 
and 15% LDH release should be regarded as the cut-off points 
to distinguish between positive and negative toxic activity 
using HL-60 cells and PMNLs respectively. However, there is 
evidence that HL-60 cells and PMNLs respond differently to 
leucotoxin and it may be more accurate to use different 
values to distinguish positive and negative strains when 
employing these different cells. In order to make progress
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in this area, standard methods and clear criteria require to 
be decided for testing leucotoxin activity which can be 
followed by all workers and so allow results to be compared. 
Although both HL-60 cells and PMNLs can be killed by 
A.actinomycetemcomitans, it is possible that another cell 
type may be more suitable. Further work is required to 
solve these problems using a wide range of A.actinomycetem­
comitans isolates.
Once these problems are solved then the next step is to est­
ablish the association of A.actinomycetemcomitans and perio­
dontal disease, because although research has been proce­
eding for ten years or more, as yet no definite conclusions 
have been reached. There is evidence that A.actino­
mycetemcomitans is strongly involved in localized juvenile 
periodontitis (Section 1.9), but not all studies have been 
able to relate the presence of A.actinomycetemcomitans in 
LJP (Moore et al., 1985). The role of A.actinomycetem­
comitans in chronic and other forms of periodontal disease 
is less clear. It might be argued that isolates from juve­
nile periodontitis are more pathogenic compared to isolates 
from chronic or other forms of periodontal disease, but 
there is very little information about this. Zambon et al., 
(1983c) reported leucotoxin production by 100 strains of 
A.actinomycetemcomitans isolated from a mixture of healthy 
volunteers, as well as patients with chronic and juvenile 
periodontitis. They reported that 16% strains of A.actino­
mycetemcomitans from 11 healthy subjects, and 43% from adult 
periodontitis patients produced leucotoxic activity.
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Although the pathogenic role of A.actinomycetemcomitans in 
LJP and to some extent in chronic periodontitis is widely 
reported in textbooks, a critical examination of the data 
cast doubts on the accuracy of some of the techniques used, 
as well as the interpretation of results. A clear view of 
the role of A.actinomycetemcomitans in periodontal disease 
will not emerge until many of the difficulties discussed 
earlier have been resolved and well planned and carefully 
linked clinical and laboratory studies are performed.
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APPENDIX I
MEDIA PREPARATION
Pouring of plates
All plates were poured in a clean air Laminar Flow Cabinet 
(Microflow Pathfinder, Intermed). Aliquots of 15 ml per 
plate were poured aseptically, and plates were left to soli­
dify at room temperature, dried, then stored at 4°C for up 
to one week.
Media:
Tryptic Soy-Serum-Bacitracin-Vancomycin Agar (TSBV)
Malchite Green Bacitracin Agar (MGB)
Columbia Blood Agar (CBA)
Peptone Agar (PA)
Diagnostic Sensitivity Agar (DST)
Anaerobic Blood Broth Supplemented (ABB)
NIH-Thioglycollate Broth (TGB)
RPMI 1640 Medium
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Tryptic Soy-Serum-Bacitracin-Vancomycin Agar (TSBV)
Slots, J. (1982) Journal of Clinical Microbiology, 15, 606- 
609.
Composition:
Peptone 140 (Gibco) 15 g/1
Peptone 110 (Gibco) 5.0 g/1
Sodium chloride (Gibco) 5.0 g/1
Yeast extract (Difco) 1.0 g/1
Horse serum (Gibco) 100 ml/1
Bacitracin (Sigma) 75 mg/1
Vancomycin (Sigma) 5.0 mg/1
Agar (Gibco) 15 g/1
Distilled water 1000 ml
The medium was prepared by dissolving 40 g of tryptic soy
agar (Gibco-Europe, Paisley, Scotland) and 1.0 g yeast extr­
act in distilled water by heating in a Koch steamer. The pH 
was adjusted to 7.4 ± 0.2 with NaOH before sterilization 
using a Kent EIL 3055 pH meter (TAIWAN, N.R.O.C). The med­
ium was next dispensed into 100 ml amounts and sterilized by 
autoclaving at 121°C for 15 minutes. The medium was then 
left to cool to about 50°C and sterilized serum, and antimi­
crobials were added aseptically in a clean air cabinet and 
poured into sterile Petri-dishes.
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Malachite Green-Bacitracin Agar (MGB)
Mandell, R.L. & Socransky, S.S. (1981) Journal of Periodon- 
tology, 52, 593-598.
Composition:
Peptone 140 (Gibco) 15 g/1
Peptone 110 (Gibco) 5.0 g/1
Sodium chloride (Gibco) 5.0 g/1
Horse blood (Gibco) 50 ml/1
Bacitracin (Sigma) 128 mg/1
Malachite green (Surrey UK) 8.0 mg/1
Agar (Gibco) 15 g/1
Distilled water 1000 ml
The medium was prepared by dissolving 40 g of tryptic soy 
agar (Gibco-Europe, Paisley, Scotland) and malachite green 
in distilled water by heating in a Koch steamer. The pH was 
adjusted to 7.4 ± 0.2 with NaOH before sterilization using a 
Kent EIL 3055 pH meter (TAIWAN, N.R.O.C). The medium was 
next dispensed into 100 ml amounts and sterilized by autocl- 
aving at 121°C for 15 minutes. The medium was then left to 
cool to about 50°C and sterilized horse blood and antimicro­
bials were added aseptically in a clean air cabinet and 
poured into sterile Petri-dishes.
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Columbia Blood Agar (CBA)
Source: Gibco-Europe Ltd., Paisley Scotland
Composition:
Peptone 140 13 g
Peptone 100 6.0 g
Yeast extract 3.0 g
Beef extract 3.0 g
Starch 1.0 g
Sodium chloride 5.0 g
Agar 13 g
Defibrinated horse blood (Gibco) 50 ml
To prepare; 44 grams of the powdered medium was dissolved in 
1000 ml distilled water by heating in a Koch steamer. The 
pH was adjusted to 7.4 ± 0.2 with NaOH before sterilization 
using a Kent EIL 3055 pH meter (TAIWAN, N.R.O.C) . The 
molten agar was dispensed in 500 ml amounts and then steri­
lized by autoclaving at 121°C for 15 minutes. The medium 
was left to cool to about 50°C and 50 ml of sterile defibri­
nated blood was added per 1000 ml and poured into sterile 
Petri-dishes.
289
Peptone Agar (PA)
Source: Mast Laboratories, Merseyside, England 
Composition:
Bacteriological peptone (RM52) 10 g
Sodium chloride 5.0 g
Agar (RM10) 14 g
To prepare; 2 9 grams of the powdered medium was dissolved in 
1000 ml distilled water by heating in a Koch steamer. The 
pH was adjusted to 7.4 ± 0.2 with NaOH before sterilization 
using a Kent EIL 3055 pH meter (TAIWAN, N.R.O.C). The med­
ium was then sterilized by autoclaving at 121°C for 15 minu­
tes and poured into sterile Petri-dishes.
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Diagnostic Sensitivity Test Agar (DST)
Source: Oxoid Ltd., Basingstoke, Hampshire England
Composition:
Proteose peptone(Oxoid L4 6) 10 g/i
Veal infusion solids 10 g/i
Dextrose 2.0 g/i
Sodium chloride 3.0 g/i
Disodium phosphate 2.0 g/i
Sodium acetate 1.0 g/i
Adenine sulphate 0.01 g/i
Guanine hydrochloride 0.01 g/i
Uracil 0.01 g/i
Xanthine 0.00002 g/i
Lysed horse blood (Gibco) 100 ml/1
Agar No.1 (Oxoid Lll) 12 g/i
The DST medium was prepared by dissolving 40 g of powdered 
medium in 1000 ml distilled water by heating in a Koch ste­
amer. The pH was adjusted to 7.3 ± 0.2 with NaOH before 
sterilization using a Kent EIL 3055 pH meter (TAIWAN, 
N.R.O.C) and sterilized by autoclaving at 121°C for 15 min­
utes. The medium was cooled to about 50°C and 100 ml lysed 
horse blood (Gibco) was added per 1000 ml of medium which 
was then poured into sterile Petri-dishes.
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Anaerobic Blood Broth Supplemented (ABB) 
Source: Gibco-Europe Ltd., Paisley Scotland
Composition:
Tryptone 10 g
Beef extract 2.0 g
Liver extract 3.0 g
Yeast extract 5.0 g
Glucose 5.0 g
Sodium chloride 5.0 g
Vitamin K 0.005 g
Haemin 0.005 g
Cysteine hydrochloride 1.0 g
Dithiothreitol 0.1 g
Sodium bicarbonate 0.9 g
To prepare; 32 grams of the powdered medium was dissolved in 
1000 ml distilled water by heating in a Koch steamer and 
dispensed in 20 ml volumes in glass universal bottles. The 
medium was then sterilized by autoclaving at 121°C for 15 
minutes and stored at room temperature.
292
NIH-Thioglycollate Broth (Difco)
Source:Difco-laboratories, Detroit,Michigan USA
Composition:
Bacto casitone 15 g/i
Bacto yeast extract 5 .0 g/1
Bacto dextrose 5 .5 g/i
Sodium chloride 2 .5 g/i
L-cysteine 0 .5 g/i
Sodium thioglycollate 0 .5 g/i
The medium was prepared by dissolving 2 9 grams of the powd­
ered medium in 1000 ml distilled water by heating in a Koch 
steamer. The pH was adjusted to 7.4 ± 0.2 with NaOH before 
sterilization using a Kent EIL 3055 pH meter (TAIWAN, 
N.R.O.C). The broth was then dispensed in 20 ml volumes and 
sterilized by autoclaving at 121°C for 15 minutes.
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RPMI 164 0 Medium
Source: Gibco-Europe Ltd., Paisley Scotland 
Composition:
INORGANIC SALTS:
Ca (NO3)2 •4H20
KC1
MgS04 .7H20
NaCl
NaHC03
Na2HP04 .7H20
OTHER COMPONENTS:
D-Glucose
Glutathione (reduced) 
Phenol Red
AMINO ACIDS:
L-Arginine
L-Asparagine
L-Aspartic Acid
L-Cystine
L-Glutamic Acid
L-Glutamine
Glycine
L-Histidine
L-Hydroxproline
L-Isoleucine
L-Lujpcine
L-Lysine.HC1
L-Methionine
L-Phenylalanine
L-Proline
L-Serine
L-Threonine
L-Trypt ophan
L-Tyrosine
L-Valine
100 mg/1
400 mg/1
100 mg/1
6000 mg/1 
2000 mg/1 
1512 mg/1
2000 mg/i
1.0 mg/1
5.0 mg/1
200 mg/1 
50 mg/1 
20 mg/1 
50 mg/1 
20 mg/1
300 mg/1 
10 mg/1 
15 mg/1 
20 mg/1 
50 mg/1 
50 mg/1 
4 0 mg/1 
15 mg/1 
15 mg/1
200 mg/1 
30 mg/1 
2 0 mg/1
5.0 mg/1 
20 mg/1 
20 mg/1
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VI T A M I N S :
Biotin
D-Ca Pantothenate 
Choline Chloride 
Folic Acid 
i-Inositol 
Nicotinamide 
Para-aminobenzoic Acid 
Pyridoxine HC1 
Riboflavin 
Thiamine HC1 
Vitamin B]_2
0.2 mg/1 
0.25 mg/1
3.0 mg/1
1.0 mg/1 
35 mg/1
1.0 mg/1
1.0 mg/1
1.0 mg/1 
0.2 mg/1
1.0 mg/1 
0.005 mg/1
The RPMI 1640 medium was supplied as a sterile solution in 
500 ml volumes by the manufacturer, and stored at 4°C.
APPENDIX II
BUFFERS AND STAINS 
Saliva Iona Buffer (SIB)
Sweet, Bt.&l., (1987) FEMS Microbiology Letters, 48, 159-
163.
Source: BDH-British Drug Houses, Laboratory Chemicals,
Poole, England
Composition:
Dipotassium hydrogen orthophosphate 0.5 mM
Potassium dihydrogen orthophosphate 0.5 mM
Potassium chloride 50 mM
Magnesium chloride 0.1 mM
Calcium chloride 1.0 mM
Distilled water 1000 ml
To prepare; dissolve potassium phosphates, potassium chlor­
ide and magnesium chloride in distilled water. The pH was 
adjusted to 7.2 with NaOH using a Kent EIL 3055 pH meter 
(TAIWAN, N.R.O.C). The medium was then dispensed into 100 
ml amounts and sterilized by autoclaving at 121°C for 15 
minutes.
Calcium chloride was prepared separately because it becomes 
turbid and autoelaved at 121QC for 15 minutes. Before use 
calcium chloride was added to the rest of the buffer solu­
tion and sterilised by filtration through a 0.2 (im pore size 
MINISART filter (Sartorius, Ltd., Epsom, Surrey, England).
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Since large quantities of this buffer were needed to carry 
out the different experiments, it was decided to prepare the 
buffer at a 50 times concentrate using the method described 
above. The buffer was stored at room temperature.
Hanks Balanced Salt Solutions (HBSS)
Source: Gibco-Europe Ltd., Paisley Scotland
Composition:
Calcium chloride 0.14 g/1
Potassium chloride 0.40 g/i
Potassium dihydrogen orthophosphate 0.06 g/i
Magnesium sulphate 0.098 g/i
Sodium chloride 8.0 g/i
Disodium hydrogen orthophosphate 0.048 g/i
Glucose 1.0 g/i
The HBSS was supplied as sterile solution in 500 ml volumes 
by the manufacturer, and stored at 4°C.
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Phosphate Buffered Saline (PBS)
Dulbecco's formula (modified) without magnesium and calcium
Source: Flow Laboratories, Rickmansworth, England
Composition: (Supplied as tablets)
Disodium hydrogen orthophosphate 1.15 g/1
Potassium dihydrogen orthophosphate 0.2 g/1
Sodium chloride 8.0 g/1
Potassium chloride 0.2 g/1
One tablet was dissolved per 100 ml of distilled water at 
room temperature and the pH adjusted to 7.2 with NaOH using 
a Kent EIL 3055 pH meter (TAIWAN, N.R.O.C). The buffer was 
then sterilized by autoclaving at 121°C for 15 minutes, and 
stored at room temperature.
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Lysis buffer composition
] B o y u m A. (1968) Journal Clin. Lab. Invest., 2 1 , Suppl., 
91, 31-50.
Source: BDH-British Drug Houses, Laboratory Chemicals,
Poole England
Composition:
Potassium hydrogen carbonate 1.0 g/1
Ammonium chloride 8.2 g/1
EDTA 0.037 g/1
Distilled water 1000 ml
The lysis buffer was prepared by dissolving the above cons­
tituents in distilled water and the solution was then steri­
lized by filtration through a 0.45 p.m Sterifil D-HA filtr­
ation unit (Nihon Millipore, Kogyo K.K., Yonezawa, Japan) 
and stored at 4°C. A fresh solution had to be prepared at 
least once a week to minimize any possible damage to the 
PMNLs.
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Acridine Orange Stain/Buffer
Sources: BDH-British Drug Houses, Laboratory Chemicals,
Poole England, and Hopkin and Williams Ltd., Essex, England
The citric acid-sodium hydroxide buffer was prepared from a 
0.1 M solution of citric acid (BDH, 21 g/1) and 0.1 M solu­
tion of sodium hydroxide (BDH). A buffer with a pH of 3 was 
prepared by mixing 100 ml of the citric acid solution with 
54 ml of the sodium hydroxide solution. At the same time a 
stock solution of 1 % acridine orange (Hopkin and Williams) 
was made in distilled water. One millilitre of the acridine 
orange was then added to 39 ml of the citric acid sodium 
hydroxide buffer to give a final concentration of 0.025 % 
acridine orange. The stain was then filter sterilized 
through a 0.45 flm Sterifil D-HA Filtration unit (Nihon Mill- 
ipore, Kogyo, Japan) to remove any debris. For safety rea­
sons a face mask and disposable gloves were worn when hand­
ling acridine orange. Both buffer and acridine orange were 
stored at 4°C and used up to four weeks.
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